Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Bladder Cancer, January 2011

Free Subscription


Abstracts

Retrieve all available abstracts of the following 1100 articles:
HTML format


 

Single Articles

  1. NAISH JH , McGrath DM, Bains LJ, Passera K, et al
    Comparison of dynamic contrast-enhanced MRI and dynamic contrast-enhanced CT biomarkers in bladder cancer.
    Magn Reson Med. 2011 Mar 24. doi: 10.1002/mrm.22774.
    Abstract     Related articles   

  2. NASTERLACK M , Feil G, Leng G, Pesch B, et al
    [Bladder Cancer Screening with Urine-Based Tumour Markers - Occupational Medical Experience.]
    Aktuelle Urol. 2011;42:128-134.
    Abstract     Related articles   

  3. EISSA S , Swellam M, Amin A, Balbaa ME, et al
    The clinical relevance of urine-based markers for diagnosis of bladder cancer.
    Med Oncol. 2011.
    Abstract     Related articles   

  4. ZHAO Y , Li Y, Wang Q, Wang L, et al
    Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers.
    Mol Cell Biochem. 2011.
    Abstract     Related articles   

  5. DOSHI TV , Doshi JV, Makaryus JN, Makaryus AN, et al
    A Rare Case of Successfully Treated Cardiac Metastasis From Transitional Cell Bladder Cancer.
    Am J Ther. 2010.
    Abstract     Related articles   

  6. TUOMIKOSKI L , Collan J, Keyrilainen J, Visapaa H, et al
    Adaptive radiotherapy in muscle invasive urinary bladder cancer - An effective method to reduce the irradiated bowel volume.
    Radiother Oncol. 2011.
    Abstract     Related articles   

  7. DRAGOESCU O , Tomescu P, Panus A, Enache M, et al
    Photodynamic diagnosis of non-muscle invasive bladder cancer using hexaminolevulinic acid.
    Rom J Morphol Embryol. 2011;52:123-7.
    Abstract     Related articles   

  8. NUCKOLS JR , Beane Freeman LE, Lubin JH, Airola MS, et al
    Estimating Water Supply Arsenic Levels in the New England Bladder Cancer Study.
    Environ Health Perspect. 2011.
    Abstract     Related articles   

  9. JANANE A , Hajji F, Ismail TO, Elondo JC, et al
    Evaluation of HER2 protein overexpression in non-muscle invasive bladder cancer with emphasis on tumour grade and recurrence.
    Actas Urol Esp. 2011.
    Abstract     Related articles   

  10. TSANG M , Chun YW, Im Y, Khang D, et al
    Effects of increasing carbon nanofiber density in polyurethane composites for inhibiting bladder cancer cell functions.
    Tissue Eng Part A. 2011.
    Abstract     Related articles   

  11. SAMRA T , Bala I, Chopra K, Podder S, et al
    Effect of intravenous ondansetron on sensory and motor block after spinal anaesthesia with hyperbaric bupivacaine.
    Anaesth Intensive Care. 2011;39:65-8.
    Abstract     Related articles   

  12. PANER GP , Zehnder P, Amin AM, Husain AN, et al
    Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
    Adv Anat Pathol. 2011;18:79-89.
    Abstract     Related articles   

  13. YE L , Letchford K, Heller M, Liggins R, et al
    Synthesis and characterization of carboxylic acid conjugated, hydrophobically derivatized, hyperbranched polyglycerols as nanoparticulate drug carriers for cisplatin.
    Biomacromolecules. 2011;12:145-55.
    Abstract     Related articles   

  14. BANAZ-YASAR F , Steffen G, Hauschild J, Bongartz BM, et al
    LINE-1 retrotransposition events affect endothelial proliferation and migration.
    Histochem Cell Biol. 2010;134:581-9.
    Abstract     Related articles   

  15. CHUNG KT , Gadupudi GS
    Possible roles of excess tryptophan metabolites in cancer.
    Environ Mol Mutagen. 2011;52:81-104.
    Abstract     Related articles   

  16. LIN HY , Wang SZ, Chen JX, Chen LW, et al
    The prognostic value of hydronephrosis in bladder cancer treated by radical cystectomy.
    Urologia. 2011;78:17-21.
    Abstract     Related articles   

  17. ONGAY S , Martin-Alvarez PJ, Neususs C, de Frutos M, et al
    Statistical evaluation of CZE-UV and CZE-ESI-MS data of intact alpha-1-acid glycoprotein isoforms for their use as potential biomarkers in bladder cancer.
    Proteomics Clin Appl. 2011;5.
    Abstract     Related articles   

  18. LEWIS JD , Ferrara A, Peng T, Hedderson M, et al
    Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study.
    Diabetes Care. 2011;34:916-22.
    Abstract     Related articles   

  19. CONTRERAS GUTIERREZ J , Frutos Esteban L, Navarro Fernandez JL, Claver Valderas MA, et al
    Positron emission tomography using (18)F-fluorodeoxy-glucose in a case of bladder cancer with a solitary cutaneous metastasis.
    Rev Esp Med Nucl. 2011.
    Abstract     Related articles   

  20. PANDITH AA , Shah Z, Rasool R, Dil-Afroze, et al
    Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Tumori. 2010;96:993-8.
    Abstract     Related articles   

  21. MIYATA Y , Sakai H
    [Update of treatment for bladder neoplasm].
    Gan To Kagaku Ryoho. 2011;38:43-7.
    Abstract     Related articles   

  22. SCHETTINI M
    Orthotopic neo- bladder in women.
    Arch Ital Urol Androl. 2010;82:170-2.
    Abstract     Related articles   

  23. CHEN YB , Epstein JI
    Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clinicopathologic study of 6 cases.
    Am J Surg Pathol. 2011;35:442-6.
    Abstract     Related articles   

  24. GOTO T , Shimizu Y, Inoue T, Okubo K, et al
    [A case of bladder paraganglioma managed by transurethral approach, using holmium laser].
    Hinyokika Kiyo. 2010;56:705-7.
    Abstract     Related articles   

  25. WU Z , Owens C, Chandra N, Popovic K, et al
    RalBP1 is necessary for metastasis of human cancer cell lines.
    Neoplasia. 2010;12:1003-12.
    Abstract     Related articles   

  26. TIWARI P , Tripathi A, Vijay M, Mitra B, et al
    Inverted papilloma of the urinary bladder: Rigorous surveillance needed? An Indian experience.
    Indian J Cancer. 2010;47:418-23.
    Abstract     Related articles   

  27. YOUSSEF RF , Shariat SF, Kapur P, Kabbani W, et al
    Expression of cell cycle-related molecular markers in patients treated with radical cystectomy for squamous cell carcinoma of the bladder.
    Hum Pathol. 2011;42:347-55.
    Abstract     Related articles   

  28. RINK M , Minner S, Tsourlakis MC, Wilczak W, et al
    [Primary diffuse neurofibroma of the urinary bladder: a rare case report and review of the literature].
    Urologe A. 2010;49:1398-400.
    Abstract     Related articles   

  29. ARORA N , Nair S, Srivastava A
    T/NK-cell post-transplant lymphoproliferative disorder of the urinary bladder: a case report.
    J Clin Pathol. 2010;63:1042.
    Abstract     Related articles   

  30. KNUCHEL-CLARKE R , Dahl E, Gaisa NT, Schwamborn K, et al
    [Current knowledge in molecular pathology of urothelial cancer].
    Pathologe. 2010;31 Suppl 2:234-8.
    Abstract     Related articles   

  31. NAWROTH R , Hartmann A, Wild P, Lehmann J, et al
    [EMMPRIN (CD147). A prognostic and potentially therapeutic marker in urothelial cancer].
    Pathologe. 2010;31 Suppl 2:251-4.
    Abstract     Related articles   

  32. BLACK P
    The Canadian Bladder Cancer Network: efforts to improve patient care.
    Can Urol Assoc J. 2011;5:88.
    Abstract     Related articles   

  33. CHALASANI V , Kassouf W, Chin JL, Fradet Y, et al
    Radical cystectomy for the treatment of T1 bladder cancer: the Canadian Bladder Cancer Network experience.
    Can Urol Assoc J. 2011;5:83-7.
    Abstract     Related articles   

  34. SIEMENS DR
    Highlights from the canadian bladder cancer network.
    Can Urol Assoc J. 2011;5:77.
    Abstract     Related articles   

  35. FREEMAN KS
    Disinfection by-products and bladder cancer. Common genetic variants may confer increased risk.
    Environ Health Perspect. 2010;118:A491.
    Abstract     Related articles   

  36. HAN Y , Chen J, Zhao X, Liang C, et al
    MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing.
    PLoS One. 2011;6:e18286.
    Abstract     Related articles   

  37. JOSHI A , Preslan E
    Risk Factors for Bladder Cancer: Challenges of Conducting a Literature Search Using PubMed.
    Perspect Health Inf Manag. 2011;8:1e.
    Abstract     Related articles   

  38. HU H , Zhang XP, Wang YL, Chua CW, et al
    Identification of a novel function of Id-1 in mediating the anticancer responses of SAMC, a water-soluble garlic derivative, in human bladder cancer cells.
    Mol Med Report. 2011;4:9-16.
    Abstract     Related articles   

  39. FENNER A
    Bladder cancer: Smoking does not affect outcome of BCG therapy.
    Nat Rev Urol. 2011;8:64.
    Abstract     Related articles   

  40. RAY K
    Bladder cancer: Neoadjuvant MVAC chemotherapy best for 'mixed' tumors?
    Nat Rev Urol. 2011;8:64.
    Abstract     Related articles   

  41. GU J , Chen M, Shete S, Amos CI, et al
    A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer.
    Cancer Prev Res (Phila). 2011;4:514-21.
    Abstract     Related articles   

  42. CHANG S , Yang Y, Zhang Z
    Single nucleotide polymorphisms in genes of one-carbon metabolism pathway and bladder cancer survival.
    Cancer Epidemiol Biomarkers Prev. 2011;20:716-7.
    Abstract     Related articles   

  43. AJIT D , Dighe S, Desai S
    Has urine cytology a role to play in the era of fluorescence in situ hybridization?
    Acta Cytol. 2010;54:1118-22.
    Abstract     Related articles   

  44. CEYLAN K , Taken K, Gecit I, Pirincci N, et al
    Comparison of cystoscopy with diffusion-weighted magnetic resonance images used in the diagnosis and follow-up of patients with bladder tumors.
    Asian Pac J Cancer Prev. 2010;11:1001-4.
    Abstract     Related articles   

  45. SONG T , Xia W, Shao N, Zhang X, et al
    Differential miRNA expression profiles in bladder urothelial carcinomas.
    Asian Pac J Cancer Prev. 2010;11:905-11.
    Abstract     Related articles   

  46. ERGUN O , Kosar A, Ciris IM
    Urethral recurrence of bladder tumor occurring as a perineal mass 2 years after transurethral resection: a case report.
    Kaohsiung J Med Sci. 2010;26:624-7.
    Abstract     Related articles   

  47. YUN HK , Yun SI, Lee YH, Kang KM, et al
    Lymphoepithelioma-like carcinoma of the urinary bladder.
    J Korean Med Sci. 2010;25:1672-5.
    Abstract     Related articles   

  48. SHELLEY M , Cleves A, Wilt TJ, Mason M, et al
    Gemcitabine for unresectable, locally advanced or metastatic bladder cancer.
    Cochrane Database Syst Rev. 2011;4:CD008976.
    Abstract     Related articles   

  49. SCHODER H , Ong SC, Reuter VE, Cai S, et al
    Initial Results with (11)C-Acetate Positron Emission Tomography/Computed Tomography (PET/CT) in the Staging of Urinary Bladder Cancer.
    Mol Imaging Biol. 2011.
    Abstract     Related articles   

  50. SZARVAS T , Vom Dorp F, Ergun S, Rubben H, et al
    Matrix metalloproteinases and their clinical relevance in urinary bladder cancer.
    Nat Rev Urol. 2011.
    Abstract     Related articles   

  51. OH JJ , Ji SH, Choi DK, Gong IH, et al
    A Six-Week Course of Bacillus Calmette-Guerin Prophylaxis Is Insufficient to Prevent Tumor Recurrence in Nonmuscle Invasive Bladder Cancer with Strong-Positive Expression of p53.
    Oncology. 2011;79.
    Abstract     Related articles   

  52. BRINKMAN MT , Kellen E, Zeegers MP, van Dongen MC, et al
    Validation of the immidiet food frequency questionnaire in an adult Belgian population: a report from the Belgian case-control study on bladder cancer risk.
    Acta Clin Belg. 2011;66:18-25.
    Abstract     Related articles   

  53. ZARAVINOS A , Lambrou GI, Boulalas I, Delakas D, et al
    Identification of common differentially expressed genes in urinary bladder cancer.
    PLoS One. 2011;6:e18135.
    Abstract     Related articles   

  54. ZARAVINOS A , Lambrou GI, Volanis D, Delakas D, et al
    Spotlight on differentially expressed genes in urinary bladder cancer.
    PLoS One. 2011;6:e18255.
    Abstract     Related articles   

  55. YANG H , Kim C, Kim MJ, Schwendener RA, et al
    Soluble Vascular Endothelial Growth Factor Receptor-3 Suppresses Lymphangiogenesis and Lymphatic Metastasis in Bladder Cancer.
    Mol Cancer. 2011;10:36.
    Abstract     Related articles   

  56. PILLAI R , Wang D, Mayer EK, Abel P, et al
    Do Standardised Prognostic Algorithms Reflect Local Practice? Application of EORTC Risk Tables for Non-Muscle Invasive (pTa/pT1) Bladder Cancer Recurrence and Progression in a Local Cohort.
    ScientificWorldJournal. 2011;11:751-9.
    Abstract     Related articles   

  57. ZHANG H , Jiang H, Wang W, Gong J, et al
    Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.
    Urol Oncol. 2011.
    Abstract     Related articles   

  58. METWALLY NS , Ali SA, Mohamed AM, Khaled HM, et al
    Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients.
    Cancer Cell Int. 2011;11:8.
    Abstract     Related articles   

  59. LIU T , Li L, Yang W, Jia H, et al
    iASPP is important for bladder cancer cell proliferation.
    Oncol Res. 2011;19.
    Abstract     Related articles   

  60. DILL AL , Eberlin LS, Costa AB, Zheng C, et al
    Multivariate statistical identification of human bladder carcinomas using ambient ionization imaging mass spectrometry.
    Chemistry. 2011;17:2897-902.
    Abstract     Related articles   

  61. SATO K , Awasaki Y, Kandori H, Tanakamaru ZY, et al
    Suppressive effects of acid-forming diet against the tumorigenic potential of pioglitazone hydrochloride in the urinary bladder of male rats.
    Toxicol Appl Pharmacol. 2011;251:234-44.
    Abstract     Related articles   

  62. LI Z , Qi F, Miao J, Zu X, et al
    Vascular endothelial growth factor-C associated with computed tomography used in the diagnosis of lymph node metastasis of bladder carcinoma.
    Arch Med Res. 2010;41:606-10.
    Abstract     Related articles   

  63. RODRIGUES G , Winquist E
    Open clinical uro-oncology trials in Canada.
    Can J Urol. 2010;17:5494-9.
    Abstract     Related articles   

  64. GUZZO TJ , Resnick MJ, Canter DJ, Balandra A, et al
    Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy.
    Can J Urol. 2010;17:5465-71.
    Abstract     Related articles   

  65. RODRIGUES G , Yartsev S, Bauman G
    Application of helical tomotherapy in genitourinary malignancies.
    Can J Urol. 2010;17:5453-8.
    Abstract     Related articles   

  66. YAMADA Y , Enokida H, Kojima S, Kawakami K, et al
    MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology.
    Cancer Sci. 2011;102:522-9.
    Abstract     Related articles   

  67. BUBENDORF L
    Fluorescence in situ hybridization in the diagnosis of urothelial carcinoma.
    Ann Pathol. 2010;30.
    Abstract     Related articles   

  68. VORDOS D
    [Photodynamic diagnosis (cystoscopy with hexaminolevulinate) in the surveillance of urothelial lesions managed with conservative treatment].
    Ann Pathol. 2010;30.
    Abstract     Related articles   

  69. PIATON E , Vordos D, Collin-Chavagnac D, Bubendorf L, et al
    [Urinary cytology and molecular markers].
    Ann Pathol. 2010;30.
    Abstract     Related articles   

  70. RESTA LP , Pili R, Eisenberger MA, Spitz A, et al
    A phase I study of OSI-461 in combination with mitoxantrone in patients with advanced solid tumors potentially responsive to mitoxantrone.
    Cancer Chemother Pharmacol. 2011;67:431-8.
    Abstract     Related articles   

  71. XU XS , Wang L, Abrams J, Wang G, et al
    Histone deacetylases (HDACs) in XPC gene silencing and bladder cancer.
    J Hematol Oncol. 2011;4:17.
    Abstract     Related articles   

  72. YUAN X , Bao S, Yang W, Ye Z, et al
    Effect of silencing LRIG3 gene on the proliferation and apoptosis of bladder cancer T24 cells.
    J Huazhong Univ Sci Technolog Med Sci. 2011;31:220-5.
    Abstract     Related articles   

  73. LI F , Ye Z, Yang W
    Evaluation of tumor formation of three bladder cancer cell lines in nude mice.
    J Huazhong Univ Sci Technolog Med Sci. 2011;31:210-4.
    Abstract     Related articles   

  74. ABD EL-MAQSOUD NM , Tawfiek ER
    Loss of Maspin Expression in Bladder Cancer: Its Relationship with p53 and Clinicopathological Parameters.
    J Egypt Natl Canc Inst. 2010;22:1-12.
    Abstract     Related articles   

  75. DAVIS-DAO CA , Delellis Henderson K, Sullivan-Halley J, Ma H, et al
    Lower Risk in Parous Women Suggests Hormonal Factors Important in Bladder Cancer Etiology.
    Cancer Epidemiol Biomarkers Prev. 2011.
    Abstract     Related articles   

  76. HERR HW
    Intravesical bacille Calmette-Guerin in patients with asymptomatic bacteriuria.
    JAMA. 2011;305:1413-4.
    Abstract     Related articles   

  77. ZHANG G , Zeng X, Li C, Li J, et al
    Inhibition of urinary bladder carcinogenesis by aqueous extract of sclerotia of Polyporus umbellatus fries and polyporus polysaccharide.
    Am J Chin Med. 2011;39:135-44.
    Abstract     Related articles   

  78. MARTIN TA , Mason MD, Jiang WG
    Tight junctions in cancer metastasis.
    Front Biosci. 2011;16:898-936.
    Abstract     Related articles   

  79. SHIGEHARA K , Sasagawa T, Doorbar J, Kawaguchi S, et al
    Etiological role of human papillomavirus infection for inverted papilloma of the bladder.
    J Med Virol. 2011;83:277-85.
    Abstract     Related articles   

  80. CHAO MP , Jaiswal S, Weissman-Tsukamoto R, Alizadeh AA, et al
    Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47.
    Sci Transl Med. 2010;2:63ra94.
    Abstract     Related articles   

  81. MO ML , Chen Z, Li J, Li HL, et al
    Use of serum circulating CCNB2 in cancer surveillance.
    Int J Biol Markers. 2010;25:236-42.
    Abstract     Related articles   

  82. LIN KW , Huang AM, Tu HY, Lee LY, et al
    Xanthine oxidase inhibitory triterpenoid and phloroglucinol from guttiferaceous plants inhibit growth and induced apoptosis in human NTUB1 cells through a ROS-dependent mechanism.
    J Agric Food Chem. 2011;59:407-14.
    Abstract     Related articles   

  83. ROELANTS M , Van Cleynenbreugel B, Lerut E, Van Poppel H, et al
    Human serum albumin as key mediator of the differential accumulation of hypericin in normal urothelial cell spheroids versus urothelial cell carcinoma spheroids.
    Photochem Photobiol Sci. 2011;10:151-9.
    Abstract     Related articles   

  84. CHEN JP , Leu YL, Fang CL, Chen CH, et al
    Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin.
    J Pharm Sci. 2011;100:655-66.
    Abstract     Related articles   

  85. AHMAD MR , Pervaiz MK
    Risk factors of urinary bladder cancer in Peshawar region of Khyber Pukhtoonkhawa.
    J Ayub Med Coll Abbottabad. 2010;22:160-3.
    Abstract     Related articles   

  86. KITAMURA H , Masumori N, Tsukamoto T
    Role of lymph node dissection in management of bladder cancer.
    Int J Clin Oncol. 2011.
    Abstract     Related articles   

  87. OBATA J , Kikuchi E, Kaneko G, Miyajima A, et al
    [Recurrence of bladder cancer in remnant urethra and inguinal lymph node metastasis nine years after total cystectomy: a case report].
    Nippon Hinyokika Gakkai Zasshi. 2011;102:34-8.
    Abstract     Related articles   

  88. ABE T , Yoshioka T, Sato M, Mori N, et al
    [Bladder preservation using chemoradiation therapy for locally invasive bladder cancer].
    Nippon Hinyokika Gakkai Zasshi. 2011;102:14-22.
    Abstract     Related articles   

  89. LIU Z , Li X, Simoneau AR, Jafari M, et al
    Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy.
    Mol Carcinog. 2011 Apr 22. doi: 10.1002/mc.20780.
    Abstract     Related articles   

  90. NANDA MS , Shah ZA, Sameer AS, Syeed N, et al
    TP53 - Molecular Soldier's Mutations in Bladder Cancer in the Kashmiri Population.
    Asian Pac J Cancer Prev. 2011;12:67-72.
    Abstract     Related articles   

  91. LEE R , Wen A, Berube C
    Moxifloxacin-acetaminophen-warfarin interaction during bacille Calmette-Guerin treatment for bladder cancer.
    Am J Health Syst Pharm. 2011;68:814-7.
    Abstract     Related articles   

  92. PICCINNI C , Motola D, Marchesini G, Poluzzi E, et al
    Assessing the Association of Pioglitazone Use and Bladder Cancer Through Drug Adverse Event Reporting.
    Diabetes Care. 2011.
    Abstract     Related articles   

  93. PANDITH AA , Shah ZA, Khan NP, Baba KM, et al
    HRAS T81C polymorphism modulates risk of urinary bladder cancer and predicts advanced tumors in ethnic Kashmiri population.
    Urol Oncol. 2011.
    Abstract     Related articles   

  94. YILDIRIM-BAYLAN M , Erdogmus N, Cureoglu S, Paparella MM, et al
    Bladder Cancer Metastases to the Temporal Bone.
    Otol Neurotol. 2011.
    Abstract     Related articles   

  95. WERNER MK , Aschoff P, Reimold M, Pfannenberg C, et al
    FDG-PET/CT-guided biopsy of bone metastases sets a new course in patient management after extensive imaging and multiple futile biopsies.
    Br J Radiol. 2011;84:e65-7.
    Abstract     Related articles   

  96. SMITH SC , Havaleshko DM, Moon K, Baras AS, et al
    Use of yeast chemigenomics and COXEN informatics in preclinical evaluation of anticancer agents.
    Neoplasia. 2011;13:72-80.
    Abstract     Related articles   

  97. HAYAKAWA N , Kikuchi E, Mikami S, Matsumoto K, et al
    The clinical impact of the classification of carcinoma in situ on tumor recurrence and their clinical course in patients with bladder tumor.
    Jpn J Clin Oncol. 2011;41:424-9.
    Abstract     Related articles   

  98. LIN T , Huang J, Han J, Xu K, et al
    Hybrid laparoscopic endoscopic single-site surgery for radical cystoprostatectomy and orthotopic ileal neobladder: an initial experience of 12 cases.
    J Endourol. 2011;25:57-63.
    Abstract     Related articles   

  99. KRAMER MW , Bach T, Wolters M, Imkamp F, et al
    Current evidence for transurethral laser therapy of non-muscle invasive bladder cancer.
    World J Urol. 2011.
    Abstract     Related articles   

  100. YATES DR , Roupret M
    Contemporary management of patients with high-risk non-muscle-invasive bladder cancer who fail intravesical BCG therapy.
    World J Urol. 2011.
    Abstract     Related articles   

  101. TSENG CH
    Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan.
    Diabetologia. 2011.
    Abstract     Related articles   

  102. VILENSKY D , Lawrentschuk N, Hersey K, Fleshner NE, et al
    A smoking cessation program as a resource for bladder cancer patients.
    Can Urol Assoc J. 2011 May 1:1-7. doi: 10.5489/cuaj.10070.
    Abstract     Related articles   

  103. OZDEMIR NO , Turk NS, Duzcan E
    IMP3 expression in urothelial carcinomas of the urinary bladder.
    Turk Patoloji Derg. 2011;27:31-7.
    Abstract     Related articles   

  104. TURCO P , Houssami N, Bulgaresi P, Troni GM, et al
    Is conventional urinary cytology still reliable for diagnosis of primary bladder carcinoma? Accuracy based on data linkage of a consecutive clinical series and cancer registry.
    Acta Cytol. 2011;55:193-6.
    Abstract     Related articles   

  105. BUBENDORF L
    Multiprobe fluorescence in situ hybridization (UroVysion) for the detection of urothelial carcinoma - FISHing for the right catch.
    Acta Cytol. 2011;55:113-9.
    Abstract     Related articles   

  106. IRIE T , Takeda A, Takada R, Saito Y, et al
    [A case of granulocyte colony-stimulating factor-producing adenosquamous carcinoma of the liver accompanied by an adenocarcinoma of the ascending colon and urothelial carcinoma of the urinary bladder].
    Nippon Shokakibyo Gakkai Zasshi. 2011;108:259-66.
    Abstract     Related articles   

  107. DE UNA-ALVAREZ J , Amorim AP
    A semiparametric estimator of the bivariate distribution function for censored gap times.
    Biom J. 2011;53:113-27.
    Abstract     Related articles   

  108. SCHETTGEN T , Heinrich K, Kraus T, Gube M, et al
    Determination of 2,5-toluylenediamine (2,5-TDA) and aromatic amines in urine after personal application of hair dyes: kinetics and doses.
    Arch Toxicol. 2011;85:127-33.
    Abstract     Related articles   

  109. SATYAM A , Singh P, Badjatia N, Seth A, et al
    A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder.
    Urol Oncol. 2011;29:58-65.
    Abstract     Related articles   

  110. TUYGUN C , Kankaya D, Imamoglu A, Sertcelik A, et al
    Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: a comparative analysis of clinicopathological features and survival outcomes according to receptor expression.
    Urol Oncol. 2011;29:43-51.
    Abstract     Related articles   

  111. OZGUR E , Heidenreich A, Dagtekin O, Engelmann U, et al
    Distribution of EphB4 and EphrinB2 in normal and malignant urogenital tissue.
    Urol Oncol. 2011;29:78-84.
    Abstract     Related articles   

  112. ZILBERMAN DE , Safran M, Paz N, Amariglio N, et al
    Does RNA editing play a role in the development of urinary bladder cancer?
    Urol Oncol. 2011;29:21-6.
    Abstract     Related articles   

  113. PLJESA-ERCEGOVAC M , Savic-Radojevic A, Dragicevic D, Mimic-Oka J, et al
    Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways.
    Urol Oncol. 2011;29:70-7.
    Abstract     Related articles   

  114. JIANG Z , Li C, Wang X
    Glutathione S-transferase M1 polymorphism and bladder cancer risk: a meta-analysis involving 33 studies.
    Exp Biol Med (Maywood). 2011.
    Abstract     Related articles   

  115. LELIVELD AM , Bastiaannet E, Doornweerd BH, Schaapveld M, et al
    High risk bladder cancer: current management and survival.
    Int Braz J Urol. 2011;37:203-12.
    Abstract     Related articles   

  116. MATSUMOTO K , Kikuchi E, Horinaga M, Takeda T, et al
    Intravesical Interleukin-15 Gene Therapy in an Orthotopic Bladder Cancer Model.
    Hum Gene Ther. 2011.
    Abstract     Related articles   

  117. WOLTERS M , Kramer MW, Becker JU, Christgen M, et al
    Tm:YAG laser en bloc mucosectomy for accurate staging of primary bladder cancer: early experience.
    World J Urol. 2011.
    Abstract     Related articles   

  118. OSMAN MM , Altinyay ME, Abdelmalik AG, Brickman TM, et al
    FDG PET/CT Incidental Diagnosis of a Synchronous Bladder Cancer as a Fourth Malignancy in a Patient With Head and Neck Cancer.
    Clin Nucl Med. 2011;36:496-7.
    Abstract     Related articles   

  119. SCOSYREV E , Wu G, Golijanin D, Messing E, et al
    Non-bladder cancer mortality in patients with urothelial cancer of the bladder.
    Urol Oncol. 2011.
    Abstract     Related articles   

  120. NOGUCHI S , Mori T, Hoshino Y, Maruo K, et al
    MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells.
    Cancer Lett. 2011.
    Abstract     Related articles   

  121. NAMDARIAN B , Wong E, Galea R, Pedersen J, et al
    Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers.
    Urol Oncol. 2011.
    Abstract     Related articles   

  122. YAN K , Zhang C, Feng J, Hou L, et al
    Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells.
    Eur J Pharmacol. 2011.
    Abstract     Related articles   

  123. YANG D , Wang H, Wang J, Zhang C, et al
    Establishment of a Fluorescent Implantation Metastasis Model of Bladder Cancer and Real-time Microscopic Detection in Nude Mice.
    Asian Pac J Cancer Prev. 2011;12:393-6.
    Abstract     Related articles   

  124. LEE W
    Urachal adenocarcinoma metastatic to the ovaries resembling primary ovarian mucinous carcinoma: a case report with the immunohistochemical study.
    Int J Clin Exp Pathol. 2010;4:118-23.
    Abstract     Related articles   

  125. YAN JA , Xiao H, Ji HX, Shen WH, et al
    Cathepsin L is associated with proliferation and clinical outcome of urothelial carcinoma of the bladder.
    J Int Med Res. 2010;38:1913-22.
    Abstract     Related articles   

  126. HUSILLOS ALONSO A , Subira Rios D, Molina Escudero R, Hernandez Fernandez C, et al
    Villous adenoma in augmentation colocystoplasty asociated to infiltrating urotelial cancer in bladder remanent.
    Arch Esp Urol. 2010;63:876-9.
    Abstract     Related articles   

  127. DRECHSLER A , Kirch W
    [Urinary bladder tuberculosis and bacillus calmette-guerin instillation: reduced efficacy of bisoprolol in hypertension].
    Aktuelle Urol. 2010;41:372-4.
    Abstract     Related articles   

  128. GU SY , Yong YS, Wang YH, Du YJ, et al
    [The application of fluorescence in situ hybridization and automated image cytometry in the diagnosis of urothelial carcinoma of bladder].
    Zhonghua Wai Ke Za Zhi. 2010;48:933-6.
    Abstract     Related articles   

  129. GIULIANI A , Galati G, Demoro M, Scimo M, et al
    Endoluminal metastasis of colon cancer to the urinary bladder via the ureter: report of a case.
    Surg Today. 2010;40:1093-6.
    Abstract     Related articles   

  130. DRUDI FM , Cantisani V, Liberatore M, Iori F, et al
    Role of low-mechanical index CEUS in the differentiation between low and high grade bladder carcinoma: a pilot study.
    Ultraschall Med. 2010;31:589-95.
    Abstract     Related articles   

  131. KURAHASHI N , Inoue M, Iwasaki M, Sasazuki S, et al
    Coffee, green tea, and caffeine consumption and subsequent risk of bladder cancer in relation to smoking status: a prospective study in Japan.
    Cancer Sci. 2009;100:294-91.
    Abstract     Related articles   

  132. RAJESH A , Sokhi H, Fung R, Mulcahy KA, et al
    Role of whole-body staging computed tomographic scans for detecting distant metastases in patients with bladder cancer.
    J Comput Assist Tomogr. 2011;35:402-5.
    Abstract     Related articles   

  133. MATSUMURA N , Hara I
    [The Prognostic Significance of Human Equilibrative Nucleoside Transporter1 (hENT1) Expression in Metastatic Bladder Cancer Patients Treated with Gemcitabine-Cisplatin Based Combination Chemotherapy.]
    Hinyokika Kiyo. 2011;57:157-161.
    Abstract     Related articles   

  134. GOERLITZ DS , El Daly M, Abdel-Hamid M, Saleh D, et al
    GSTM1, GSTT1 Null Variants and GPX1 Single Nucleotide Polymorphism Are Not Associated With Bladder Cancer Risk in Egypt.
    Cancer Epidemiol Biomarkers Prev. 2011.
    Abstract     Related articles   

  135. CHUNG W , Bondaruk J, Jelinek J, Lotan Y, et al
    Detection of bladder cancer using novel DNA methylation biomarkers in urine sediments.
    Cancer Epidemiol Biomarkers Prev. 2011.
    Abstract     Related articles   

  136. SHANG PF , Kwong J, Wang ZP, Tian J, et al
    Intravesical Bacillus Calmette-Guerin versus epirubicin for Ta and T1 bladder cancer.
    Cochrane Database Syst Rev. 2011;5:CD006885.
    Abstract     Related articles   


  137. Bladder cancer: men at risk.
    Harv Mens Health Watch. 2011;15:1-5.
    Abstract     Related articles   

  138. ALSINNAWI M , Quinlan M, Brady A, Khan N, et al
    An unusual pelvic mass: bladder lymphoma.
    JBR-BTR. 2011;94:40.
    Abstract     Related articles   


  139. Vinflunine.
    Prescrire Int. 2011;20:11-3.
    Abstract     Related articles   

  140. WILLIAMSON SR , Zhang S, Lopez-Beltran A, Shah RB, et al
    Lymphoepithelioma-like carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, and molecular features.
    Am J Surg Pathol. 2011;35:474-83.
    Abstract     Related articles   

  141. WON KY , Lee CH, Kim YW, Park YK, et al
    Primary giant-cell-rich osteosarcoma of the urinary bladder: usefulness of osteocalcin and osteonectin immunohistochemical staining and literature review.
    Pathology. 2011;43:161-4.
    Abstract     Related articles   

  142. YANG GL , Zhang LH, Bo JJ, Chen HG, et al
    UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer.
    Med Oncol. 2011.
    Abstract     Related articles   

  143. KITAMURA H , Takei F, Nishida S, Muranaka T, et al
    Lymph node metastasis mapping in extended lymphadenectomy to the level of the inferior mesenteric artery for bladder cancer.
    Int J Clin Oncol. 2011.
    Abstract     Related articles   

  144. WANG C , Jiang H
    Meat intake and risk of bladder cancer: a meta-analysis.
    Med Oncol. 2011.
    Abstract     Related articles   

  145. RESNICK MJ , Guzzo TJ
    Bladder cancer: Improvements in clinical staging of muscle-invasive bladder cancer.
    Nat Rev Urol. 2011.
    Abstract     Related articles   

  146. YU M , Du Z, Xue J, Wang K, et al
    [The study of absorbable sustained-release implants and animal experiments to prevent recurrence of bladder cancer].
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011;28:322-5.
    Abstract     Related articles   

  147. TOMASZEWSKI JJ , Larson JA, Smaldone MC, Hayn MH, et al
    Management of Bladder Cancer following Solid Organ Transplantation.
    Adv Urol. 2011;2011:256985.
    Abstract     Related articles   

  148. GAO J , Zhu J, Li HY, Pan XY, et al
    Small interfering RNA targeting integrin-linked kinase inhibited the growth and induced apoptosis in human bladder cancer cells.
    Int J Biochem Cell Biol. 2011.
    Abstract     Related articles   

  149. CHEN PC , Tsai MH, Yip SK, Jou YC, et al
    Distinct DNA methylation epigenotypes in bladder cancer from different Chinese sub-populations and its implication in cancer detection using voided urine.
    BMC Med Genomics. 2011;4:45.
    Abstract     Related articles   

  150. ARIANAYAGAM R , Arianayagam M, Rashid P
    Bladder cancer - current management.
    Aust Fam Physician. 2011;40:209-13.
    Abstract     Related articles   

  151. KOUKOURAKIS G , Kouloulias V, Zacharias G, Sotiropoulou-Lontou A, et al
    Therapeutic interventions targeting organ preservation in muscle-invasive bladder cancer: a review.
    Clin Transl Oncol. 2011;13:315-21.
    Abstract     Related articles   

  152. DE NUNZIO C , Carbone A, Albisinni S, Alpi G, et al
    Long-term experience with early single Mitomycin C instillations in patients with low-risk non-muscle-invasive bladder cancer: prospective, single-centre randomised trial.
    World J Urol. 2011.
    Abstract     Related articles   

  153. SHIMADA K , Anai S, Marco DA, Fujimoto K, et al
    Cyclooxygenase 2-dependent and independent activation of Akt through casein kinase 2alpha contributes to human bladder cancer cell survival.
    BMC Urol. 2011;11:8.
    Abstract     Related articles   

  154. SUMIYOSHI T , Utsunomiya N, Segawa T, Muguruma K, et al
    [Compartment syndrome in bilateral lower legs after total cystectomy: a case report].
    Hinyokika Kiyo. 2011;57:87-90.
    Abstract     Related articles   

  155. MONCHARMONT C , Auberdiac P, Melis A, Afqir S, et al
    [Cisplatin or carboplatin, that is the question].
    Bull Cancer. 2011;98:164-75.
    Abstract     Related articles   

  156. ROUISSI K , Stambouli N, Marrakchi R, Slama MR, et al
    Smoking and polymorphisms in folate metabolizing genes and their effects on the histological stage and grade for bladder tumors.
    Bull Cancer. 2011;98:E1-10.
    Abstract     Related articles   

  157. PORTER MP , Gore JL, Wright JL
    Hospital volume and 90-day mortality risk after radical cystectomy: a population-based cohort study.
    World J Urol. 2011;29:73-7.
    Abstract     Related articles   

  158. ELLIOTT SP , Malaeb BS
    Long-term urinary adverse effects of pelvic radiotherapy.
    World J Urol. 2011;29:35-41.
    Abstract     Related articles   

  159. KHODAKARAM-TAFTI A , Shirian S, Vesal N, Hadadi Sh, et al
    Lipoma of the urinary bladder in a cat.
    J Comp Pathol. 2011;144.
    Abstract     Related articles   

  160. DENEWER A , Roshdy S, Farouk O, Elnahas W, et al
    Continent catheterizable umbilical low-pressure intestinal pouch with split ileal end seromuscular anti-reflux technique.
    J Surg Res. 2011;166:e129-33.
    Abstract     Related articles   

  161. VANDEPITTE J , Van Cleynenbreugel B, Hettinger K, Van Poppel H, et al
    Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder.
    Cancer Chemother Pharmacol. 2011;67:775-81.
    Abstract     Related articles   

  162. BUNIMOVICH-MENDRAZITSKY S , Goltser Y
    Use of quasi-normal form to examine stability of tumor-free equilibrium in a mathematical model of bcg treatment of bladder cancer.
    Math Biosci Eng. 2011;8:529-47.
    Abstract     Related articles   

  163. PARKER J , Spiess PE
    Current and emerging bladder cancer urinary biomarkers.
    ScientificWorldJournal. 2011;11:1103-12.
    Abstract     Related articles   

  164. BURGUES JP , Conde G, Oliva J, Abascal JM, et al
    Hexaminolevulinate photodynamic diagnosis in non-muscle invasive bladder cancer: experience of the BLUE group.
    Actas Urol Esp. 2011.
    Abstract     Related articles   

  165. TOLAN S , Kong V, Rosewall T, Craig T, et al
    Patient-specific PTV margins in radiotherapy for bladder cancer - A feasibility study using cone beam CT.
    Radiother Oncol. 2011.
    Abstract     Related articles   

  166. MITTAL RD , Gangwar R, Mandal RK, Srivastava P, et al
    Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer.
    Mol Biol Rep. 2011.
    Abstract     Related articles   

  167. HARA T , Nishijima J, Miyachika Y, Yamamoto Y, et al
    Primary cT2 Bladder Cancer: A Good Candidate for Radiotherapy Combined with Cisplatin for Bladder Preservation.
    Jpn J Clin Oncol. 2011.
    Abstract     Related articles   

  168. GARCIA LOZANO T , Aznar Oroval E, Perez Ballestero P, Lorente Alegre P, et al
    [Isolation of Beauveria bassiana in a bronchoalveolar lavage specimen from a patient with bladder cancer.]
    Rev Iberoam Micol. 2011.
    Abstract     Related articles   

  169. ZHENG Y , Izumi K, Yao JL, Miyamoto H, et al
    Androgen up-regulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells.
    Endocr Relat Cancer. 2011.
    Abstract     Related articles   

  170. LI H , Jeong YM, Kim SY, Kim MK, et al
    Arbutin inhibits TCCSUP human bladder cancer cell proliferation via up-regulation of p21.
    Pharmazie. 2011;66:306-9.
    Abstract     Related articles   

  171. BRIERLEY R
    2011 ASCO Genitourinary Cancers Symposium.
    Lancet Oncol. 2011;12:330.
    Abstract     Related articles   

  172. HELLER DS , Kadire B, Cracchiolo B
    Malignant female adnexal tumor of probable Wolffian origin: a case report.
    J Reprod Med. 2011;56.
    Abstract     Related articles   

  173. ONO T , Kushikata T, Tsubo T, Ishihara H, et al
    [A case of asystole following povidone iodine administration].
    Masui. 2011;60:499-501.
    Abstract     Related articles   

  174. BODAREVA NV , Anichkov NM, Komiakov BK
    [Adaptive changes in enteric explants instead of the urinary bladder].
    Arkh Patol. 2011;73:27-9.
    Abstract     Related articles   

  175. TEKNOS D , Baranyai Z, Sinko D, Jakab F, et al
    [Surgical prevention of radiation enteritis: case report and review of literature].
    Magy Seb. 2011;64:85-8.
    Abstract     Related articles   

  176. ABDULLAEV FK , Nikolaev VV, Kulaev VD, Cherkashina EN, et al
    [Urinary bladder hemangiomas in children: experience with endoscopic treatment].
    Urologiia. 2011;:46-9.
    Abstract     Related articles   

  177. MARCONATO L , Zini E, Lindner D, Suslak-Brown L, et al
    Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
    J Am Vet Med Assoc. 2011;238:1004-10.
    Abstract     Related articles   

  178. BOUCHOT O
    [Bladder tumors].
    Rev Prat. 2011;61:111-8.
    Abstract     Related articles   

  179. WU JN , Meyers FJ, Evans CP
    Palliative care in urology.
    Surg Clin North Am. 2011;91:429-44.
    Abstract     Related articles   

  180. SEITZ G , Dantonello TM, Int-Veen C, Blumenstock G, et al
    Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96.
    Pediatr Blood Cancer. 2011;56:718-24.
    Abstract     Related articles   

  181. SANTOS CORTES JA , Grahan J, Soloway MS
    Photodynamic diagnosis in urology: state of the art.
    Arch Esp Urol. 2011;64:18-31.
    Abstract     Related articles   

  182. CHEN YG , Lin TY, Lin GM, Lin JC, et al
    Pulmonary cryptococcus infection after mono-chemotherapy with gemcitabine.
    Respir Care. 2011;56:339-41.
    Abstract     Related articles   

  183. SHARMA VK , Sethy PK, Dogra PN, Singh U, et al
    Primary tuberculosis of glans penis after intravesical Bacillus Calmette Guerin immunotherapy.
    Indian J Dermatol Venereol Leprol. 2011;77:47-50.
    Abstract     Related articles   

  184. SMRKOLJ T , Mihelic M, Sedlar A, Sterle I, et al
    Performance of nuclear matrix protein 22 urine marker and voided urine cytology in the detection of urinary bladder tumors.
    Clin Chem Lab Med. 2011;49:311-6.
    Abstract     Related articles   

  185. LUO S , Lin Y, Zhang W
    Does simultaneous transurethral resection of bladder tumor and prostate affect the recurrence of bladder tumor? A meta-analysis.
    J Endourol. 2011;25:291-6.
    Abstract     Related articles   

  186. VUKOMANOVIC I , Colovic V, Soldatovic I, Hadzi-Djokic J, et al
    Prognostic significance of tumor location in high-grade non-muscle-invasive bladder cancer.
    Med Oncol. 2011.
    Abstract     Related articles   

  187. FAJKOVIC H , Halpern JA, Cha EK, Bahadori A, et al
    Impact of gender on bladder cancer incidence, staging, and prognosis.
    World J Urol. 2011.
    Abstract     Related articles   

  188. ROUISSI K , Ouerhani S, Hamrita B, Bougatef K, et al
    Smoking and Polymorphisms in Xenobiotic Metabolism and DNA Repair Genes are Additive Risk Factors Affecting Bladder Cancer in Northern Tunisia.
    Pathol Oncol Res. 2011.
    Abstract     Related articles   

  189. GERULLIS H , Ecke TH, Janusch B, Arndt C, et al
    Long-term response in advanced bladder cancer involving the use of temsirolimus and vinflunine after platin resistance.
    Anticancer Drugs. 2011.
    Abstract     Related articles   

  190. XIAO XY , Jiang GS, Wang L, Lv L, et al
    Predominant enhancement of apoptosis induced by methyl jasmonate in bladder cancer cells: therapeutic effect of the Antp-conjugated Smac peptide.
    Anticancer Drugs. 2011.
    Abstract     Related articles   

  191. HAMPTON T
    Studies probe role of telomere length in predicting, modulating cancer risk.
    JAMA. 2011;305:2278-9.
    Abstract     Related articles   

  192. SCHMID S , Heiss P
    Embolic occlusion of forearm arteries: percutaneous embolus aspiration via antegrade brachial access.
    Cardiovasc Intervent Radiol. 2011;34 Suppl 2:S312-4.
    Abstract     Related articles   

  193. MICHAELIDES M , Dimarelos V, Stratilati S, Tsitouridis I, et al
    Intramural dissection of the renal collecting system during percutaneous nephrostomy: computed tomography findings of a rare complication.
    Cardiovasc Intervent Radiol. 2011;34 Suppl 2:S324-7.
    Abstract     Related articles   

  194. YOO JO , Lim YC, Kim YM, Ha KS, et al
    Differential cytotoxic responses to low- and high-dose photodynamic therapy in human gastric and bladder cancer cells.
    J Cell Biochem. 2011 Jun 15. doi: 10.1002/jcb.23231.
    Abstract     Related articles   


  195. WITHDRAWN: Neoadjuvant cisplatin for advanced bladder cancer.
    Cochrane Database Syst Rev. 2011;6:CD001426.
    Abstract     Related articles   

  196. SATOH M , Nakano O, Kuwahara M, Ito A, et al
    [A Case of Marked Efficacy of Low-Dose UFT Against Metastatic Bladder Cancer.]
    Gan To Kagaku Ryoho. 2011;38:1029-1033.
    Abstract     Related articles   

  197. AL OTHMAN K , Bazarbashi S, Balaraj K, Al Otaibi M, et al
    Saudi Oncology Society clinical management guidelines for urinary bladder cancer.
    Urol Ann. 2011;3 Suppl:S6-9.
    Abstract     Related articles   

  198. LI N , Yang L, Zhang Y, Zhao P, et al
    Human Papillomavirus Infection and Bladder Cancer Risk: A Meta-analysis.
    J Infect Dis. 2011;204:217-23.
    Abstract     Related articles   

  199. CHEN R , Feng C, Xu Y
    Cyclin-dependent Kinase-associated Protein Cks2 is Associated with Bladder Cancer Progression.
    J Int Med Res. 2011;39:533-40.
    Abstract     Related articles   

  200. PAYTON S
    Bladder cancer: Predicting response to BCG.
    Nat Rev Urol. 2011 Jun 14. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  201. CASEY RG , So AI
    Bladder cancer: Are provider volumes a suitable measure of quality of care?
    Nat Rev Urol. 2011 Jun 14. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  202. BRYAN RT
    Bladder cancer and cancer stem cells: basic science and implications for therapy.
    ScientificWorldJournal. 2011;11:1187-94.
    Abstract     Related articles   

  203. KANEKO G , Kikuchi E, Matsumoto K, Obata J, et al
    Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer.
    Jpn J Clin Oncol. 2011.
    Abstract     Related articles   

  204. CHENG L , Zhang S, Alexander R, Maclennan GT, et al
    Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation.
    Am J Surg Pathol. 2011;35:e34-46.
    Abstract     Related articles   

  205. THOMAS JG , Sethi S, Norby SM
    Chronic thrombotic microangiopathy secondary to chemotherapy for urothelial carcinoma in a patient with a history of Wegener granulomatosis.
    Am J Kidney Dis. 2011;57:799-802.
    Abstract     Related articles   

  206. PIATON E , Advenier AS, Benaim G, Petrucci MD, et al
    [Atypical urothelial cells (AUC): A Bethesda-derived wording applicable to urinary cytopathology].
    Ann Pathol. 2011;31:11-7.
    Abstract     Related articles   

  207. GIBB H , Haver C, Gaylor D, Ramasamy S, et al
    Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic.
    Environ Health Perspect. 2011;119:284-90.
    Abstract     Related articles   

  208. CORTEGGIO A , Florio J, Roperto F, Borzacchiello G, et al
    Expression of gap junction protein connexin 43 in bovine urinary bladder tumours.
    J Comp Pathol. 2011;144:86-90.
    Abstract     Related articles   

  209. WAHAFU W , He ZS, Zhang XY, Zhang CJ, et al
    The nucleosome binding protein NSBP1 is highly expressed in human bladder cancer and promotes the proliferation and invasion of bladder cancer cells.
    Tumour Biol. 2011.
    Abstract     Related articles   

  210. SEILER R , Thalmann GN, Fleischmann A
    MMP-2 and MMP-9 in lymph-node-positive bladder cancer.
    J Clin Pathol. 2011.
    Abstract     Related articles   

  211. MORSE MA , Bradley DA, Keler T, Laliberte RJ, et al
    CDX-1307: a novel vaccine under study as treatment for muscle-invasive bladder cancer.
    Expert Rev Vaccines. 2011;10:733-42.
    Abstract     Related articles   

  212. YAKASAI A , Allam M, Thompson AJ
    Incidence of bladder cancer in a one-stop clinic.
    Ann Afr Med. 2011;10:112-4.
    Abstract     Related articles   

  213. QIAO B , Scott GB, Elliott F, Vaslin L, et al
    Functional assays to determine the significance of two common XPC 3'UTR variants found in bladder cancer patients.
    BMC Med Genet. 2011;12:84.
    Abstract     Related articles   

  214. KOBAYASHI S , Koga F, Yoshida S, Masuda H, et al
    Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.
    Eur Radiol. 2011.
    Abstract     Related articles   

  215. HA SB , Park YH, Lee E, Ku JH, et al
    Combined treatment with anticancer vaccine using genetically modified endothelial cells and imatinib in bladder cancer.
    Korean J Urol. 2011;52:327-34.
    Abstract     Related articles   

  216. JUNG SJ , Chang HS, Park CH, Kim CI, et al
    Effectiveness of an immediate mitomycin C instillation in patients with superficial bladder cancer receiving periodic mitomycin C instillation.
    Korean J Urol. 2011;52:323-6.
    Abstract     Related articles   

  217. AMIT D , Tamir S, Birman T, Gofrit ON, et al
    Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P3 and IGF2-P4 regulatory sequences.
    Int J Clin Exp Med. 2011;4:91-102.
    Abstract     Related articles   

  218. CEBRIAN V , Fierro M, Orenes-Pinero E, Grau L, et al
    KISS1 Methylation and Expression as Tumor Stratification Biomarkers and Clinical Outcome Prognosticators for Bladder Cancer Patients.
    Am J Pathol. 2011.
    Abstract     Related articles   

  219. DUMACHE R , David D, Kaycsa A, Minciu R, et al
    Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
    Rev Med Chir Soc Med Nat Iasi. 2011;115:163-7.
    Abstract     Related articles   

  220. EISSA S , Swellam M, El-Khouly IM, Kassim SK, et al
    Aberrant Methylation of RAR{beta}2 and APC Genes in Voided Urine as Molecular Markers for Early Detection of Bilharzial and Non-Bilharzial Bladder Cancer.
    Cancer Epidemiol Biomarkers Prev. 2011.
    Abstract     Related articles   

  221. HSIEH CH , Chung SD, Chan PH, Lai SK, et al
    Intensity modulated radiotherapy for elderly bladder cancer patients.
    Radiat Oncol. 2011;6:75.
    Abstract     Related articles   

  222. VLAHOU A
    Back to the future in bladder cancer research.
    Expert Rev Proteomics. 2011;8:295-7.
    Abstract     Related articles   

  223. DJURASIC L , Crnomarkovic D, Pejcic T, Jovanovic M, et al
    The importance of physical therapy in the postoperative period after total cystectomy of bladder carcinoma.
    Acta Chir Iugosl. 2011;58:103-5.
    Abstract     Related articles   

  224. DE LA MATTA MARTIN M , Herrera Gonzalez A, Lopez Conejos JA, Lopez Romero JL, et al
    [Utility of preoperative chest radiography in smokers undergoing transurethral resection of urinary bladder tumors].
    Rev Esp Anestesiol Reanim. 2011;58:203-10.
    Abstract     Related articles   

  225. SARI A , Bal K, Tunakan M, Ozturk C, et al
    A case of a sporadic malignant peripheral nerve sheath tumor of the urinary bladder with concomitant in situ urothelial carcinoma treated by transuretheral resection.
    Indian J Pathol Microbiol. 2011;54:147-9.
    Abstract     Related articles   

  226. KUMAR N , Rehrauer H, Cai H, Baudis M, et al
    CDCOCA: a statistical method to define complexity dependence of co-occuring chromosomal aberrations.
    BMC Med Genomics. 2011;4:21.
    Abstract     Related articles   

  227. SELEVSEK N , Matondo M, Sanchez Carbayo M, Aebersold R, et al
    Systematic quantification of peptides/proteins in urine using selected reaction monitoring.
    Proteomics. 2011;11:1135-47.
    Abstract     Related articles   

  228. REXER H
    [AUO-study AB34/09: an open-label, randomised, multicentre, phase II study to evaluate the efficacy of chemotherapy with gemcitabine and cisplatin in combination with the EGF receptor antibody panitumumab (GemCisP) versus GemCis in the first-line ther
    Urologe A. 2011;50:230-2.
    Abstract     Related articles   

  229. KIYOSHIMA K , Kuroiwa K, Uchino H, Yokomizo A, et al
    Depth and origin of prostatic involvement by urothelial carcinoma: prognostic significance and staging interpretation.
    Jpn J Clin Oncol. 2011;41:642-6.
    Abstract     Related articles   

  230. KECK B , Stoehr R, Wach S, Rogler A, et al
    [Plasmacytoid and micropapillary urothelial carcinoma: rare forms of urothelial carcinoma].
    Urologe A. 2011;50:217-20.
    Abstract     Related articles   

  231. SCARSELLI A , Scanno P, Marinaccio A, Iavicoli S, et al
    Bladder cancer and occupational exposure: estimating the workers potentially at risk in Italy.
    Ann Ist Super Sanita. 2011;47:200-206.
    Abstract     Related articles   

  232. OZTURK T , Kahraman OT, Toptas B, Kisakesen HI, et al
    The Effect of CYP1A1 and GSTM1 Gene Polymorphisms in Bladder Cancer Development in a Turkish Population.
    In Vivo. 2011;25:663-8.
    Abstract     Related articles   

  233. TANJI N , Ozawa A, Kikugawa T, Miura N, et al
    Potential of histone deacetylase inhibitors for bladder cancer treatment.
    Expert Rev Anticancer Ther. 2011;11:959-65.
    Abstract     Related articles   

  234. HILTON WM , Ercole B, Parekh DJ, Sonpavde G, et al
    Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
    Expert Rev Anticancer Ther. 2011;11:949-57.
    Abstract     Related articles   

  235. DANESHMAND S , Bartsch G
    Improving selection of appropriate urinary diversion following radical cystectomy for bladder cancer.
    Expert Rev Anticancer Ther. 2011;11:941-8.
    Abstract     Related articles   

  236. BOURNAKIS E , Dimopoulos MA, Bamias A
    Management of advanced bladder cancer in patients with impaired renal function.
    Expert Rev Anticancer Ther. 2011;11:931-9.
    Abstract     Related articles   

  237. LAMMERS RJ , Witjes JA
    Discussion on the influence of HER2 status on the clinical outcome of bladder cancer continues.
    Expert Rev Anticancer Ther. 2011;11:853-8.
    Abstract     Related articles   

  238. MITRA AP , Cote RJ
    Molecular signatures that predict nodal metastasis in bladder cancer: does the primary tumor tell tales?
    Expert Rev Anticancer Ther. 2011;11:849-52.
    Abstract     Related articles   

  239. WANG J , Wang FW, Kessinger A
    The impact of signet-ring cell carcinoma histology on bladder cancer outcome.
    World J Urol. 2011.
    Abstract     Related articles   

  240. RYK C , Peter Wiklund N, Nyberg T, de Verdier PJ, et al
    Polymorphisms in nitric-oxide synthase 3 may influence the risk of urinary-bladder cancer.
    Nitric Oxide. 2011.
    Abstract     Related articles   

  241. MALHOTRA P , Farber BF
    Isoniazid resistance among Bacillus Calmette Guerin strains: implications on bladder cancer immunotherapy related infections.
    Can J Urol. 2011;18:5671-5.
    Abstract     Related articles   

  242. MITTAL RD , Srivastava P, Mittal T, Verma A, et al
    Association of death receptor 4, Caspase 3 and 5 gene polymorphism with increased risk to bladder cancer in North Indians.
    Eur J Surg Oncol. 2011.
    Abstract     Related articles   

  243. NIESET JR , Harmon JF, Larue SM
    USE OF CONE-BEAM COMPUTED TOMOGRAPHY TO CHARACTERIZE DAILY URINARY BLADDER VARIATIONS DURING FRACTIONATED RADIOTHERAPY FOR CANINE BLADDER CANCER.
    Vet Radiol Ultrasound. 2011 Jun 23. doi: 10.1111/j.1740-8261.2011.01838.
    Abstract     Related articles   

  244. HIRAMOTO K , Kuroki M, Nakano E, Kanno N, et al
    [Successful management with partial splenic embolization (PSE) of splenomegaly and thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colorectal cancer].
    Gan To Kagaku Ryoho. 2011;38:835-9.
    Abstract     Related articles   

  245. MYLES ML
    Urinary diversions.
    Medsurg Nurs. 2011;20:94-5.
    Abstract     Related articles   

  246. TSAI CC , Wu WJ, Chueh KS, Li WM, et al
    Paraganglioma of the urinary bladder first presented by bladder bloody tamponade: two case reports and review of the literatures.
    Kaohsiung J Med Sci. 2011;27:108-13.
    Abstract     Related articles   

  247. MANSOOR M , Ali S, Fasihuddin Q, Baloch MU, et al
    Superficial bladder tumours: recurrence and progression.
    J Coll Physicians Surg Pak. 2011;21:157-60.
    Abstract     Related articles   

  248. PARAMASIVAN S , Huddart R, Hall E, Lewis R, et al
    Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011).
    Trials. 2011;12:78.
    Abstract     Related articles   

  249. RAYMUNDO EM , Lipkin ME, Banez LB, Mancini JG, et al
    Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma.
    J Endourol. 2011;25:377-84.
    Abstract     Related articles   

  250. DAVILI Z , Makhuli Z, Hartman C, Rong R, et al
    Presentation of bladder leiomyoma concurrent with transitional cell carcinoma.
    Can J Urol. 2011;18:5559-63.
    Abstract     Related articles   

  251. REHMAN J , Sangalli MN, Guru K, de Naeyer G, et al
    Total intracorporeal robot-assisted laparoscopic ileal conduit (Bricker) urinary diversion: technique and outcomes.
    Can J Urol. 2011;18:5548-56.
    Abstract     Related articles   

  252. DJAVAN B
    EDITORIAL COMMENT Re: Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma.
    Can J Urol. 2011;18:5536.
    Abstract     Related articles   

  253. ARCE J , Gaya JM, Huguet J, Rodriguez O, et al
    Can we identify those patients who will benefit from prostate-sparing surgery? Predictive factors for invasive prostatic involvement by transitional cell carcinoma.
    Can J Urol. 2011;18:5529-36.
    Abstract     Related articles   

  254. ZUPANCIC D , Ovcak Z, Vidmar G, Romih R, et al
    Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
    Virchows Arch. 2011;458:603-13.
    Abstract     Related articles   

  255. OTTO W , Fritsche HM, Wild PJ, Wieland WF, et al
    Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.
    Pathol Res Pract. 2011;207:161-3.
    Abstract     Related articles   

  256. LIM MG , Adsay NV, Grignon DJ, Osunkoya AO, et al
    E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
    Mod Pathol. 2011;24:241-7.
    Abstract     Related articles   

  257. MEHAN R , Misseri R, Vanderbrink B, Rink RC, et al
    Metastatic transitional cell carcinoma of the bladder arising in a patient with bladder autoaugmentation.
    J Pediatr Urol. 2011;7:137-9.
    Abstract     Related articles   

  258. PATRIARCA C , Colecchia M, Lopez-Beltran A, Sirugo G, et al
    Nest-like features in bladder, simulating the nested variant of urothelial carcinoma.
    Int J Surg Pathol. 2011;19:11-9.
    Abstract     Related articles   

  259. RATANAJARAYA C , Nishiyama H, Takahashi M, Kawaguchi T, et al
    A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese males.
    J Hum Genet. 2011 Jul 7. doi: 10.1038/jhg.2011.
    Abstract     Related articles   

  260. AFONSO J , Longatto-Filho A, Baltazar F, Sousa N, et al
    CD147 overexpression allows an accurate discrimination of bladder cancer patients' prognosis.
    Eur J Surg Oncol. 2011.
    Abstract     Related articles   

  261. WEI JA , Zeng X, Han L, Huang Y, et al
    The regulatory effects of polyporus polysaccharide on the nuclear factor kappa B signal pathway of bladder cancer cells stimulated by Bacillus Calmette-Guerin.
    Chin J Integr Med. 2011;17:531-6.
    Abstract     Related articles   

  262. SAMPLASKI MK , Heston W, Elson P, Magi-Galluzzi C, et al
    Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
    Mod Pathol. 2011 Jul 1. doi: 10.1038/modpathol.2011.
    Abstract     Related articles   

  263. BLAIS N
    Are we undertreating invasive bladder cancer? Optimizing outcomes in a high-risk disease.
    Curr Opin Support Palliat Care. 2011.
    Abstract     Related articles   

  264. PLOEG M , Kums AC, Aben KK, van Lin EN, et al
    Prognostic Factors for Survival in Patients With Recurrence of Muscle Invasive Bladder Cancer After Treatment With Curative Intent.
    Clin Genitourin Cancer. 2011.
    Abstract     Related articles   

  265. LU YC , Chen CN, Wang B, Hsu WM, et al
    Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-Regulation of Calreticulin Expression.
    Am J Pathol. 2011.
    Abstract     Related articles   

  266. GARCIA AB , Arranz EM, Sanz RR, Serrano EM, et al
    [Signet ring cell carcinoma of the ampulla of Vater].
    Gastroenterol Hepatol. 2011;34:141-6.
    Abstract     Related articles   

  267. GRIFFITH TS , Kucaba TA, O'Donnell MA, Burns J, et al
    Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.
    Apoptosis. 2011;16:13-26.
    Abstract     Related articles   

  268. YUAN Q , Wang M, Wang M, Zhang Z, et al
    Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.
    Mol Biol Rep. 2011.
    Abstract     Related articles   

  269. BOCHNER BH
    Chemotherapy: Standardizing the care of invasive bladder cancer.
    Nat Rev Clin Oncol. 2011 Jul 12. doi: 10.1038/nrclinonc.2011.
    Abstract     Related articles   

  270. STEPHENSON J
    Diabetes drug may be associated with increase in risk of bladder cancer.
    JAMA. 2011;306:143.
    Abstract     Related articles   

  271. RAFNAR T , Vermeulen SH, Sulem P, Thorleifsson G, et al
    European Genome-Wide Association Study Identifies SLC14A1 as a New Urinary Bladder Cancer Susceptibility Gene.
    Hum Mol Genet. 2011.
    Abstract     Related articles   

  272. BOUKOVINAS I , Androulakis N, Kentepozidis N, Polyzos A, et al
    Chemotherapy with gemcitabine, cisplatin, and docetaxel in the treatment for patients with muscle-invasive bladder cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).
    Cancer Chemother Pharmacol. 2011.
    Abstract     Related articles   

  273. PAYTON S
    Bladder cancer: Time to embrace neoadjuvant chemotherapy for invasive disease.
    Nat Rev Urol. 2011;8:354.
    Abstract     Related articles   

  274. ILIC M , Stojadinovic M, Milosavljevic Z
    Familial aggregation of bladder cancer.
    Vojnosanit Pregl. 2011;68:447-51.
    Abstract     Related articles   

  275. BRINKMAN MT , Karagas MR, Zens MS, Schned AR, et al
    Intake of alpha-linolenic acid and other fatty acids in relation to the risk of bladder cancer: results from the New Hampshire case-control study.
    Br J Nutr. 2011.
    Abstract     Related articles   

  276. BENABDALLAH JO , Collins CW, Carucci LR, Moores KE, et al
    Aggressive bladder carcinoma in an HIV-positive man with tetraplegia and neurogenic bladder.
    J Spinal Cord Med. 2011;34:248-50.
    Abstract     Related articles   

  277. NISHIKAWA R , Fujimura M, Endo Y, Sekita N, et al
    [A case of carcinosarcoma of the urinary bladder].
    Hinyokika Kiyo. 2011;57:199-202.
    Abstract     Related articles   

  278. PANER GP , McKenney JK, Barkan GA, Yao JL, et al
    Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls.
    Am J Surg Pathol. 2011;35:787-98.
    Abstract     Related articles   

  279. KAPUR P , Lotan Y, King E, Kabbani W, et al
    Primary adenocarcinoma of the urinary bladder: value of cell cycle biomarkers.
    Am J Clin Pathol. 2011;135:822-30.
    Abstract     Related articles   

  280. WANG H , Yang D, Wang K, Wang J, et al
    Expression and potential role of chemokine receptor CXCR4 in human bladder carcinoma cell lines with different metastatic ability.
    Mol Med Report. 2011;4:525-8.
    Abstract     Related articles   

  281. WANG ST , Chang CC, Yen MC, Tu CF, et al
    RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.
    Gene Ther. 2011;18:372-83.
    Abstract     Related articles   

  282. HAN C , Gong Z, Hao L, Yang J, et al
    Mechanism of Monoclonal Antibody-Coupled Staphylococcus Superantigen-A Induced Apoptosis in Human Bladder Cancer Cells.
    Cell Biochem Biophys. 2011.
    Abstract     Related articles   

  283. SHAPUR NK , Katz R, Pode D, Shapiro A, et al
    Is radical cystectomy mandatory in every patient with variant histology of bladder cancer.
    Rare Tumors. 2011;3:e22.
    Abstract     Related articles   

  284. GINGRICH JR
    Bladder cancer: Chemohyperthermia for bladder cancer-clinically effective?
    Nat Rev Urol. 2011 Jul 19. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  285. PANTAZIS E , Soulitzis N, Soufla G, Karyotis I, et al
    mRNA expression of G(1)-phase cell cycle regulatory molecules in bladder cancer.
    J BUON. 2011;16:323-30.
    Abstract     Related articles   

  286. KURIAN A , Lee J, Born A
    Urothelial bladder cancer with cavitary lung metastases.
    Can Respir J. 2011;18:e46-7.
    Abstract     Related articles   

  287. ABDEL-HALEEM AM , El-Zeiry MI, Mahran LG, Abou-Aisha K, et al
    Expression of RFC/SLC19A1 is Associated with Tumor Type in Bladder Cancer Patients.
    PLoS One. 2011;6:e21820.
    Abstract     Related articles   

  288. YUAN SY , Lin CC, Hsu SL, Cheng YW, et al
    Leaf Extracts of Calocedrus formosana (Florin) Induce G2/M Cell Cycle Arrest and Apoptosis in Human Bladder Cancer Cells.
    Evid Based Complement Alternat Med. 2011;2011:380923.
    Abstract     Related articles   

  289. LIU HS , Ke CS, Cheng HC, Huang CY, et al
    Curcumin-induced Mitotic Spindle Defect and Cell Cycle Arrest in Human Bladder Cancer Cells is partly through Inhibition of Aurora-A.
    Mol Pharmacol. 2011.
    Abstract     Related articles   

  290. REIS LO
    The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 national comprehensive cancer network practice guidelines for bladder cancer treatment.
    Int Braz J Urol. 2011;37:413-4.
    Abstract     Related articles   

  291. NAKANO M , Tashiro K
    Association studies getting broader: A commentary on A polymorphism of the POLG2 gene is genetically associated with the invasiveness of urinary bladder cancer in Japanese males.
    J Hum Genet. 2011 Jul 14. doi: 10.1038/jhg.2011.
    Abstract     Related articles   

  292. VOL'PINA OM , Zavalishina LE, Volkova TD, Akhidova EV, et al
    [The apoptosis inhibitor survivin in transitional cell carcinoma of the urinary bladder].
    Arkh Patol. 2011;73:8-10.
    Abstract     Related articles   

  293. TANAKA MF , Sonpavde G
    Diagnosis and management of urothelial carcinoma of the bladder.
    Postgrad Med. 2011;123:43-55.
    Abstract     Related articles   

  294. STEINBERG GD , Smith ND, Ryder K, Strangman NM, et al
    Factors affecting valrubicin response in patients with bacillus Calmette-Guerin-refractory bladder carcinoma in situ.
    Postgrad Med. 2011;123:28-34.
    Abstract     Related articles   

  295. BLACKBURN EH
    Walking the walk from genes through telomere maintenance to cancer risk.
    Cancer Prev Res (Phila). 2011;4:473-5.
    Abstract     Related articles   

  296. ABBASOV B , Munguia G, Mazal PR, Haitel A, et al
    Epithelioid angiosarcoma of the bladder: report of a new case with immunohistochemical profile and review of the literature.
    Pathology. 2011;43:290-3.
    Abstract     Related articles   

  297. FERNANDEZ-ACENERO MJ , Cordova S, Santonja C
    Aberrant TTF-1 expression in papillary high-grade urothelial neoplasm: case report and literature review.
    Rom J Morphol Embryol. 2011;52:171-4.
    Abstract     Related articles   

  298. CHEKRINE T , De Bari B, Cassier P, Kulisa M, et al
    [Small cell neuroendocrine carcinoma of the bladder: A case report and review of the literature].
    Cancer Radiother. 2011;15:250-3.
    Abstract     Related articles   

  299. CASTANO-VINYALS G , Cantor KP, Villanueva CM, Tardon A, et al
    Socioeconomic status and exposure to disinfection by-products in drinking water in Spain.
    Environ Health. 2011;10:18.
    Abstract     Related articles   

  300. POTENZA D , Vasile F, Belvisi L, Civera M, et al
    STD and trNOESY NMR study of receptor-ligand interactions in living cancer cells.
    Chembiochem. 2011;12:695-9.
    Abstract     Related articles   

  301. KITAMURA H , Taguchi K, Kunishima Y, Yanase M, et al
    Paclitaxel, ifosfamide, and nedaplatin as second-line treatment for patients with metastatic urothelial carcinoma: a phase II study of the SUOC group.
    Cancer Sci. 2011;102:1171-5.
    Abstract     Related articles   

  302. SIATELIS A , Houhoula DP, Papaparaskevas J, Delakas D, et al
    Detection of bacillus Galmette-Guerin (Mycobacterium bovis BCG) DNA in urine and blood specimens after intravesical immunotherapy for bladder carcinoma.
    J Clin Microbiol. 2011;49:1206-8.
    Abstract     Related articles   

  303. KAWAOKA T , Miyagawa Y, Tsujihata M, Kamoto A, et al
    [Two cases of bladder cancer with hereditary nonpolyposis colorectal cancer].
    Hinyokika Kiyo. 2011;57:319-21.
    Abstract     Related articles   

  304. CHE X , Yang D, Zong H, Wang J, et al
    Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients.
    Urol Oncol. 2011.
    Abstract     Related articles   

  305. VISHNU P , Mathew J, Tan WW
    Current therapeutic strategies for invasive and metastatic bladder cancer.
    Onco Targets Ther. 2011;4:97-113.
    Abstract     Related articles   

  306. BAU DT , Chang CH, Tsai RY, Wang HC, et al
    Significant association of caveolin-1 genotypes with bladder cancer susceptibility in Taiwan.
    Chin J Physiol. 2011;54:153-60.
    Abstract     Related articles   


  307. [Molecular markers for the diagnosis of non-muscle-invasive bladder cancer].
    Klin Lab Diagn. 2011;:16-20.
    Abstract     Related articles   

  308. BOTELHO MC , Machado JC, Brindley PJ, Correia da Costa JM, et al
    Targeting molecular signaling pathways of Schistosoma haemotobium infection in bladder cancer.
    Virulence. 2011;2.
    Abstract     Related articles   

  309. LEE JW , Lorenzo EI, Ahn B, Oh CK, et al
    Palpation device for the identification of kidney and bladder cancer: a pilot study.
    Yonsei Med J. 2011;52:768-72.
    Abstract     Related articles   

  310. ANDERSON JK , Alanee S, Lindgren B, Slaton J, et al
    The risk of bladder cancer in patients diagnosed with other primary neoplasms: Analysis of the SEER database.
    Urol Oncol. 2011.
    Abstract     Related articles   

  311. SRIVASTAVA P , Kapoor R, Mittal RD
    Association of single nucleotide polymorphisms in promoter of matrix metalloproteinase-2, 8 genes with bladder cancer risk in Northern India.
    Urol Oncol. 2011.
    Abstract     Related articles   

  312. PARK J , Song C, Shin E, Hong JH, et al
    Do molecular biomarkers have prognostic value in primary T1G3 bladder cancer treated with bacillus Calmette-Guerin intravesical therapy?
    Urol Oncol. 2011.
    Abstract     Related articles   

  313. HSIEH DS , Wang H, Tan SW, Huang YH, et al
    The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles.
    Biomaterials. 2011.
    Abstract     Related articles   

  314. GLADKOVA N , Streltsova O, Zagaynova E, Kiseleva E, et al
    Cross-polarization optical coherence tomography for early bladder-cancer detection: statistical study.
    J Biophotonics. 2011;4.
    Abstract     Related articles   

  315. PARK CH , Jang MA, Ahn YH, Hwang YY, et al
    Mycobacterial infection after intravesical bacillus calmette-guerin treatment for bladder cancer: a case report.
    Korean J Lab Med. 2011;31:197-200.
    Abstract     Related articles   

  316. GOLDSTEIN MR , Mascitelli L
    Pioglitazone for diabetes prevention.
    N Engl J Med. 2011;365:183.
    Abstract     Related articles   

  317. EREKSON EA , McMahon MD, Moule BA, Rardin CR, et al
    Microscopic hematuria in women.
    Obstet Gynecol. 2011;117:1429-34.
    Abstract     Related articles   

  318. BAI E , Aiani MR, Crosignani P
    [OCCAM: a tool for the workpractice of the units of occupational health, safety and prevention].
    Epidemiol Prev. 2011;35:55-6.
    Abstract     Related articles   

  319. AL-AHMADIE HA , Iyer G, Janakiraman M, Lin O, et al
    Somatic mutation of fibroblast growth factor receptor-3 (FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.
    J Pathol. 2011;224:270-9.
    Abstract     Related articles   

  320. CLARKE LL , Kennedy CT, Hollingworth P
    Palmar fasciitis and polyarthritis syndrome associated with transitional cell carcinoma of the bladder.
    J Am Acad Dermatol. 2011;64:1159-63.
    Abstract     Related articles   

  321. HEKAL IA , Mosbah A, El-Bahnasawy MS, El-Assmy A, et al
    Penile haemodynamic changes in post-radical cystectomy patients.
    Int J Androl. 2011;34:27-32.
    Abstract     Related articles   

  322. PALMEIRA C , Lameiras C, Amaro T, Lima L, et al
    CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.
    Urol Oncol. 2011;29:205-11.
    Abstract     Related articles   

  323. AZEMAR MD , Comperat E, Richard F, Cussenot O, et al
    Bladder recurrence after surgery for upper urinary tract urothelial cell carcinoma: frequency, risk factors, and surveillance.
    Urol Oncol. 2011;29:130-6.
    Abstract     Related articles   

  324. VINCI S , Giannarini G, Selli C, Kuncova J, et al
    Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: a prospective, two-center validation study.
    Urol Oncol. 2011;29:150-6.
    Abstract     Related articles   

  325. LUND L , Erichsen R, Norgaard M, Larsen EH, et al
    Survival of invasive bladder cancer patients, 1998-2009; a central and northern Denmark population-based cohort study.
    Clin Epidemiol. 2011;3 Suppl 1:47-51.
    Abstract     Related articles   

  326. CAUBERG EVELYNE CC , de la Rosette JJ, de Reijke TM
    Emerging optical techniques in advanced cystoscopy for bladder cancer diagnosis: A review of the current literature.
    Indian J Urol. 2011;27:245-51.
    Abstract     Related articles   

  327. AYYATHURAI R , Soloway MS
    Monitoring of the upper urinary tract in patients with bladder cancer.
    Indian J Urol. 2011;27:238-44.
    Abstract     Related articles   

  328. MANDHANI A
    Proactive approach to treat high-grade lamina-invasive bladder cancer.
    Indian J Urol. 2011;27:233-7.
    Abstract     Related articles   

  329. KHOCHIKAR MV
    Rationale for an early detection program for bladder cancer.
    Indian J Urol. 2011;27:218-25.
    Abstract     Related articles   

  330. NAIK DS , Sharma S, Ray A, Hedau S, et al
    Epidermal growth factor receptor expression in urinary bladder cancer.
    Indian J Urol. 2011;27:208-14.
    Abstract     Related articles   

  331. KEKRE NS
    Bladder cancer - When will the paradigm change?
    Indian J Urol. 2011;27:161-2.
    Abstract     Related articles   

  332. BRYAN RT , Wei W, Shimwell NJ, Collins SI, et al
    Assessment of High-Throughput High-Resolution MALDI-TOF-MS of Urinary Peptides for the Detection of Muscle-Invasive Bladder Cancer.
    Proteomics Clin Appl. 2011 Aug 1. doi: 10.1002/prca.201100011.
    Abstract     Related articles   

  333. KOBAYASHI Y , Saika T, Miyaji Y, Saegusa M, et al
    Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    World J Urol. 2011.
    Abstract     Related articles   

  334. HUANG Z , Lin L, Gao Y, Chen Y, et al
    Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.
    Mol Cell Proteomics. 2011.
    Abstract     Related articles   

  335. HUANG AM , Kao YT, Toh S, Lin PY, et al
    UBE2M-mediated p27(Kip1) degradation in gemcitabine cytotoxicity.
    Biochem Pharmacol. 2011;82:35-42.
    Abstract     Related articles   

  336. PAJOR G , Somogyi L, Melegh B, Alpar D, et al
    Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria.
    Cytometry A. 2011;79:375-82.
    Abstract     Related articles   

  337. SCHILLING D , Todenhofer T, Taran FA, Hartkopf A, et al
    [Mechanisms of tumour cell dissemination and methods for detection of circulating tumour cells in transitional cell carcinoma].
    Aktuelle Urol. 2011;42:122-7.
    Abstract     Related articles   

  338. ALLOUSSI SH , Huber S, Gakis G, Stenzl A, et al
    [The importance of lymphadenectomy for muscle invasive transitional cell carcinoma of the human bladder - a review of the literature].
    Aktuelle Urol. 2011;42:115-21.
    Abstract     Related articles   

  339. GAKIS G , Jentzmik F, Schrader M, Stenzl A, et al
    [Benefits and risks of orthotopic neobladder reconstruction in female patients].
    Aktuelle Urol. 2011;42:109-14.
    Abstract     Related articles   

  340. SCHWENTNER C , Todenhofer T, Mundhenk J, Horstmann M, et al
    [Robotic laparoscopic cystectomy: on the way to a standard procedure?].
    Aktuelle Urol. 2011;42:103-8.
    Abstract     Related articles   

  341. GOMEZ FJ , Galan JM, Gomez AT
    High grade transitionl cell carcinoma of the bladder with diffuse squamous differentiation.
    Arch Esp Urol. 2011;64:138-9.
    Abstract     Related articles   

  342. TSAUR I , Karalis A, Blaheta R, Juengel E, et al
    Transitional Cell Carcinoma of the Native Urinary Tract After Kidney Transplantation: Recommendations Following a Long-Term Retrospective Analysis.
    Am J Med Sci. 2011.
    Abstract     Related articles   

  343. TABIBI A , Simforoosh N, Parvin M, Abdi H, et al
    Predictive factors for prostatic involvement by transitional cell carcinoma of the bladder.
    Urol J. 2011;8:43-7.
    Abstract     Related articles   

  344. MARTIN IJ , Vilar DG, Aguado JM, Perello CG, et al
    Large cell neuroendocrine carcinoma of the urinary bladder. Bibliographic review.
    Arch Esp Urol. 2011;64:105-13.
    Abstract     Related articles   

  345. TREIYER A , Saar M, Kopper B, Kamradt J, et al
    [Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results].
    Actas Urol Esp. 2011;35:152-7.
    Abstract     Related articles   

  346. PALOU J
    [Comment to: "Robotic-assisted laparoscopic radical cystectomy: evaluation of functional and oncological results"].
    Actas Urol Esp. 2011;35:158.
    Abstract     Related articles   

  347. DIXON BP , Henry J, Siroky BJ, Chu A, et al
    Cell cycle control and DNA damage response of conditionally immortalized urothelial cells.
    PLoS One. 2011;6:e16595.
    Abstract     Related articles   

  348. SHORNING BY , Griffiths D, Clarke AR
    Lkb1 and Pten synergise to suppress mTOR-mediated tumorigenesis and epithelial-mesenchymal transition in the mouse bladder.
    PLoS One. 2011;6:e16209.
    Abstract     Related articles   

  349. GARCIA-SEGUI A , Gascon M
    [Gastrointestinal stromal tumour in the urinary bladder].
    Actas Urol Esp. 2011;35:124-5.
    Abstract     Related articles   

  350. CIMINO-MATHEWS A , Ali SZ
    Metastatic urothelial carcinoma with signet ring features: cytomorphologic findings in abdominal paracentesis.
    Diagn Cytopathol. 2011;39:132-4.
    Abstract     Related articles   

  351. RASHIDI B , Tongson-Ignacio JE
    Melamed-Wolinska bodies in urine cytology an interesting aggregate in a degenerated urothelial cell.
    Diagn Cytopathol. 2011;39:117.
    Abstract     Related articles   

  352. BOHM F , Schmid D, Denzinger S, Wieland WF, et al
    DNA adducts of ortho-toluidine in human bladder.
    Biomarkers. 2011;16:120-8.
    Abstract     Related articles   

  353. GENHEIMER CW , Guthrie KI, Shokes JE, Bruce AT, et al
    Increased urothelial cell detection in the primary bladder smooth muscle cell cultures with dual MACS/qRT-PCR approach.
    Appl Immunohistochem Mol Morphol. 2011;19:184-9.
    Abstract     Related articles   

  354. SAINI S , Arora S, Majid S, Shahryari V, et al
    Curcumin modulates microRNA-203 mediated regulation of the Src-Akt axis in bladder cancer.
    Cancer Prev Res (Phila). 2011.
    Abstract     Related articles   

  355. SEILER R , von Gunten M, Thalmann GN, Fleischmann A, et al
    High CD10 expression predicts favorable outcome in surgically treated lymph node-positive bladder cancer patients.
    Hum Pathol. 2011.
    Abstract     Related articles   

  356. CODOLO G , Fassan M, Munari F, Volpe A, et al
    HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response.
    Cancer Immunol Immunother. 2011.
    Abstract     Related articles   

  357. GROSSMAN HB
    Bladder cancer: neoadjuvant is new again.
    Lancet Oncol. 2011.
    Abstract     Related articles   

  358. DI STASI SM , Valenti M, Verri C, Liberati E, et al
    Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Lancet Oncol. 2011.
    Abstract     Related articles   

  359. CHENG G , Xie L
    Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro.
    Molecules. 2011;16:6758-68.
    Abstract     Related articles   

  360. BOSCOLO-BERTO R , Viel G, Lamon C, Agostini A, et al
    Giant scrotal lymphedema as unique onset sign of muscle-invasive bladder cancer. The risk of a misdiagnosis.
    Arch Ital Urol Androl. 2011;83:95-8.
    Abstract     Related articles   

  361. SHIH C , Porter MP
    Health-related quality of life after cystectomy and urinary diversion for bladder cancer.
    Adv Urol. 2011;2011:715892.
    Abstract     Related articles   

  362. GARCIA-CLOSAS M , Ye Y, Rothman N, Figueroa JD, et al
    A genome-wide association study of bladder cancer identifies a new susceptibility locus within SLC14A1, a urea transporter gene on chromosome 18q12.3.
    Hum Mol Genet. 2011.
    Abstract     Related articles   

  363. VALLO S , Xi W, Hudak L, Juengel E, et al
    HDAC inhibition delays cell cycle progression of human bladder cancer cells in vitro.
    Anticancer Drugs. 2011.
    Abstract     Related articles   

  364. MORALES R , Font A, Carles J, Isla D, et al
    SEOM clinical guidelines for the treatment of invasive bladder cancer.
    Clin Transl Oncol. 2011;13:552-9.
    Abstract     Related articles   

  365. STAMATIOU K
    Hexavalent chromium and bladder cancer risk.
    Actas Urol Esp. 2011.
    Abstract     Related articles   

  366. LI Z , Qi F, Qi L, Zhang H, et al
    VEGF-C as a Biomarker for Selected Patients with Muscle-invasive Bladder Cancer and Bladder Preservation with Radical Transurethral Resection.
    Arch Med Res. 2011.
    Abstract     Related articles   

  367. RISTIC A , Velickovic LJ, Stokanovic D
    Prognostic value of apoptotic activity in muscle-invasive bladder cancer.
    Vojnosanit Pregl. 2011;68:511-4.
    Abstract     Related articles   

  368. BOSTROM PJ , Toren PJ, Xi H, Chow R, et al
    Point-of-care clinical documentation: assessment of a bladder cancer informatics tool (eCancerCareBladder): a randomized controlled study of efficacy, efficiency and user friendliness compared with standard electronic medical records.
    J Am Med Inform Assoc. 2011.
    Abstract     Related articles   

  369. MIYAKE M , Hirao S, Mibu H, Tanaka M, et al
    Clinical significance of subepithelial growth patterns in non-muscle invasive bladder cancer.
    BMC Urol. 2011;11:17.
    Abstract     Related articles   

  370. NARANMANDURA H , Michael CW, Xu S, Lee J, et al
    Comparative toxicity of arsenic metabolites in human bladder cancer EJ-1 cells.
    Chem Res Toxicol. 2011.
    Abstract     Related articles   

  371. CEVIK Y , Ozer M, Das M, Ertok I, et al
    Complications of misuse of Bacillus Calmette-Guerin.
    Bratisl Lek Listy. 2011;112:363-4.
    Abstract     Related articles   

  372. DOWDY DW
    Trained to avoid primary care.
    Ann Intern Med. 2011;154:776-7.
    Abstract     Related articles   

  373. HAIE-MEDER C , Martelli H, Dumas I, Mazeron R, et al
    [Brachytherapy in paediatric sarcoma].
    Bull Cancer. 2011;98:549-57.
    Abstract     Related articles   

  374. DUFRESNE M , Dumas G, Asselin E, Carrier C, et al
    Pro-inflammatory type-1 and anti-inflammatory type-2 macrophages differentially modulate cell survival and invasion of human bladder carcinoma T24 cells.
    Mol Immunol. 2011;48.
    Abstract     Related articles   

  375. LINDH C , Nilsson R, Lindstrom ML, Lundin L, et al
    Detection of smoothelin expression in the urinary bladder is strongly dependent on pretreatment conditions: a critical analysis with possible consequences for cancer staging.
    Virchows Arch. 2011;458:665-70.
    Abstract     Related articles   

  376. SOINI Y , Haapasaari KM, Vaarala MH, Turpeenniemi-Hujanen T, et al
    8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.
    Int J Clin Exp Pathol. 2011;4:267-75.
    Abstract     Related articles   

  377. TUNA B , Yorukoglu K, Duzcan E, Sen S, et al
    Histologic grading of urothelial papillary neoplasms: impact of combined grading (two-numbered grading system) on reproducibility.
    Virchows Arch. 2011;458:659-64.
    Abstract     Related articles   

  378. SZOPINSKI TR , Sudol-Szopinska I, Dzik T, Borowka A, et al
    Incidental sonographic detection of mucosa-associated lymphoid tissue lymphoma of the urinary bladder found in a very young woman: report of a case.
    J Clin Ultrasound. 2011;39:233-5.
    Abstract     Related articles   

  379. CANETTA E , Mazilu M, De Luca AC, Carruthers AE, et al
    Modulated Raman spectroscopy for enhanced identification of bladder tumor cells in urine samples.
    J Biomed Opt. 2011;16:037002.
    Abstract     Related articles   

  380. GUSTAFSON P , Burstyn I
    Bayesian inference of gene-environment interaction from incomplete data: what happens when information on environment is disjoint from data on gene and disease?
    Stat Med. 2011;30:877-89.
    Abstract     Related articles   

  381. AYALA DE LA PENA F , Kanasaki K, Kanasaki M, Tangirala N, et al
    Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma.
    J Biol Chem. 2011;286:20778-87.
    Abstract     Related articles   

  382. AHMAD I , Patel R, Liu Y, Singh LB, et al
    Ras mutation cooperates with beta-catenin activation to drive bladder tumourigenesis.
    Cell Death Dis. 2011;2:e124.
    Abstract     Related articles   

  383. KASPRZAK MM , Szmigiero L, Zyner E, Ochocki J, et al
    Proapoptotic activity in vitro of two novel ruthenium(II) complexes with flavanone-based ligands that overcome cisplatin resistance in human bladder carcinoma cells.
    J Inorg Biochem. 2011;105:518-24.
    Abstract     Related articles   

  384. LINDEMANN-DOCTER K , Gaisa NT, Smeets D, Knuchel-Clarke R, et al
    [Urine markers with special regard to fluorescent in situ hybridization (FISH)].
    Urologe A. 2011;50:297-302.
    Abstract     Related articles   

  385. HAKIME A , Deschamps F, De Carvalho EG, Teriitehau C, et al
    Clinical evaluation of spatial accuracy of a fusion imaging technique combining previously acquired computed tomography and real-time ultrasound for imaging of liver metastases.
    Cardiovasc Intervent Radiol. 2011;34:338-44.
    Abstract     Related articles   

  386. STEINBERG GD
    Response to Lammers and Witjes article: New developments in intravesical therapy for non-muscle-invasive bladder cancer.
    Expert Rev Anticancer Ther. 2011.
    Abstract     Related articles   

  387. FREEDMAN ND , Silverman DT, Hollenbeck AR, Schatzkin A, et al
    Association between smoking and risk of bladder cancer among men and women.
    JAMA. 2011;306:737-45.
    Abstract     Related articles   

  388. HUANG JL , Qiu M, Ma LL, Huang Y, et al
    [Analysis of perioperative complications of laparoscopic radical cystectomy for bladder cancer].
    Beijing Da Xue Xue Bao. 2011;43:544-7.
    Abstract     Related articles   

  389. BUETHE DD , Sexton WJ
    Bladder cancer: Validating the EORTC risk tables in BCG-treated patients.
    Nat Rev Urol. 2011 Aug 16. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  390. MOYER VA
    Screening for Bladder Cancer: U.S. Preventive Services Task Force Recommendation Statement.
    Ann Intern Med. 2011;155:246-251.
    Abstract     Related articles   


  391. Screening for bladder cancer: recommendations from the u.s. Preventive services task force.
    Ann Intern Med. 2011;155:I36.
    Abstract     Related articles   

  392. SUPIT W , Mochtar CA, Sugiono M, Umbas R, et al
    Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.
    Asian Pac J Cancer Prev. 2011;12:549-53.
    Abstract     Related articles   

  393. GONZALEZ J , Angulo J
    ["T antireflux mechanism" Ileal neobladder].
    Arch Esp Urol. 2011;64:237-45.
    Abstract     Related articles   

  394. ROSSI E , Pavanello P, Marzola A, Franchella A, et al
    Eosinophilic cystitis and nephrogenic adenoma of the bladder: a rare association of 2 unusual findings in childhood.
    J Pediatr Surg. 2011;46:e31-4.
    Abstract     Related articles   

  395. GRUBISIC I , Lenicek T, Tomas D, Dzombeta T, et al
    Primary osteosarcoma of bladder diverticulum mimicking intradiverticular calculus: a case report.
    Diagn Pathol. 2011;6:37.
    Abstract     Related articles   

  396. LI YF , Yu CP, Wu ST, Dai MS, et al
    Malignant mesenchymal tumor with leiomyosarcoma, rhabdomyosarcoma, chondrosarcoma, and osteosarcoma differentiation: case report and literature review.
    Diagn Pathol. 2011;6:35.
    Abstract     Related articles   

  397. NUNEZ-MORA C , Cabrera P, Garcia-Mediero JM, de Fata FR, et al
    [Laparoscopic radical cystectomy and orthotopic urinary diversion in the male patient: technique].
    Arch Esp Urol. 2011;64:195-206.
    Abstract     Related articles   

  398. SAHAKITRUNGRUANG C , Thum-Umnuaysuk S, Patiwongpaisarn A, Atittharnsakul P, et al
    A novel treatment for haemorrhagic radiation proctitis using colonic irrigation and oral antibiotic administration.
    Colorectal Dis. 2011;13:e79-82.
    Abstract     Related articles   

  399. ROJAS A , Gonzalez I, Romero J, Figueroa H, et al
    Identity crisis--bladder cells in vascular biology.
    Toxicol In Vitro. 2011;25:999.
    Abstract     Related articles   

  400. HE HC , Chen JH, Chen XB, Qin GQ, et al
    Expression of Hedgehog Pathway Components is Associated with Bladder Cancer Progression and Clinical Outcome.
    Pathol Oncol Res. 2011.
    Abstract     Related articles   

  401. PARK SJ , Lee TJ, Chang IH
    Role of the mTOR Pathway in the Progression and Recurrence of Bladder Cancer: An Immunohistochemical Tissue Microarray Study.
    Korean J Urol. 2011;52:466-73.
    Abstract     Related articles   

  402. YOO S , You D, Jeong IG, Hong JH, et al
    Does radical cystectomy improve overall survival in octogenarians with muscle-invasive bladder cancer?
    Korean J Urol. 2011;52:446-51.
    Abstract     Related articles   

  403. COGNETTI F , Ruggeri EM, Felici A, Gallucci M, et al
    Adjuvant chemotherapy with cisplatin and gemcitabine versus chemotherapy at relapse in patients with muscle-invasive bladder cancer submitted to radical cystectomy: an Italian, multicenter, randomized phase III trial.
    Ann Oncol. 2011.
    Abstract     Related articles   

  404. DANCIK G , Aisner D, Theodorescu D
    A 20 gene model for predicting nodal involvement in bladder cancer patients with muscle invasive tumors.
    PLoS Curr. 2011;3:RRN1248.
    Abstract     Related articles   

  405. YAVARI N , Andersson-Engels S, Segersten U, Malmstrom PU, et al
    An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.
    Can J Urol. 2011;18:5778-86.
    Abstract     Related articles   

  406. SUNDERSINGH S , Majhi U, Narayanaswamy K, Balasubramanian S, et al
    Primary spindle cell melanoma of the urinary bladder.
    Indian J Pathol Microbiol. 2011;54:422-4.
    Abstract     Related articles   

  407. SINGH NG , Mannan AA, Kahvic M, Sara YA, et al
    Sarcomatoid carcinoma of the urinary bladder: a report of two cases.
    Indian J Pathol Microbiol. 2011;54:400-1.
    Abstract     Related articles   

  408. LIN CC , Yu YL, Shih CC, Liu KJ, et al
    A novel adjuvant Ling Zhi-8 enhances the efficacy of DNA cancer vaccine by activating dendritic cells.
    Cancer Immunol Immunother. 2011;60:1019-27.
    Abstract     Related articles   

  409. RICHARDS KA , Hemal AK
    Current status and outcomes of robot-assisted laparoscopic radical cystectomy and urinary diversion.
    Curr Urol Rep. 2011;12:107-14.
    Abstract     Related articles   

  410. RESENDES AR , Roperto S, Trapani F, Urraro C, et al
    Association of bovine papillomavirus type 2 (BPV-2) and urinary bladder tumours in cattle from the Azores archipelago.
    Res Vet Sci. 2011;90:526-9.
    Abstract     Related articles   

  411. IKEDA M , Matsumoto K, Niibe Y, Satoh T, et al
    The Radiotherapy with Methotrexate, Vinblastine, Doxorubicin, and Cisplatin Treatment Is an Effective Therapeutic Option in Patients with Advanced or Metastatic Bladder Cancer.
    J Radiat Res (Tokyo). 2011.
    Abstract     Related articles   

  412. SABICHI AL , Lee JJ, Grossman HB, Liu S, et al
    A Randomized Controlled Trial of Celecoxib to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer.
    Cancer Prev Res (Phila). 2011.
    Abstract     Related articles   

  413. RETZ M
    [Interdisciplinary Working Group Bladder Cancer (IABC) in the German Cancer Society newly founded].
    Urologe A. 2011;50:1161-2.
    Abstract     Related articles   

  414. CAO M , Ma CK, Ma J, Chen HG, et al
    [Evaluation of the efficacy and safety of intravesical instillation with gemcitabine after first-line intravesical chemotherapy failure in the treatment of non-muscle-invasive bladder cancer].
    Zhonghua Zhong Liu Za Zhi. 2011;33:385-7.
    Abstract     Related articles   

  415. SALEHI A , Khezri AA, Malekmakan L, Aminsharifi A, et al
    Epidemiologic status of bladder cancer in shiraz, southern iran.
    Asian Pac J Cancer Prev. 2011;12:1323-7.
    Abstract     Related articles   

  416. LI Z , Zhu Y, Yu M, Ji D, et al
    c-Jun is involved in interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human bladder cancer T24 cells.
    Urol Oncol. 2011.
    Abstract     Related articles   

  417. SALEM H , El-Mazny A
    A clinicopathologic study of gynecologic organ involvement at radical cystectomy for bladder cancer.
    Int J Gynaecol Obstet. 2011.
    Abstract     Related articles   

  418. GHALEB KI , Alkaladi A
    Homozygous deletion of the FHIT gene, p21WAF1 protein expression and apoptosis in bilharzial bladder cancer.
    Pak J Biol Sci. 2011;14:212-8.
    Abstract     Related articles   

  419. RAO MV , Ellimoottil C, Sondej T, Flanigan RC, et al
    Intravesical bacillus Calmette-Guerin immunotherapy after previous prostate radiotherapy for high-grade non-muscle-invasive bladder cancer
    Urol Oncol. 2011.
    Abstract     Related articles   

  420. COLIN P , Estevez JP, Betrouni N, Nevoux P, et al
    [Photodynamic therapy and urothelial carcinoma].
    Bull Cancer. 2011;98:769-78.
    Abstract     Related articles   

  421. CHAKRAVARTHY R , Ahmed K, Abbasi S, Cotterill A, et al
    In response--a modified staining protocol for Smoothelin immunostaining.
    Virchows Arch. 2011;459:119-20.
    Abstract     Related articles   

  422. GONZALEZ JR , Rodriguez-Santiago B, Caceres A, Pique-Regi R, et al
    A fast and accurate method to detect allelic genomic imbalances underlying mosaic rearrangements using SNP array data.
    BMC Bioinformatics. 2011;12:166.
    Abstract     Related articles   

  423. MACEDO LT , Ribeiro J, Curigliano G, Fumagalli L, et al
    Multidisciplinary approach in the treatment of patients with small cell bladder carcinoma.
    Eur J Surg Oncol. 2011;37:558-62.
    Abstract     Related articles   

  424. TAKAWA M , Masuda K, Kunizaki M, Daigo Y, et al
    Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker.
    Cancer Sci. 2011;102:1298-305.
    Abstract     Related articles   

  425. SJODAHL G , Lauss M, Gudjonsson S, Liedberg F, et al
    A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1.
    PLoS One. 2011;6:e18583.
    Abstract     Related articles   

  426. HUA MY , Chen HC, Chuang CK, Tsai RY, et al
    The intrinsic redox reactions of polyamic acid derivatives and their application in hydrogen peroxide sensor.
    Biomaterials. 2011;32:4885-95.
    Abstract     Related articles   

  427. WARDE N
    Bladder cancer: Robot-assisted laparoscopic radical cystectomy: a single-center experience.
    Nat Rev Urol. 2011;8:472.
    Abstract     Related articles   

  428. FENNER A
    Bladder cancer: EMDA mitomycin before TURBT is the best treatment for non-muscle-invasive disease.
    Nat Rev Urol. 2011;8:472.
    Abstract     Related articles   

  429. LU YY , Chen JH, Liang JA, Wang HY, et al
    Clinical value of FDG PET or PET/CT in urinary bladder cancer: A systemic review and meta-analysis.
    Eur J Radiol. 2011.
    Abstract     Related articles   

  430. GONDO T , Nakashima J, Ozu C, Ohno Y, et al
    Risk stratification of survival by lymphovascular invasion, pathological stage, and surgical margin in patients with bladder cancer treated with radical cystectomy.
    Int J Clin Oncol. 2011.
    Abstract     Related articles   

  431. KELLY JD , Hall E
    Boxing Bladder Cancer with COX-2-specific Inhibition.
    Cancer Prev Res (Phila). 2011.
    Abstract     Related articles   

  432. SELINSKI S , Lehmann ML, Blaszkewicz M, Ovsiannikov D, et al
    Urinary bladder cancer risk in relation to a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor-binding protein-3 (IGFBP3) gene.
    Arch Toxicol. 2011.
    Abstract     Related articles   

  433. BORUT K , Lijana ZK
    Phase I study of radiochemotherapy with gemcitabine in invasive bladder cancer.
    Radiother Oncol. 2011.
    Abstract     Related articles   

  434. FAIREY AS , Kassouf W, Aprikian AG, Chin JL, et al
    Age >/= 80 years is independently associated with survival outcomes after radical cystectomy: Results from the Canadian Bladder Cancer Network Database.
    Urol Oncol. 2011.
    Abstract     Related articles   

  435. BEHNSAWY HM , Miyake H, Kusuda Y, Fujisawa M, et al
    Small interfering RNA targeting heat shock protein 70 enhances chemosensitivity in human bladder cancer cells.
    Urol Oncol. 2011.
    Abstract     Related articles   

  436. WADA A , Maezawa T, Kageyama S, Johnin K, et al
    [Bladder metastasis of renal cell carcinoma : report of a case].
    Hinyokika Kiyo. 2011;57:381-3.
    Abstract     Related articles   

  437. LIN HH , Ke HL, Hsiao KH, Tsai CW, et al
    Potential role of CCND1 G870A genotype as a predictor for urothelial carcinoma susceptibility and muscle-invasiveness in Taiwan.
    Chin J Physiol. 2011;54:196-202.
    Abstract     Related articles   

  438. WESCHE J , Haglund K, Haugsten EM
    Fibroblast growth factors and their receptors in cancer.
    Biochem J. 2011;437:199-213.
    Abstract     Related articles   

  439. NIU HT , Yang CM, Jiang G, Xu T, et al
    Cancer stroma proteome expression profile of superficial bladder transitional cell carcinoma and biomarker discovery.
    J Cancer Res Clin Oncol. 2011;137:1273-82.
    Abstract     Related articles   

  440. SUN YF , Yang XR, Zhou J, Qiu SJ, et al
    Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance.
    J Cancer Res Clin Oncol. 2011;137:1151-73.
    Abstract     Related articles   

  441. BSCHLEIPFER T , Wagenlehner F, Weidner W
    [Etiology and pathogenesis of overactive bladder].
    Urologe A. 2011;50:477-80.
    Abstract     Related articles   

  442. FIERLBECK I , Helmbold P
    [Bilateral periorbital metastases of transtional cell carcinoma of the bladder].
    Hautarzt. 2011;62:287-9.
    Abstract     Related articles   

  443. AUTENRIETH M , Retz M, Gschwend JE
    [The significance of extended pelvic lymphadenectomy in bladder cancer.]
    Urologe A. 2011.
    Abstract     Related articles   

  444. OOSTERLINCK W
    Chemotherapy: Electromotive mitomycin in superficial bladder cancer.
    Nat Rev Clin Oncol. 2011 Sep 13. doi: 10.1038/nrclinonc.2011.
    Abstract     Related articles   

  445. PANZERI E , Conconi D, Antolini L, Redaelli S, et al
    Chromosomal Aberrations in Bladder Cancer: Fresh versus Formalin Fixed Paraffin Embedded Tissue and Targeted FISH versus Wide Microarray-Based CGH Analysis.
    PLoS One. 2011;6:e24237.
    Abstract     Related articles   

  446. MORGAN TM , Barocas DA, Chang SS, Phillips SE, et al
    The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer.
    Urol Oncol. 2011.
    Abstract     Related articles   

  447. ISMAILI N , Amzerin M, Flechon A
    Chemotherapy in advanced bladder cancer: current status and future.
    J Hematol Oncol. 2011;4:35.
    Abstract     Related articles   

  448. KUCUKGERGIN C , Sanli O, Amasyali AS, Tefik T, et al
    Genetic variants of MnSOD and GPX1 and susceptibility to bladder cancer in a Turkish population.
    Med Oncol. 2011.
    Abstract     Related articles   

  449. BALAR A , Bajorin DF, Milowsky MI
    Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.
    Ther Adv Urol. 2011;3:107-17.
    Abstract     Related articles   

  450. ELZAYAT EA , Al-Zahrani AA
    Pelvic lymphadenectomy in the treatment of invasive bladder cancer: literature review.
    Adv Urol. 2011;2011:701481.
    Abstract     Related articles   

  451. ZACHOS I , Tzortzis V, Konstantinopoulos PA, Karatzas A, et al
    Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies.
    Curr Mol Med. 2011.
    Abstract     Related articles   

  452. ZHANG HH , Qi F, Shi YR, Miao JG, et al
    RNA Interference-Mediated Vascular Endothelial Growth Factor-C Reduction Suppresses Malignant Progression and Enhances Mitomycin C Sensitivity of Bladder Cancer T24 Cells.
    Cancer Biother Radiopharm. 2011.
    Abstract     Related articles   

  453. TAKEZAWA K , Okumi M, Nakayama M, Miyagawa Y, et al
    [Adenocarcinoma of the sigmoid segment 38 years after sigmoidcystoplasty : a case report].
    Hinyokika Kiyo. 2011;57:327-30.
    Abstract     Related articles   

  454. KASTRITIS E , Zagouri F, Dimopoulos MA, Papadimitriou CA, et al
    Carcinomatous meningitis from transitional cell carcinoma of the urinary bladder.
    J BUON. 2011;16:373-4.
    Abstract     Related articles   

  455. TARMAN K , Lindequist U, Wende K, Porzel A, et al
    Isolation of a new natural product and cytotoxic and antimicrobial activities of extracts from fungi of Indonesian marine habitats.
    Mar Drugs. 2011;9:294-306.
    Abstract     Related articles   

  456. BOUJELBENE N , Prior JO, Boubaker A, Azria D, et al
    [Value of positron emission tomography and computer tomography (PET/CT) for urologic malignancies].
    Cancer Radiother. 2011;15:307-15.
    Abstract     Related articles   

  457. CASTILLO OA , Campos R, Vidal I, Foneron A, et al
    [Laparoscopic radical cystectomy with extracorporeal creation of a "Y" shaped orthotopic ileal neobladder using non-reabsorbable mechanical suture (Fontana)].
    Actas Urol Esp. 2011;35:296-301.
    Abstract     Related articles   

  458. RASPOLLINI MR , Sardi I, Giunti L, Di Lollo S, et al
    Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series.
    Hum Pathol. 2011;42:1149-58.
    Abstract     Related articles   

  459. LUO Y , Henning J, O'Donnell MA
    Th1 Cytokine-Secreting Recombinant Mycobacterium bovis Bacillus Calmette-Guerin and Prospective Use in Immunotherapy of Bladder Cancer.
    Clin Dev Immunol. 2011;2011:728930.
    Abstract     Related articles   

  460. TANAKA T , Miyazawa K, Tsukamoto T, Kuno T, et al
    Pathobiology and Chemoprevention of Bladder Cancer.
    J Oncol. 2011;2011:528353.
    Abstract     Related articles   

  461. TADEPALLI S , Coleman T, Hacket LA, Liles GB, et al
    Carcinomatous Meningitis: The Natural History of Successfully Treated Metastatic Bladder Cancer.
    Case Rep Oncol. 2011;4:406-412.
    Abstract     Related articles   

  462. KARL A , Tritschler S, Staehler M, Schneevoigt BS, et al
    [Bladder cancer--symptoms and diagnosis].
    MMW Fortschr Med. 2011;153.
    Abstract     Related articles   

  463. OVSIANNIKOV D , Stohr R, Hartmann A, Bottrich R, et al
    [Bladder cancer at an early age in father and son.]
    Urologe A. 2011.
    Abstract     Related articles   

  464. VIANELLO A , Costantini E, Del Zingaro M, Bini V, et al
    Repeated White Light Transurethral Resection of the Bladder in Nonmuscle-Invasive Urothelial Bladder Cancers: Systematic Review and Meta-Analysis.
    J Endourol. 2011.
    Abstract     Related articles   

  465. TAKEUCHI A , Shiota M, Tatsugami K, Yokomizo A, et al
    p300 mediates cellular resistance to doxorubicin in bladder cancer.
    Mol Med Report. 2011 Sep 20. doi: 10.3892/mmr.2011.
    Abstract     Related articles   

  466. TAO J , Wu D, Li P, Xu B, et al
    microRNA-18a, a member of the oncogenic miR1792 cluster, targets Dicer and suppresses cell proliferation in bladder cancer T24 cells.
    Mol Med Report. 2011 Sep 20. doi: 10.3892/mmr.2011.
    Abstract     Related articles   

  467. AHIRWAR DK , Manchanda PK, Mittal RD, Bid HK, et al
    BCG response prediction with cytokine gene variants and bladder cancer: where we are?
    J Cancer Res Clin Oncol. 2011.
    Abstract     Related articles   

  468. HYNDMAN ME , Mullins JK, Bivalacqua TJ
    Metabolomics and bladder cancer.
    Urol Oncol. 2011;29:558-61.
    Abstract     Related articles   

  469. LI Z , Yu J, Miao Q, Sun S, et al
    The association of fish consumption with bladder cancer risk: a meta-analysis.
    World J Surg Oncol. 2011;9:107.
    Abstract     Related articles   

  470. SOMJI S , Cao L, Mehus A, Zhou XD, et al
    Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As(+3)- and Cd (+2)-induced bladder cancer : Keratin 6, 7, 16, 17, and 19 in bladder cancer.
    Cell Biol Toxicol. 2011.
    Abstract     Related articles   

  471. GU J , Wu X
    Genetic susceptibility to bladder cancer risk and outcome.
    Per Med. 2011;8:365-374.
    Abstract     Related articles   

  472. DEGRAFF DJ , Cates JM, Mauney JR, Clark PE, et al
    When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression.
    Urol Oncol. 2011.
    Abstract     Related articles   

  473. SHI X , Zhang X, Li J, Guo F, et al
    Sequential administration of GM-CSF and IL-2 surface-modified MB49 cells vaccines against the metastatic bladder cancer.
    Urol Oncol. 2011.
    Abstract     Related articles   

  474. BARDGETT HP
    T-staging of bladder cancer - is it time to admit defeat?
    Clin Radiol. 2011.
    Abstract     Related articles   

  475. RAJESH A , Sokhi HK, Fung R, Mulcahy KA, et al
    Bladder cancer: Evaluation of staging accuracy using dynamic MRI.
    Clin Radiol. 2011.
    Abstract     Related articles   

  476. YAMADA A
    [Peptide-based cancer vaccine therapy for prostate cancer, bladder cancer, and malignant glioma].
    Nihon Rinsho. 2011;69:1657-61.
    Abstract     Related articles   

  477. SUGINO T , Baba K, Hoshi N, Aikawa K, et al
    Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients.
    Med Mol Morphol. 2011;44:146-50.
    Abstract     Related articles   

  478. OTTO W , Burger M, Fritsche HM, Rossler W, et al
    The enlightenment of bladder cancer treatment: origin and progress of photodynamic diagnosis.
    Future Oncol. 2011;7:1057-1066.
    Abstract     Related articles   

  479. GEOK CHIN T , Masir N, Noor Hussin H, Mohd Sidik S, et al
    Myeloid sarcoma of the urinary bladder with cutaneous tumour seeding after percutaneous suprapubic catheterization.
    Malays J Pathol. 2011;33:47-51.
    Abstract     Related articles   

  480. CHANG LC , Wu CL, Liu CW, Chuo WH, et al
    Preparation, characterization and cytotoxicity evaluation of tanshinone IIA nanoemulsions.
    J Biomed Nanotechnol. 2011;7:558-67.
    Abstract     Related articles   

  481. ZEITLIN I , Dessau H, Lorberboym M, Beigel Y, et al
    Malignant pheochromocytoma of the urinary bladder: challenges in diagnosis and management.
    Isr Med Assoc J. 2011;13:311-3.
    Abstract     Related articles   

  482. SHARABI Y
    Pheochromocytoma: progress and challenges.
    Isr Med Assoc J. 2011;13:304-5.
    Abstract     Related articles   

  483. ZAGHLOUL MS
    Joint genitourinary cancer symposium between Egyptian and American centers.
    Expert Rev Anticancer Ther. 2011;11:697-9.
    Abstract     Related articles   

  484. SCHEPMANN D , Lehmkuhl K, Brune S, Wunsch B, et al
    Expression of sigma receptors of human urinary bladder tumor cells (RT-4 cells) and development of a competitive receptor binding assay for the determination of ligand affinity to human sigma(2) receptors.
    J Pharm Biomed Anal. 2011;55:1136-41.
    Abstract     Related articles   

  485. TAKEYAMA N , Ohgiya Y, Hayashi T, Takahashi T, et al
    CT urography in the urinary bladder: to compare excretory phase images using a low noise index and a high noise index with adaptive noise reduction filter.
    Acta Radiol. 2011;52:692-8.
    Abstract     Related articles   

  486. MONTIRONI R , Cheng L, Scarpelli M, Mazzucchelli R, et al
    How much do you know about benign, preneoplastic, non-invasive and invasive neoplastic lesions of the urinary bladder classified according to the 2004 WHO scheme?
    Diagn Pathol. 2011;6:31.
    Abstract     Related articles   

  487. NUNNINK CJ , de Vries RR, Meinhardt W, van der Poel HG, et al
    [Pregnancy following sexuality-preserving cystectomy for bladder carcinoma].
    Ned Tijdschr Geneeskd. 2011;155:A2820.
    Abstract     Related articles   

  488. KRIJNEN P , Bos MM, Kloosterman-Boele WM, Bevers RF, et al
    [Variations in the treatment of non-metastatic muscle-invasive bladder carcinoma].
    Ned Tijdschr Geneeskd. 2011;155:A2703.
    Abstract     Related articles   

  489. PUNWANI S
    Diffusion weighted imaging of female pelvic cancers: Concepts and clinical applications.
    Eur J Radiol. 2010.
    Abstract     Related articles   

  490. PUNWANI S
    Contrast enhanced MR imaging of female pelvic cancers: established methods and emerging applications.
    Eur J Radiol. 2011;78:2-11.
    Abstract     Related articles   

  491. NIEDERSUSS-BEKE D
    [Systemic therapy of muscle invasive bladder cancer - an update.]
    Wien Med Wochenschr. 2011;161.
    Abstract     Related articles   

  492. PAN JG , Zhou X, Zeng GW, Han RF, et al
    Potent antitumour activity of the combination of HSV-TK and endostatin armed oncolytic adeno-associated virus for bladder cancer in vitro and in vivo.
    J Surg Oncol. 2011 Sep 27. doi: 10.1002/jso.22107.
    Abstract     Related articles   

  493. MA N , Thanan R, Kobayashi H, Hammam O, et al
    Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosomahaematobium infection.
    Biochem Biophys Res Commun. 2011.
    Abstract     Related articles   


  494. [Peculiarities of urinary bladder cancer tumor cells apoptosis response on neoadjuvant chemotherapy].
    Tsitol Genet. 2011;45:3-8.
    Abstract     Related articles   

  495. OKAMURA T , Akita H, Ando R, Ikegami Y, et al
    Single monthly bacillus Calmette-Guerin intravesical instillation is effective maintenance therapy to prevent recurrence in Japanese patients with non-muscle-invasive bladder cancer.
    Int J Clin Oncol. 2011.
    Abstract     Related articles   

  496. KARAGAS MR , Andrew AS, Nelson HH, Li Z, et al
    SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer.
    Hum Genet. 2011.
    Abstract     Related articles   

  497. TUNIO MA , Hashmi A, Qayyum A, Mohsin R, et al
    Whole-Pelvis or Bladder-Only Chemoradiation for Lymph Node-Negative Invasive Bladder Cancer: Single-Institution Experience.
    Int J Radiat Oncol Biol Phys. 2011.
    Abstract     Related articles   

  498. SHAH RU , Lawrence C, Fickenscher KA, Shao L, et al
    Imaging of pediatric pelvic neoplasms.
    Radiol Clin North Am. 2011;49:729-48.
    Abstract     Related articles   

  499. DIGHE MK , Bhargava P, Wright J
    Urinary bladder masses: techniques, imaging spectrum, and staging.
    J Comput Assist Tomogr. 2011;35:411-24.
    Abstract     Related articles   

  500. WANG K , Yan J, Liu X, Zhang J, et al
    Novel cytotoxity exhibition mode of polybia-CP, a novel antimicrobial peptide from the venom of the social wasp Polybia paulista.
    Toxicology. 2011;288.
    Abstract     Related articles   

  501. SAKAMOTO Y , Nishioka J, Noma K, Yasuda K, et al
    [Usefulness of survivin/glyceraldehyde-3-phosphate dehydrogenase ratio in urine exfoliated cells for the detection of bladder tumor].
    Rinsho Byori. 2011;59:446-51.
    Abstract     Related articles   

  502. STEPAN A , Simionescu C, Margaritescu C, Ciurea R, et al
    P16, c-erbB2 and Ki67 immunoexpression in urothelial carcinomas of the bladder.
    Rom J Morphol Embryol. 2011;52:653-8.
    Abstract     Related articles   

  503. AHN HK , Uhm JE, Lee J, Lim do H, et al
    Analysis of prognostic factors of pediatric-type sarcomas in adult patients.
    Oncology. 2011;80.
    Abstract     Related articles   

  504. CHO EJ , Yang J, Mohamedali KA, Lim EK, et al
    Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF121/rGel.
    Invest Radiol. 2011;46:441-9.
    Abstract     Related articles   

  505. LI C , Balluz LS, Ford ES, Okoro CA, et al
    Association Between Diagnosed Diabetes and Self-Reported Cancer Among U.S. Adults: Findings from the 2009 Behavioral Risk Factor Surveillance System.
    Diabetes Care. 2011.
    Abstract     Related articles   

  506. RADOVIC M , Damjanovic S, Nale D, Micic S, et al
    Modulation of aldosterone release by epidural analgesia impacts brain natriuretic peptide: a link to stress cardiomyopathy? Pilot study.
    Clin Endocrinol (Oxf). 2011;74:649-56.
    Abstract     Related articles   

  507. TALEB C , Pelissier P, Choughri H
    [Bladder urothelial carcinoma with acrometastasis: a case report and review of the literature].
    Chir Main. 2011;30:136-9.
    Abstract     Related articles   

  508. CEKMEN N , Aciksoz S, Serdaroglu H, Erdemli O, et al
    Endobronchial metastasis of a primary transitional-cell and signet-ring cell carcinoma of the urinary bladder.
    Respir Care. 2011;56:1033-6.
    Abstract     Related articles   

  509. YAFI FA , Duclos M, Correa JA, Tanguay S, et al
    Contemporary outcome and management of patients who had an aborted cystectomy due to unresectable bladder cancer.
    Urol Oncol. 2011;29:309-13.
    Abstract     Related articles   

  510. SANTOS LE , Guilhen AC, de Andrade RA, Sumi LG, et al
    The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer.
    Urol Oncol. 2011;29:291-4.
    Abstract     Related articles   

  511. PORTER MP , Kerrigan MC, Donato BM, Ramsey SD, et al
    Patterns of use of systemic chemotherapy for Medicare beneficiaries with urothelial bladder cancer.
    Urol Oncol. 2011;29:252-8.
    Abstract     Related articles   

  512. HALACHMI S , Moskovitz B, Maffezzini M, Conti G, et al
    Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder.
    Urol Oncol. 2011;29:259-64.
    Abstract     Related articles   

  513. HOLLINGSWORTH JM , Zhang YS, Miller DC, Skolarus TA, et al
    Identifying Better Practices for Early-stage Bladder Cancer.
    Med Care. 2011.
    Abstract     Related articles   

  514. ALKHATEEB SS , Neill M, Bar-Moshe S, Rhijn BV, et al
    Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guerin.
    Urol Ann. 2011;3:119-26.
    Abstract     Related articles   

  515. GABRIEL U , Li L, Bolenz C, Steidler A, et al
    New insights into the influence of cigarette smoking on urothelial carcinogenesis: Smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Mol Carcinog. 2011 Oct 4. doi: 10.1002/mc.20860.
    Abstract     Related articles   

  516. WANG HC , Choudhary S
    Reactive oxygen species-mediated therapeutic control of bladder cancer.
    Nat Rev Urol. 2011 Oct 4. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  517. COX R , Epstein JI
    Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
    Am J Surg Pathol. 2011;35:1337-42.
    Abstract     Related articles   

  518. TSUBOI S , Sutoh M, Hatakeyama S, Hiraoka N, et al
    A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans.
    EMBO J. 2011;30:3173-85.
    Abstract     Related articles   

  519. MAUNDRELL J , Fletcher S, Roberts P, Stein A, et al
    Mycotic aneurysm of the aorta as a complication of Bacillus Calmette-Guerin instillation.
    J R Coll Physicians Edinb. 2011;41:114-6.
    Abstract     Related articles   

  520. LIN YL , Sun G, Liu XQ, Li WP, et al
    Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
    J Int Med Res. 2011;39:179-86.
    Abstract     Related articles   

  521. DAS D , Chaudhuri S, Deb AR, Aich RK, et al
    Treatment of cervical carcinoma with high-dose rate intracavitary brachytherapy: two years follow-up study.
    Asian Pac J Cancer Prev. 2011;12:807-10.
    Abstract     Related articles   

  522. VALDERRAMA JA , Ibacache A, Rodriguez JA, Theoduloz C, et al
    Studies on quinones. Part 47. Synthesis of novel phenylaminophenanthridinequinones as potential antitumor agents.
    Eur J Med Chem. 2011;46:3398-409.
    Abstract     Related articles   

  523. ADAMS W , Wu K, Liu JJ, Hsiao ST, et al
    Comparison of 2.6- and 1.4-mm imaging probes for confocal laser endomicroscopy of the urinary tract.
    J Endourol. 2011;25:917-21.
    Abstract     Related articles   

  524. WINQUIST E , Rodrigues G
    Open clinical uro-oncology trials in Canada.
    Can J Urol. 2011;18:5650-6.
    Abstract     Related articles   

  525. FARR A , Herout R, Margreiter M, Tosev G, et al
    New findings in bladder and prostate cancer: highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, Austria.
    Can J Urol. 2011;18:5601-7.
    Abstract     Related articles   

  526. EKROLL IK , Gederaas OA, Helander L, Hjelde A, et al
    Photo induced hexylaminolevulinate destruction of rat bladder cells AY-27.
    Photochem Photobiol Sci. 2011;10:1072-9.
    Abstract     Related articles   

  527. YANG N , Li SH, Lu YZ, Chen LS, et al
    Attenuated Salmonella typhimurium carrying shRNA-expressing vectors elicit RNA interference in murine bladder tumors.
    Acta Pharmacol Sin. 2011;32:368-74.
    Abstract     Related articles   

  528. MAY M , Herrmann E, Bolenz C, Brookman-May S, et al
    Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy.
    Ann Surg Oncol. 2011;18:2018-25.
    Abstract     Related articles   

  529. TSALLAS A , Jackson J, Burt H
    The uptake of paclitaxel and docetaxel into ex vivo porcine bladder tissue from polymeric micelle formulations.
    Cancer Chemother Pharmacol. 2011;68:431-44.
    Abstract     Related articles   

  530. WILLIAMSON SR , Lopez-Beltran A, Montironi R, Cheng L, et al
    Glandular lesions of the urinary bladder:clinical significance and differential diagnosis.
    Histopathology. 2011;58:811-34.
    Abstract     Related articles   

  531. LEGRAND G , Soliman H, Dubosq F, Verine J, et al
    Prevalence and spectrum of microsatellite alterations in nonmuscle invasive bladder cancers.
    Am J Cancer Res. 2011;1:595-603.
    Abstract     Related articles   

  532. IWAI A , Koga F, Fujii Y, Masuda H, et al
    Perioperative Complications of Radical Cystectomy After Induction Chemoradiotherapy in Bladder-sparing Protocol Against Muscle-invasive Bladder Cancer: A Single Institutional Retrospective Comparative Study with Primary Radical Cystectomy.
    Jpn J Clin Oncol. 2011.
    Abstract     Related articles   

  533. YANG D , Wang J, Li J, Wang H, et al
    Effect of membrane toxin 12 isolated from Naja naja atra on proliferation and invasion of human bladder cancer EJ cells.
    Mol Med Report. 2011 Oct 11. doi: 10.3892/mmr.2011.
    Abstract     Related articles   

  534. BITSIKA V , Roubelakis MG, Zagoura D, Trohatou O, et al
    Human Amniotic Fluid-Derived Mesenchymal Stem Cells As Therapeutic Vehicles: A Novel Approach For the Treatment of Bladder Cancer.
    Stem Cells Dev. 2011.
    Abstract     Related articles   

  535. MOUSSA O , Ciupek A, Watson DK, Halushka PV, et al
    Urinary thromboxane B(2) and thromboxane receptors in bladder cancer: Opportunity for detection and monitoring.
    Prostaglandins Other Lipid Mediat. 2011.
    Abstract     Related articles   

  536. LU Y , Liu P, Wen W, Grubbs CJ, et al
    Modulation of Gene Expression and Cell Cycle Signaling Pathways in Iressa-treated Urinary Bladder Cancer in Rats.
    Cancer Prev Res (Phila). 2011.
    Abstract     Related articles   

  537. TURKBEY B , Turkbey EB, Ravizzini G, Karcaaltincaba M, et al
    Imaging of bladder cancer: update on current approaches for diagnosis.
    JBR-BTR. 2011;94:178-84.
    Abstract     Related articles   

  538. RASTOGI R , Singh AK, Rastogi UC, Mohan C, et al
    Neurological deficit as the first manifestation of vesical transitional cell carcinoma.
    Saudi J Kidney Dis Transpl. 2011;22:1022-5.
    Abstract     Related articles   

  539. GUNIA S , Kakies C, May M, Koch S, et al
    Lewis(y) antigen (blood group 8, BG8) is a useful marker in the histopathological differential diagnosis of flat urothelial lesions of the urinary bladder.
    J Clin Pathol. 2011;64:672-6.
    Abstract     Related articles   

  540. LOGHAVI S , Bose S
    Polyomavirus infection and urothelial carcinoma.
    Diagn Cytopathol. 2011;39:531-5.
    Abstract     Related articles   

  541. THAM SM , Ng KH, Pook SH, Esuvaranathan K, et al
    Tumor and Microenvironment Modification during Progression of Murine Orthotopic Bladder Cancer.
    Clin Dev Immunol. 2011;2011:865684.
    Abstract     Related articles   

  542. BRYAN RT , James ND
    Bladder cancer: time for a rethink?
    Oncology (Williston Park). 2011;25:965.
    Abstract     Related articles   

  543. SANDLER H
    Bladder cancer: a condition worthy of clinical investigation.
    Oncology (Williston Park). 2011;25:960.
    Abstract     Related articles   

  544. KAMAT AM , Mathew P
    Bladder cancer: imperatives for personalized medicine.
    Oncology (Williston Park). 2011;25:951-8.
    Abstract     Related articles   

  545. BELLMUNT J , Orsola A, Wiegel T, Guix M, et al
    Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Ann Oncol. 2011;22 Suppl 6:vi45-9.
    Abstract     Related articles   

  546. VOLANIS D , Zaravinos A, Kadiyska T, Delakas D, et al
    Expression profile of Rho kinases in urinary bladder cancer.
    J BUON. 2011;16:511-21.
    Abstract     Related articles   

  547. HU J , Xuan X, Han C, Hao L, et al
    Anti-tumor Function of Double-promoter Regulated Adenovirus Carrying SEA Gene, in the Treatment of Bladder Cancer.
    Cell Biochem Biophys. 2011.
    Abstract     Related articles   

  548. AZZOUZ H , Cauberg EC, De Reijke TM
    Controversies in the management of T1 urothelial bladder cancer.
    Minerva Urol Nefrol. 2011;63:309-15.
    Abstract     Related articles   

  549. MANINDERPAL KG , Amir FH, Azad HA, Mun KS, et al
    Imaging findings of a primary bladder maltoma.
    Br J Radiol. 2011;84:e186-90.
    Abstract     Related articles   

  550. GUI Y , Guo G, Huang Y, Hu X, et al
    Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder.
    Nat Genet. 2011;43:875-8.
    Abstract     Related articles   

  551. YANG MH , Chu PY, Chen SC, Chung TW, et al
    Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.
    Biochem Biophys Res Commun. 2011;411:714-20.
    Abstract     Related articles   

  552. ANEIROS-FERNANDEZ J , Nicolae A, Preda O
    Smoothelin in bladder and gastrointestinal tract again.
    Histopathology. 2011;58:1173.
    Abstract     Related articles   

  553. SUN CH , Chang YH, Pan CC
    Activation of the PI3K/Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder.
    Histopathology. 2011;58:1054-63.
    Abstract     Related articles   

  554. HUYSENTRUYT CJ , Baldewijns MM, Ruland AM, Tonk RJ, et al
    Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology.
    Histopathology. 2011;58:1048-53.
    Abstract     Related articles   

  555. XIAO J , Zhu X, Hao GY, Zhu YC, et al
    Association between urothelial carcinoma after renal transplantation and infection by human papillomavirus types 16 and 18.
    Transplant Proc. 2011;43:1638-40.
    Abstract     Related articles   

  556. SINGH AK , Floyd MS, De Bolla AR
    Bladder amyloidosis mimicking carcinoma.
    Urol J. 2011;8:97.
    Abstract     Related articles   

  557. SHIN HS , Cho CH, Kum YS
    Extragastrointestinal stromal tumor of the urinary bladder: a case report.
    Urol J. 2011;8:165-7.
    Abstract     Related articles   

  558. SINGH O , Gupta SS, Hastir A
    Laparoscopic enucleation of leiomyoma of the urinary bladder: a case report and review of the literature.
    Urol J. 2011;8:155-8.
    Abstract     Related articles   

  559. CHENG L , HUANG WB
    [Pathologic diagnosis of benign glandular lesions of urinary bladder].
    Zhonghua Bing Li Xue Za Zhi. 2011;40:147-50.
    Abstract     Related articles   

  560. MATOSO A , Resnick MB, Wang LJ
    Comparison of 2 monoclonal TTF-1 antibodies.
    Appl Immunohistochem Mol Morphol. 2011;19:384.
    Abstract     Related articles   

  561. ERUSLANOV E , Daurkin I, Vieweg J, Daaka Y, et al
    Aberrant PGE metabolism in bladder tumor microenvironment promotes immunosuppressive phenotype of tumor-infiltrating myeloid cells.
    Int Immunopharmacol. 2011;11:848-55.
    Abstract     Related articles   

  562. MOSBAH A , El Bahnasawy M, Osman Y, Hekal IA, et al
    Early versus late rehabilitation of erectile function after nerve-sparing radical cystoprostatectomy: a prospective randomized study.
    J Sex Med. 2011;8:2106-11.
    Abstract     Related articles   

  563. KIM SK , Yun SJ, Kim J, Lee OJ, et al
    Identification of gene expression signature modulated by nicotinamide in a mouse bladder cancer model.
    PLoS One. 2011;6:e26131.
    Abstract     Related articles   

  564. WANG ZQ , Zhao J, Zeng J, Wu KJ, et al
    Specific survivin dual fluorescence resonance energy transfer molecular beacons for detection of human bladder cancer cells.
    Acta Pharmacol Sin. 2011 Oct 24. doi: 10.1038/aps.2011.
    Abstract     Related articles   

  565. MITTAL RD , Mandal RK, Gangwar R
    Base excision repair pathway genes polymorphism in prostate and bladder cancer risk in North Indian population.
    Mech Ageing Dev. 2011.
    Abstract     Related articles   

  566. GUO HR
    Age adjustment in ecological studies: using a study on arsenic ingestion and bladder cancer as an example.
    BMC Public Health. 2011;11:820.
    Abstract     Related articles   

  567. BERTZ S , Denzinger S, Otto W, Wieland WF, et al
    Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.
    Histopathology. 2011;59:722-32.
    Abstract     Related articles   

  568. SHINAGARE AB , Sadow CA, Sahni VA, Silverman SG, et al
    Urinary bladder: normal appearance and mimics of malignancy at CT urography.
    Cancer Imaging. 2011;11:100-8.
    Abstract     Related articles   

  569. MARINACCIO A , Belli S, Binazzi A, Scarselli A, et al
    Residential proximity to industrial sites in the area of Taranto (Southern Italy). A case-control cancer incidence study.
    Ann Ist Super Sanita. 2011;47:192-9.
    Abstract     Related articles   

  570. LORENTE JA , Bielsa O, Rijo E, Cortadellas R, et al
    Clinical-pathological differences and smoking habit depending on gender in a cohort of patients with transitional cell carcinoma of the bladder: retrospective study.
    Arch Esp Urol. 2011;64:427-33.
    Abstract     Related articles   

  571. STAMATIOU K , Moschouris H, Papadaki M, Perlepes G, et al
    Accuracy of modern ultrasonographic techniques in the follow up of patients with superficial bladder carcinoma.
    Med Ultrason. 2011;13:114-9.
    Abstract     Related articles   

  572. TOLOSI L , Lengauer T
    Classification with correlated features: unreliability of feature ranking and solutions.
    Bioinformatics. 2011;27:1986-94.
    Abstract     Related articles   

  573. ABD-ELFATTAH EF
    Saddlepoint p-values and confidence intervals for a class of two sample permutation tests for current status and panel count data.
    Lifetime Data Anal. 2011;17:461-72.
    Abstract     Related articles   

  574. SAMPLASKI MK , Heston W, Elson P, Magi-Galluzzi C, et al
    Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature.
    Mod Pathol. 2011;24:1531.
    Abstract     Related articles   

  575. BURKHARD FC , Roth B, Zehnder P, Studer UE, et al
    Lymphadenectomy for bladder cancer: indications and controversies.
    Urol Clin North Am. 2011;38:397-405.
    Abstract     Related articles   

  576. CARRADORI S , Cristini C, Secci D, Gulia C, et al
    Current and Emerging Strategies in Bladder Cancer.
    Anticancer Agents Med Chem. 2011.
    Abstract     Related articles   

  577. MAO QQ , Dai Y, Lin YW, Qin J, et al
    Milk Consumption and Bladder Cancer Risk: A Meta-Analysis of Published Epidemiological Studies.
    Nutr Cancer. 2011.
    Abstract     Related articles   

  578. MARUYAMA T , Yamamoto S, Qiu J, Ueda Y, et al
    Apoptosis of bladder cancer by sodium butyrate and cisplatin.
    J Infect Chemother. 2011.
    Abstract     Related articles   

  579. ZHANG ZL , Xiong YH, Li YH, Hou GL, et al
    Reassessment of the predictive role of perivesical fat invasion in invasive bladder cancer prognosis in 151 Chinese patients.
    Chin Med J (Engl). 2011;124:2915-9.
    Abstract     Related articles   

  580. PELUCCHI C , Galeone C, Tramacere I, Bagnardi V, et al
    Alcohol drinking and bladder cancer risk: a meta-analysis.
    Ann Oncol. 2011.
    Abstract     Related articles   

  581. RYDER RE
    Pioglitazone and bladder cancer.
    Lancet. 2011;378:1544.
    Abstract     Related articles   

  582. HILLAIRE-BUYS D , Faillie JL, Montastruc JL
    Pioglitazone and bladder cancer.
    Lancet. 2011;378:1543-4.
    Abstract     Related articles   

  583. RUSTAGI T , Rai M, Alekshun TJ
    Granulomatous hepatitis from disseminated Mycobacterium bovis infection: shift of an intended local towards a detrimental systemic infection.
    Trop Gastroenterol. 2011;32:157-8.
    Abstract     Related articles   

  584. BADMOS KB , Ibrahim OK, Aboyeji AP, Omotayo JA, et al
    Squamous cell carcinoma arising in a mature cystic ovarian teratoma with bladder invasion: a case report.
    Afr Health Sci. 2011;11:285-7.
    Abstract     Related articles   

  585. NITZ MD , Harding MA, Smith SC, Thomas S, et al
    RREB1 transcription factor splice variants in urologic cancer.
    Am J Pathol. 2011;179:477-86.
    Abstract     Related articles   

  586. PUTZKE AP , Ventura AP, Bailey AM, Akture C, et al
    Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases.
    Am J Pathol. 2011;179:400-10.
    Abstract     Related articles   

  587. XUE K , Pridgeon S, Gillibrand R, Sanchez de Crespo J, et al
    Clinical presentations of schistosoma hematobium: three case reports and review.
    Can J Urol. 2011;18:5757-62.
    Abstract     Related articles   

  588. RODRIGUES G , Winquist E
    Open clinical uro-oncology trials in Canada.
    Can J Urol. 2011;18:5751-6.
    Abstract     Related articles   

  589. STRIFFOLINO CB , Moore T
    Flexible bronchoscopy with transbronchial needle aspiration confirmed by endobronchial ultrasound.
    Gastroenterol Nurs. 2011;34:243-4.
    Abstract     Related articles   

  590. WITTSCHIEBER D , Stenzinger A, Klauschen F, Stephan C, et al
    Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
    Pathobiology. 2011;78:123-31.
    Abstract     Related articles   

  591. HA ID , Sylvester R, Legrand C, Mackenzie G, et al
    Frailty modelling for survival data from multi-centre clinical trials.
    Stat Med. 2011;30:2144-59.
    Abstract     Related articles   

  592. BAGLO Y , Sousa MM, Slupphaug G, Hagen L, et al
    Photodynamic therapy with hexyl aminolevulinate induces carbonylation, posttranslational modifications and changed expression of proteins in cell survival and cell death pathways.
    Photochem Photobiol Sci. 2011;10:1137-45.
    Abstract     Related articles   

  593. SAKAI H , Yonemaru K, Takeda M, Niimi K, et al
    Ganglioneuroma in the urinary bladder of a dog.
    J Vet Med Sci. 2011;73:801-3.
    Abstract     Related articles   


  594. Bladder cancer: Plant lectins have the potential to facilitate targeted delivery of intravesical chemotherapy agents.
    Nat Rev Urol. 2011;8:589.
    Abstract     Related articles   

  595. NOON AP , Pickvance SM, Catto JW
    Occupational exposure to crack detection dye penetrants and the potential for bladder cancer.
    Occup Environ Med. 2011.
    Abstract     Related articles   

  596. LINDEN M , Lind SB, Mayrhofer C, Segersten U, et al
    Proteomic analysis of urinary biomarker candidates for non-muscle invasive bladder cancer.
    Proteomics. 2011 Nov 8. doi: 10.1002/pmic.201000810.
    Abstract     Related articles   

  597. ICHIHARA K , Kitamura H, Masumori N, Fukuta F, et al
    Transurethral prostate biopsy before radical cystectomy remains clinically relevant for decision-making on urethrectomy in patients with bladder cancer.
    Int J Clin Oncol. 2011.
    Abstract     Related articles   

  598. THARIAT J , Aluwini S, Pan Q, Caullery M, et al
    Image-guided radiation therapy for muscle-invasive bladder cancer.
    Nat Rev Urol. 2011 Nov 8. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   


  599. Bladder cancer: Prognostic potential of ANXA10 expression.
    Nat Rev Urol. 2011 Nov 8. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  600. UENO K , Hirata H, Majid S, Yamamura S, et al
    Tumor suppressor microRNA-493 decreases cell motility and migration ability in human bladder cancer cells by down-regulating RhoC and FZD4.
    Mol Cancer Ther. 2011.
    Abstract     Related articles   

  601. LOTAN Y , Amiel G, Boorjian SA, Clark PE, et al
    Comprehensive handbook for developing a bladder cancer cystectomy database.
    Urol Oncol. 2011.
    Abstract     Related articles   

  602. LACHMANN S , Jevons A, De Rycker M, Casamassima A, et al
    Regulatory domain selectivity in the cell-type specific PKN-dependence of cell migration.
    PLoS One. 2011;6:e21732.
    Abstract     Related articles   

  603. GUNES S , Yegin Z, Sullu Y, Buyukalpelli R, et al
    SOX4 expression levels in urothelial bladder carcinoma.
    Pathol Res Pract. 2011;207:423-7.
    Abstract     Related articles   

  604. DOBEK GL , Zhang X, Balazs DA, Godbey WT, et al
    Analysis of promoters and expression-targeted gene therapy optimization based on doubling time and transfectability.
    FASEB J. 2011;25:3219-28.
    Abstract     Related articles   

  605. AHMAD I , Singh LB, Foth M, Morris CA, et al
    K-Ras and beta-catenin mutations cooperate with Fgfr3 mutations in mice to promote tumorigenesis in the skin and lung, but not in the bladder.
    Dis Model Mech. 2011;4:548-55.
    Abstract     Related articles   

  606. AVCU S , Koseoglu MN, Ceylan K, Dbulutand M, et al
    The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions.
    Br J Radiol. 2011.
    Abstract     Related articles   

  607. ZHAO X , Zhou J, Sun L
    Semiparametric transformation models with time-varying coefficients for recurrent and terminal events.
    Biometrics. 2011;67:404-14.
    Abstract     Related articles   

  608. OHZEKI T , Hashimoto K, Katoh Y, Iguchi M, et al
    [Invasive Bladder Cancer with Concomitant Carcinoma in Situ Treated with Chemoradiotherapy Followed by BCG Intravesical Infusion Therapy to Preserve the Bladder : Report of Three Cases.]
    Hinyokika Kiyo. 2011;57:581-584.
    Abstract     Related articles   

  609. KHOSRAVI-SHAHI P , Cabezon-Gutierrez L
    Selective organ preservation in muscle-invasive bladder cancer: Review of the literature.
    Surg Oncol. 2011.
    Abstract     Related articles   

  610. FLETCHER A , Choudhury A, Alam N
    Metastatic bladder cancer: a review of current management.
    ISRN Urol. 2011;2011:545241.
    Abstract     Related articles   

  611. VAN DIJK PR , Ploeg M, Aben KK, Weijerman PC, et al
    Downstaging of TURBT-Based Muscle-Invasive Bladder Cancer by Radical Cystectomy Predicts Better Survival.
    ISRN Urol. 2011;2011:458930.
    Abstract     Related articles   

  612. XIAO Z , Hanel E, Mak A, Moore RB, et al
    Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-alpha and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model.
    Clin Med Insights Oncol. 2011;5:315-23.
    Abstract     Related articles   

  613. CODOLO G , Fassan M, D'Elios MM, de Bernard M, et al
    HP-NAP new therapy for bladder cancer: numquam periculum sine periculo vincitur.
    Cancer Immunol Immunother. 2011.
    Abstract     Related articles   

  614. JACKSON AM , Franks HA
    Response to the rebuttal letter of Kountouras and colleagues regarding the paper by Codolo et al. 'HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response'
    Cancer Immunol Immunother. 2011.
    Abstract     Related articles   

  615. ISMAILI N
    A rare bladder cancer - small cell carcinoma: review and update.
    Orphanet J Rare Dis. 2011;6:75.
    Abstract     Related articles   

  616. YAMAMOTO Y , Nishimura K, Ueda N, Kawamura N, et al
    [Bilateral upper tract urothelial carcinoma eight years after total cystectomy and indiana pouch urinary diversion for bladder cancer : a case report].
    Hinyokika Kiyo. 2011;57:509-12.
    Abstract     Related articles   

  617. IKEDA M , Matsumoto K, Tabata K, Minamida S, et al
    Combination of gemcitabine and paclitaxel is a favorable option for patients with advanced or metastatic urothelial carcinoma previously treated with cisplatin-based chemotherapy.
    Jpn J Clin Oncol. 2011;41:1214-20.
    Abstract     Related articles   

  618. MATSUGASUMI T , Kamoi K, Harikai S, Inagaki T, et al
    [Localized amyloidosis of the urinary bladder: a case report].
    Hinyokika Kiyo. 2011;57:439-43.
    Abstract     Related articles   

  619. SZEKELY E , Torzsok P, Riesz P, Korompay A, et al
    Expression of claudins and their prognostic significance in noninvasive urothelial neoplasms of the human urinary bladder.
    J Histochem Cytochem. 2011;59:932-41.
    Abstract     Related articles   

  620. SATYAM A , Singh P, Sharma M, Seth A, et al
    CYFRA 21-1: a potential molecular marker for noninvasive differential diagnosis of urothelial carcinoma of bladder.
    Biomarkers. 2011;16:413-21.
    Abstract     Related articles   

  621. WANG YC , Han BM, Wang XH, Yu SQ, et al
    [Characterization of stromal cell cultures from the prostatic peripheral zone of men at different ages].
    Zhonghua Nan Ke Xue. 2011;17:219-23.
    Abstract     Related articles   

  622. CZERNIAK B
    Molecular pathology and biomarkers of bladder cancer.
    Cancer Biomark. 2011;9:159-76.
    Abstract     Related articles   

  623. XUE Y , Li L, Zhang D, Wu K, et al
    Twisted Epithelial-to-Mesenchymal Transition Promotes Progression of Surviving Bladder Cancer T24 Cells with hTERT-Dysfunction.
    PLoS One. 2011;6:e27748.
    Abstract     Related articles   

  624. NAWROTH R , Stellwagen F, Schulz WA, Stoehr R, et al
    S6K1 and 4E-BP1 Are Independent Regulated and Control Cellular Growth in Bladder Cancer.
    PLoS One. 2011;6:e27509.
    Abstract     Related articles   

  625. KAWASHIMA A , Takayama H, Tsujimura A
    A Review of ERCC1 Gene in Bladder Cancer: Implications for Carcinogenesis and Resistance to Chemoradiotherapy.
    Adv Urol. 2012;2012:812398.
    Abstract     Related articles   

  626. DOWDY D
    Tobacco smoking and bladder cancer.
    JAMA. 2011;306:2216-7.
    Abstract     Related articles   

  627. NICHOLSON S
    Chemotherapy for bladder cancer in patients with impaired renal function.
    Nat Rev Urol. 2011 Nov 22. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  628. KOGA F , Yoshida S, Tatokoro M, Kawakami S, et al
    ErbB2 and NFkappaB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder Cancer.
    PLoS One. 2011;6:e27616.
    Abstract     Related articles   

  629. JAISWAL PK , Goel A, Mittal RD
    Association of p53 codon 248 (exon7) with urinary bladder cancer risk in the North Indian population.
    Biosci Trends. 2011;5:205-10.
    Abstract     Related articles   

  630. BOHLE A
    The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscleinvasive bladder cancer treated with bacillus Calmette-Guerin: external validation of the EORTC risk tables.
    Int Braz J Urol. 2011;37:671-2.
    Abstract     Related articles   

  631. REIS LO
    Diminished efficacy of bacille calmette-guerin among elderly patients with nonmuscle invasive bladder cancer.
    Int Braz J Urol. 2011;37:679-80.
    Abstract     Related articles   

  632. BOHLE A
    Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystoscopy: A multicenter randomized, double-blind, placebo-controlled trial.
    Int Braz J Urol. 2011;37:674-5.
    Abstract     Related articles   

  633. BOHLE A
    Compliance with guidelines for patients with bladder cancer: Variation in the Delivery of Care.
    Int Braz J Urol. 2011;37:673.
    Abstract     Related articles   

  634. CHAMIE K , Litwin MS
    Quality of bladder cancer care in the USA.
    Expert Rev Pharmacoecon Outcomes Res. 2011;11:619-21.
    Abstract     Related articles   

  635. YOSHIDA S , Koga F, Tatokoro M, Kawakami S, et al
    Low-dose Hsp90 inhibitors tumor-selectively sensitize bladder cancer cells to chemoradiotherapy.
    Cell Cycle. 2011;10.
    Abstract     Related articles   

  636. XU R , Zhang L, Zhao X, Jiang H, et al
    Benzalkonium bromide as a new potential instillation drug for bladder cancer: Hypothesis and pilot study.
    Med Sci Monit. 2011;17:HY36-39.
    Abstract     Related articles   

  637. KIM Y , Kim WJ, Cha EJ
    Quercetin-induced Growth Inhibition in Human Bladder Cancer Cells Is Associated with an Increase in Ca-activated K Channels.
    Korean J Physiol Pharmacol. 2011;15:279-83.
    Abstract     Related articles   

  638. JACOBS BL , Montgomery JS, Zhang Y, Skolarus TA, et al
    Disparities in bladder cancer.
    Urol Oncol. 2011.
    Abstract     Related articles   

  639. SANCHO G , Maroto P, Palou J
    Current management of muscle-invasive bladder cancer.
    Clin Transl Oncol. 2011;13:855-61.
    Abstract     Related articles   

  640. IZMIRLI M , Inandiklioglu N, Abat D, Alptekin D, et al
    MTHFR Gene Polymorphisms in Bladder Cancer in the Turkish Population.
    Asian Pac J Cancer Prev. 2011;12:1833-5.
    Abstract     Related articles   

  641. DUDZIEC E , Goepel JR, Catto JW
    Global epigenetic profiling in bladder cancer.
    Epigenomics. 2011;3:35-45.
    Abstract     Related articles   

  642. HOFFMAN AM , Cairns P
    Epigenetics of kidney cancer and bladder cancer.
    Epigenomics. 2011;3:19-34.
    Abstract     Related articles   

  643. LEI AQ , Cheng L, Pan CX
    Current treatment of metastatic bladder cancer and future directions.
    Expert Rev Anticancer Ther. 2011;11:1851-62.
    Abstract     Related articles   

  644. ZHENG YL , Amr S, Saleh D, Dash C, et al
    Urinary bladder cancer risk factors in Egypt: a multi-center case-control study.
    Cancer Epidemiol Biomarkers Prev. 2011.
    Abstract     Related articles   

  645. CHEUNG JM , Hou SS, Yip SKh, Ng CF, et al
    An unusual cause of retention of urine after intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer.
    Hong Kong Med J. 2011;17:492-4.
    Abstract     Related articles   

  646. SMITH AB , Raynor M, Amling CL, Busby JE, et al
    Multi-Institutional Analysis of Robotic Radical Cystectomy for Bladder Cancer: Perioperative Outcomes and Complications in 227 Patients.
    J Laparoendosc Adv Surg Tech A. 2011.
    Abstract     Related articles   

  647. ZHU J , Jiang Z, Gao F, Hu X, et al
    A Systematic Analysis on DNA Methylation and the Expression of Both mRNA and microRNA in Bladder Cancer.
    PLoS One. 2011;6:e28223.
    Abstract     Related articles   

  648. ROCKENBACH L , Bavaresco L, Fernandes Farias P, Cappellari AR, et al
    Alterations in the extracellular catabolism of nucleotides are involved in the antiproliferative effect of quercetin in human bladder cancer T24 cells.
    Urol Oncol. 2011.
    Abstract     Related articles   

  649. PLISSONNIER ML , Fauconnet S, Bittard H, Lascombe I, et al
    The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL.
    PLoS One. 2011;6:e28354.
    Abstract     Related articles   

  650. CHU H , Ma L, Wang M, Shi D, et al
    The polymorphisms of IL-4, IL-4R and IL-13 genes and bladder cancer risk in a Chinese population: a case-control study.
    Mol Biol Rep. 2011.
    Abstract     Related articles   

  651. ZHANG MM , Long YT, Ding Z
    Cisplatin effects on evolution of reactive oxygen species from single human bladder cancer cells investigated by scanning electrochemical microscopy.
    J Inorg Biochem. 2011.
    Abstract     Related articles   

  652. VASCONCELOS-NOBREGA C , Pinto-Leite R, Arantes-Rodrigues R, Ferreira R, et al
    In vivo and in vitro effects of RAD001 on bladder cancer.
    Urol Oncol. 2011.
    Abstract     Related articles   


  653. [The fluorescent hybridization in situ as applied in diagnostics of urinary bladder cancer].
    Klin Lab Diagn. 2011;:38-40.
    Abstract     Related articles   

  654. HENNENLOTTER J , Huber S, Todenhofer T, Kuehs U, et al
    Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria.
    Adv Urol. 2011;2011:937561.
    Abstract     Related articles   

  655. PORTA N , Luz Calle M, Malats N, Gomez G, et al
    A dynamic model for the risk of bladder cancer progression.
    Stat Med. 2011 Dec 9. doi: 10.1002/sim.4433.
    Abstract     Related articles   

  656. ZOIDAKIS J , Makridakis M, Zerefos PG, Bitsika V, et al
    Profilin 1 is a potential biomarker for bladder cancer aggressiveness.
    Mol Cell Proteomics. 2011.
    Abstract     Related articles   

  657. DU P , Ye L, Li H, Ruge F, et al
    Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.
    Int J Mol Med. 2011 Dec 12. doi: 10.3892/ijmm.2011.
    Abstract     Related articles   

  658. OTTO KB , Acharya SS, Robinson VL
    Stress-activated kinase pathway alteration is a frequent event in bladder cancer.
    Urol Oncol. 2011.
    Abstract     Related articles   

  659. SAFARINEJAD MR , Safarinejad S, Shafiei N, Safarinejad S, et al
    Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility.
    Urol Oncol. 2011.
    Abstract     Related articles   

  660. HAFNER C , Toll A, Real FX
    HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.
    N Engl J Med. 2011;365:1940-2.
    Abstract     Related articles   

  661. HASSAN SA , Qayyum MA
    Quiz page november 2011 hypertension with urination.
    Am J Kidney Dis. 2011;58:A29-31.
    Abstract     Related articles   

  662. BAYDAR DE , Tasar C
    Carcinoid tumor in the urinary bladder: unreported features.
    Am J Surg Pathol. 2011;35:1754-7.
    Abstract     Related articles   

  663. ISFOSS BL , Majak B, Busch C, Braathen GJ, et al
    Simplification of grading papillary urothelial neoplasia using a reduced set of diagnostic features.
    Anal Quant Cytol Histol. 2011;33:68-74.
    Abstract     Related articles   

  664. BLALOCK TW , Haun PL, Lesher JL Jr
    Cutaneous metastases of transitional cell carcinoma clinically mimicking lymphatic malformation.
    J Am Acad Dermatol. 2011;65:e112-4.
    Abstract     Related articles   

  665. TYAN YC , Yang MH, Chen SC, Jong SB, et al
    Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
    Rapid Commun Mass Spectrom. 2011;25:2851-62.
    Abstract     Related articles   

  666. YOHN NL , Bingaman CN, DuMont AL, Yoo LI, et al
    Phosphatidylinositol 3'-kinase, mTOR, and glycogen synthase kinase-3beta mediated regulation of p21 in human urothelial carcinoma cells.
    BMC Urol. 2011;11:19.
    Abstract     Related articles   

  667. HERR HH
    Narrow band imaging cystoscopy.
    Urol Oncol. 2011;29:353-7.
    Abstract     Related articles   

  668. BROECKER JS , Steelman CK, Broecker BH, Shehata BM, et al
    Nephrogenic adenoma of the bladder in a prune belly syndrome patient: case report and review of the literature.
    Fetal Pediatr Pathol. 2011;30:296-300.
    Abstract     Related articles   

  669. IOZZO RV , Buraschi S, Genua M, Xu SQ, et al
    Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling.
    J Biol Chem. 2011;286:34712-21.
    Abstract     Related articles   

  670. MAKIS W , Ciarallo A, Lisbona R
    Three Synchronous Primary Malignancies Detected by F-18 FDG PET/CT: Breast, Rectal, and Urothelial Bladder Carcinomas.
    Clin Nucl Med. 2011;36:791-4.
    Abstract     Related articles   

  671. STEWART GD , Humphries KJ, Cutress ML, Riddick AC, et al
    Long-term comparative outcomes of open versus laparoscopic nephroureterectomy for upper urinary tract urothelial-cell carcinoma after a median follow-up of 13 years*.
    J Endourol. 2011;25:1329-35.
    Abstract     Related articles   

  672. CHILDRESS MO , Adams LG, Ramos-Vara JA, Freeman LJ, et al
    Results of biopsy via transurethral cystoscopy and cystotomy for diagnosis of transitional cell carcinoma of the urinary bladder and urethra in dogs: 92 cases (2003-2008).
    J Am Vet Med Assoc. 2011;239:350-6.
    Abstract     Related articles   

  673. NEVES TR , Covita A, Soares M, Monteiro P, et al
    Bladder metastasis of gastric adenocarcinoma. Report of 2 cases and bibliographic review.
    Arch Esp Urol. 2011;64:544-50.
    Abstract     Related articles   

  674. SATO M , Yanai H, Morito T, Oda W, et al
    Association between the expression pattern of p16, pRb and p53 and the response to intravesical bacillus Calmette-Guerin therapy in patients with urothelial carcinoma in situ of the urinary bladder.
    Pathol Int. 2011;61:456-60.
    Abstract     Related articles   

  675. GENG F , Tang L, Li Y, Yang L, et al
    Allyl isothiocyanate arrests cancer cells in mitosis, and mitotic arrest in turn leads to apoptosis via Bcl-2 protein phosphorylation.
    J Biol Chem. 2011;286:32259-67.
    Abstract     Related articles   

  676. LEE TK , Chaux A, Karram S, Miyamoto H, et al
    Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center.
    Hum Pathol. 2011;42:1799-803.
    Abstract     Related articles   

  677. CHIANG PH , Luo HL, Chen YT, Kang CH, et al
    Is hand-assisted retroperitoneoscopic nephroureterectomy better than transurethral bladder cuff incision-assisted nephroureterectomy?
    J Endourol. 2011;25:1307-13.
    Abstract     Related articles   

  678. MARDI K , Gupta N
    Urachal papillary cystadenocarcinoma: a rare case report.
    J Cancer Res Ther. 2011;7:223-5.
    Abstract     Related articles   

  679. SALEMIS NS , Gakis C, Zografidis A, Gourgiotis S, et al
    Cutaneous metastasis of transitional cell bladder carcinoma: a rare presentation and literature review.
    J Cancer Res Ther. 2011;7:217-9.
    Abstract     Related articles   

  680. DHARASKAR A , Kumar V, Kapoor R, Jain M, et al
    Does extended lymph node dissection affect the lymph node density and survival after radical cystectomy?
    Indian J Cancer. 2011;48:230-3.
    Abstract     Related articles   

  681. THORNQVIST S , Bentzen L, Petersen JB, Hysing LB, et al
    Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques.
    Acta Oncol. 2011;50:926-34.
    Abstract     Related articles   

  682. THOR M , Petersen JB, Bentzen L, Hoyer M, et al
    Deformable image registration for contour propagation from CT to cone-beam CT scans in radiotherapy of prostate cancer.
    Acta Oncol. 2011;50:918-25.
    Abstract     Related articles   

  683. BING Z , Zhang PJ
    Adult urinary bladder tumors with rhabdomyosarcomatous differentiation: clinical, pathological and immunohistochemical studies.
    Diagn Pathol. 2011;6:66.
    Abstract     Related articles   

  684. XIAO L , Wang CF, Zhu XZ, Yin YL, et al
    [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Zhonghua Bing Li Xue Za Zhi. 2011;40:319-23.
    Abstract     Related articles   

  685. LOZANO MAYA M , Campos Cantero R, Plaza Santos R, Alberdi Alonso JM, et al
    Endoscopic extraction of a pig-tail catheter after urological surgery with Mainz II pouch urinary diversion.
    Rev Esp Enferm Dig. 2011;103:333-4.
    Abstract     Related articles   

  686. KANDASAMY M , Bay BH, Lee YK, Mahendran R, et al
    Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells.
    Cell Immunol. 2011;271:89-96.
    Abstract     Related articles   

  687. MANASSERO F , Di Paola G, Mogorovich A, Giannarini G, et al
    Orthotopic bladder substitute in renal transplant recipients: experience with Studer technique and literature review.
    Transpl Int. 2011 Jul 1. doi: 10.1111/j.1432-2277.2011.01292.
    Abstract     Related articles   

  688. KOVALA-DEMERTZI D , Staninska M, Garcia-Santos I, Castineiras A, et al
    Synthesis, crystal structures and spectroscopy of meclofenamic acid and its metal complexes with manganese(II), copper(II), zinc(II) and cadmium(II). Antiproliferative and superoxide dismutase activity.
    J Inorg Biochem. 2011;105:1187-95.
    Abstract     Related articles   

  689. HANSEL DE , Paner GP, Nese N, Amin MB, et al
    Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula.
    Hum Pathol. 2011;42:1770-6.
    Abstract     Related articles   

  690. MICHALOWSKA-MITCZUK D , Brzezinska S, Augustynowicz-Kopec E, Langfort R, et al
    [Granuloma of epididymis of patient treated with intravesical BCG therapy--complication of BCG therapy or tuberculosis?].
    Pneumonol Alergol Pol. 2011;79:305-8.
    Abstract     Related articles   

  691. BURGER M
    [Comment to "Photodynamic diagnosis with hexaminolevulinate in Non-Muscle-Invasive Bladder Cancer. Experience of the BLUE GROUP"].
    Actas Urol Esp. 2011;35:446-7.
    Abstract     Related articles   

  692. NOZAKI T , Yasuda K, Watanabe A, Fuse H, et al
    Laparoscopic management of urachal mucinous borderline tumor associated with pseudomyxoma peritonei.
    Surg Laparosc Endosc Percutan Tech. 2011;21:e152-5.
    Abstract     Related articles   

  693. TERADA T
    Primary CD5-positive mucosa-associated lymphoid tissue lymphoma of the urinary bladder.
    Ann Diagn Pathol. 2011;15:382-4.
    Abstract     Related articles   

  694. DUAN C , Yuan K, Liu F, Xiao P, et al
    Volume-based features for detection of bladder wall abnormal regions via MR cystography.
    IEEE Trans Biomed Eng. 2011;58:2506-12.
    Abstract     Related articles   

  695. IACONO F , Ruffo A, Di Lauro G, Romis L, et al
    A case of giant cell tumor of the hipbone invading the bladder.
    Urologia. 2011;78:142-4.
    Abstract     Related articles   

  696. GAMAL WM , Osman MM, Hammady A, Eldahshoury M, et al
    Modified N-shaped ileal neobladder after radical cystectomy.
    Urol Oncol. 2011;29:366-71.
    Abstract     Related articles   

  697. LOPEZ-BELTRAN A , Jimenez RE, Montironi R, Patriarca C, et al
    Flat urothelial carcinoma in situ of the bladder with glandular differentiation.
    Hum Pathol. 2011;42:1653-9.
    Abstract     Related articles   

  698. CHING CB , Amin MB, Tubbs RR, Elson P, et al
    HER2 gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization.
    Mod Pathol. 2011;24:1111-9.
    Abstract     Related articles   

  699. WILLIAMSON SR , Zhang S, Yao JL, Huang J, et al
    ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin.
    Mod Pathol. 2011;24:1120-7.
    Abstract     Related articles   

  700. BRIMO F , Herawi M, Sharma R, Netto GJ, et al
    Hepatocyte nuclear factor-1beta expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis.
    Hum Pathol. 2011;42:1613-9.
    Abstract     Related articles   

  701. HESS J , Tschirdewahn S, Szarvas T, Rossi R, et al
    [Urothelial carcinoma of the bladder: evaluation by combined endoscopy and urine cytology: is incontrovertible assessment possible?].
    Urologe A. 2011;50:702-5.
    Abstract     Related articles   

  702. OZKORKMAZ EG
    Microscopic investigations in a diabetic rat urinary bladder infected with Trichosomoides crassicauda.
    J Electron Microsc (Tokyo). 2011;60:261-5.
    Abstract     Related articles   

  703. BOHN OL , Pardo-Castillo E, Fuertes-Camilo M, Rios-Luna NP, et al
    Urinary bladder paraganglioma in childhood: a case report and review of the literature.
    Pediatr Dev Pathol. 2011;14:327-32.
    Abstract     Related articles   

  704. KAUFMANN OG , Young JL, Sountoulides P, Kaplan AG, et al
    Robotic radical anterior pelvic exenteration: the UCI experience.
    Minim Invasive Ther Allied Technol. 2011;20:240-6.
    Abstract     Related articles   

  705. OKADA Y , Kamata S, Akashi T, Kurata M, et al
    Primitive neuroectodermal tumor/Ewing's sarcoma of the urinary bladder: a case report and its molecular diagnosis.
    Int J Clin Oncol. 2011;16:435-8.
    Abstract     Related articles   

  706. OHSAKI H , Hirakawa E, Nakamura M, Norimatsu Y, et al
    Expression of vimentin and high-molecular-weight cytokeratin (clone 34ssE12) in differentiating reactive renal tubular cells from low-grade urothelial carcinoma cells in voided urine.
    Cytopathology. 2011;22:247-52.
    Abstract     Related articles   

  707. NIKPOUR P , Baygi ME, Steinhoff C, Hader C, et al
    The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells.
    J Cell Mol Med. 2011;15:1210-24.
    Abstract     Related articles   

  708. HU Z , Ai Q, Xu H, Ma X, et al
    Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637.
    Urol Oncol. 2011;29:430-5.
    Abstract     Related articles   

  709. PRUTHI RS , Belsante J, Kurpad R, Nielsen ME, et al
    Robotic cystectomy and the Internet: separating fact from fiction.
    Urol Oncol. 2011;29:393-7.
    Abstract     Related articles   

  710. KU JH , Choi WS, Kwak C, Kim HH, et al
    Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Urol Oncol. 2011;29:383-7.
    Abstract     Related articles   

  711. JAISWAL PK , Goel A, Mandhani A, Mittal RD, et al
    Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort.
    Mol Biol Rep. 2011.
    Abstract     Related articles   

  712. SUN XF , Sun ZY, Pan B, Li L, et al
    Alteration in methylation pattern of oncogene Akt1 promoter region in bladder cancer.
    Mol Biol Rep. 2011.
    Abstract     Related articles   

  713. YUTKIN V , Chin J
    Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer.
    Expert Opin Investig Drugs. 2011.
    Abstract     Related articles   

  714. FLAIG TW , Theodorescu D
    Bladder cancer in 2011: The dawn of personalized medicine.
    Nat Rev Urol. 2011 Dec 20. doi: 10.1038/nrurol.2011.
    Abstract     Related articles   

  715. WU D , Tao J, Xu B, Li P, et al
    Downregulation of Dicer, a component of the microRNA machinery, in bladder cancer.
    Mol Med Report. 2011 Dec 14. doi: 10.3892/mmr.2011.
    Abstract     Related articles   

  716. LIN HY , Yang MC, Huang CH, Wu WJ, et al
    Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis.
    Urol Oncol. 2011.
    Abstract     Related articles   

  717. YOSHINO H , Enokida H, Chiyomaru T, Tatarano S, et al
    Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor arginine/serine-rich 9 (SRSF9/SRp30c) in bladder cancer.
    Biochem Biophys Res Commun. 2011.
    Abstract     Related articles   

  718. DAMJANOV I , Golubovic M
    Histopathology of urinary bladder carcinoma: less common variants.
    Srp Arh Celok Lek. 2011;139.
    Abstract     Related articles   

  719. HAKIMI AA , Ghavamian R
    Feasibility of minimally invasive lymphadenectomy in bladder and prostate cancer surgery.
    Urol Clin North Am. 2011;38:407-18.
    Abstract     Related articles   

  720. TORZSOK P , Riesz P, Kenessey I, Szekely E, et al
    Claudins and ki-67: potential markers to differentiate low- and high-grade transitional cell carcinomas of the urinary bladder.
    J Histochem Cytochem. 2011;59:1022-30.
    Abstract     Related articles   

  721. REXER H
    [First line therapy for local advanced or metastatic urothelial cell carcinoma: randomized phase II study to investigate the combination of vinflunine with gemcitabine and vinflunine with carboplatin in patients unfit for cisplatin therapy with advanc
    Urologe A. 2011;50:974-6.
    Abstract     Related articles   

  722. FREDERICKS WJ , McGarvey T, Wang H, Lal P, et al
    The bladder tumor suppressor protein TERE1 (UBIAD1) modulates cell cholesterol: implications for tumor progression.
    DNA Cell Biol. 2011;30:851-64.
    Abstract     Related articles   

  723. MULLER SC , Strunk T
    [Is the training and continuing education for urologists in Germany still up to date?].
    Urologe A. 2011;50:946-51.
    Abstract     Related articles   

  724. LAMBRECHTS S , Van Calsteren K, Capoen A, Op de Beeck K, et al
    A case of polypoid endometriosis of the bladder during pregnancy mimicking urachal carcinoma.
    Ultrasound Obstet Gynecol. 2011 Mar 3. doi: 10.1002/uog.8985.
    Abstract     Related articles   

  725. MAY M , Fritsche HM, Gilfrich C, Brookman-May S, et al
    [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder].
    Urologe A. 2011;50:821-9.
    Abstract     Related articles   

  726. FERNANDEZ-ACENERO MJ , Cordova S, Manzarbeitia F, Medina C, et al
    Immunohistochemical profile of urothelial and small cell carcinomas of the bladder.
    Pathol Oncol Res. 2011;17:519-23.
    Abstract     Related articles   

  727. KRAUSE FS , Walter B, Ott OJ, Haberle L, et al
    15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment.
    Anticancer Res. 2011;31:985-90.
    Abstract     Related articles   

  728. HOU JC , Landas S, Wang CY, Shapiro O, et al
    Instillation of mitomycin C after transurethral resection of bladder cancer impairs wound healing: an animal model.
    Anticancer Res. 2011;31:929-32.
    Abstract     Related articles   

  729. CHARACIEJUS D , Pasukoniene V, Jacobs JJ, Eidukevicius R, et al
    Prognostic significance of peripheral blood CD8highCD57+ lymphocytes in bladder carcinoma patients after intravesical IL-2.
    Anticancer Res. 2011;31:699-703.
    Abstract     Related articles   

  730. ONISHI T , Sasaki T, Hoshina A, Yabana T, et al
    Continuous saline bladder irrigation after transurethral resection is a prophylactic treatment choice for non-muscle invasive bladder tumor.
    Anticancer Res. 2011;31:1471-4.
    Abstract     Related articles   

  731. VASCONCELOS-NOBREGA C , Colaco A, Santos L, Vala H, et al
    Experimental study of the anticancer effect of gemcitabine combined with sirolimus on chemically induced urothelial lesions.
    Anticancer Res. 2011;31:1637-42.
    Abstract     Related articles   

  732. DU P , Ye L, Ruge F, Yang Y, et al
    Metastasis Suppressor-1, MTSS1, Acts as a Putative Tumour Suppressor in Human Bladder Cancer.
    Anticancer Res. 2011;31:3205-12.
    Abstract     Related articles   

  733. MIYATA Y , Sagara Y, Matsuo T, Ohba K, et al
    Response of recurrent urachal cancer to gemcitabine and cisplatin therapy: a case report and literature review.
    Anticancer Res. 2011;31:2335-8.
    Abstract     Related articles   

  734. MIYAZAKI J , Nishiyama H, Yano I, Nakaya A, et al
    The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma.
    Anticancer Res. 2011;31:2065-71.
    Abstract     Related articles   

  735. RAMACHANDRAN K , Gordian E, Singal R
    5-azacytidine reverses drug resistance in bladder cancer cells.
    Anticancer Res. 2011;31:3757-66.
    Abstract     Related articles   

  736. KAMAT AM , Karam JA, Grossman HB, Kader AK, et al
    Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
    BJU Int. 2011 Mar 22. doi: 10.1111/j.1464-410X.2010.10026.
    Abstract     Related articles   

  737. HODGES KB , Lopez-Beltran A, Maclennan GT, Montironi R, et al
    Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management.
    BJU Int. 2011;107:532-7.
    Abstract     Related articles   

  738. KAUFFMAN EC , Ng CK, Lee MM, Otto BJ, et al
    Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.
    BJU Int. 2011;107:628-35.
    Abstract     Related articles   

  739. KENNEY PA , Wszolek MF, Rieger-Christ KM, Neto BS, et al
    Novel ZEB1 expression in bladder tumorigenesis.
    BJU Int. 2011;107:656-63.
    Abstract     Related articles   

  740. BALTACI S , Adsan O, Ugurlu O, Aslan G, et al
    Reliability of frozen section examination of obturator lymph nodes and impact on lymph node dissection borders during radical cystectomy: results of a prospective multicentre study by the Turkish Society of Urooncology.
    BJU Int. 2011;107:547-53.
    Abstract     Related articles   

  741. HELLENTHAL NJ , Hussain A, Andrews PE, Carpentier P, et al
    Lymphadenectomy at the time of robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
    BJU Int. 2011;107:642-6.
    Abstract     Related articles   

  742. NEULANDER EZ , Kaneti J
    Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (nmibc).
    BJU Int. 2011;107:1685.
    Abstract     Related articles   

  743. TICKOO SK , Milowsky MI, Dhar N, Dudas ME, et al
    Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.
    BJU Int. 2011;107:844-9.
    Abstract     Related articles   

  744. GAKIS G , Schilling D, Renninger M, Seibold J, et al
    Comparison of the new American Joint Committee on Cancer substratification in node-negative pT2 urothelial carcinoma of the bladder: analysis of patient outcomes in a contemporary series.
    BJU Int. 2011;107:919-23.
    Abstract     Related articles   

  745. SVATEK RS , Shariat SF, Novara G, Skinner EC, et al
    Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort.
    BJU Int. 2011;107:898-904.
    Abstract     Related articles   

  746. LIBERMAN D , Alasker A, Sun M, Ismail S, et al
    Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
    BJU Int. 2011;107:905-11.
    Abstract     Related articles   

  747. GHADJAR P , Burkhard FC, Gautschi O, Thalmann GN, et al
    Induction chemotherapy for unresectable urothelial carcinoma of the bladder.
    BJU Int. 2011;107:894-7.
    Abstract     Related articles   

  748. ZHANG Y , Zhu C, Curado MP, Zheng T, et al
    Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease.
    BJU Int. 2011 May 18. doi: 10.1111/j.1464-410X.2011.10283.
    Abstract     Related articles   

  749. SCHNEIDER AC , Heukamp LC, Rogenhofer S, Fechner G, et al
    Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer.
    BJU Int. 2011 May 31. doi: 10.1111/j.1464-410X.2011.10203.
    Abstract     Related articles   

  750. BIRNIE A , Blick C, Fawcett D
    Long-term follow-up of t1 high-grade bladder cancer after intravesical bacille calmette-guerin treatment.
    BJU Int. 2011;107:2002.
    Abstract     Related articles   

  751. OZCAN MF , Dizdar O, Canda AE, Balbay MD, et al
    Regional lymph node status in patients with bladder cancer found to be pathological stage t0 at radical cystectomy following systemic chemotherapy.
    BJU Int. 2011;107:2002-3.
    Abstract     Related articles   

  752. FITZPATRICK JM , Bellmunt J, Dreicer R, Fleshner NE, et al
    Maximizing outcomes in genitourinary cancers across the treatment continuum.
    BJU Int. 2011;107 Suppl 2:1-12.
    Abstract     Related articles   

  753. GOLAN S , Baniel J, Lask D, Livne PM, et al
    Transurethral resection of bladder tumour complicated by perforation requiring open surgical repair - clinical characteristics and oncological outcomes.
    BJU Int. 2011;107:1065-8.
    Abstract     Related articles   

  754. MALMSTROM PU
    Bladder tumours: time for a paradigm shift?
    BJU Int. 2011;107:1543-5.
    Abstract     Related articles   

  755. SAKANO S , Matsuyama H, Takai K, Yoshihiro S, et al
    Risk group stratification to predict recurrence after transurethral resection in Japanese patients with stage Ta and T1 bladder tumours: validation study on the European Association of Urology guidelines.
    BJU Int. 2011;107:1598-604.
    Abstract     Related articles   

  756. GEAVLETE B , Multescu R, Georgescu D, Jecu M, et al
    Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
    BJU Int. 2011 Jun 28. doi: 10.1111/j.1464-410X.2011.10374.
    Abstract     Related articles   

  757. TAYLOR JM , Feifer A, Savage CJ, Maschino AC, et al
    Evaluating the utility of a preoperative nomogram for predicting 90-day mortality following radical cystectomy for bladder cancer.
    BJU Int. 2011 Jul 1. doi: 10.1111/j.1464-410X.2011.10391.
    Abstract     Related articles   

  758. ZUIVERLOON TC , Beukers W, van der Keur KA, Munoz JR, et al
    A methylation assay for the detection of non-muscle-invasive bladder cancer (NMIBC) recurrences in voided urine.
    BJU Int. 2011 Jul 14. doi: 10.1111/j.1464-410X.2011.10428.
    Abstract     Related articles   

  759. WATTS KL , Ristau BT, Yamase HT, Taylor Iii JA, et al
    Prognostic implications of lymph node involvement in bladder cancer: are we understaging using current methods?
    BJU Int. 2011;108:484-92.
    Abstract     Related articles   

  760. MITRA AP , Quinn DI, Dorff TB, Skinner EC, et al
    Factors influencing post-recurrence survival in bladder cancer following radical cystectomy.
    BJU Int. 2011 Aug 4. doi: 10.1111/j.1464-410X.2011.10455.
    Abstract     Related articles   

  761. ZHOU M , He L, Zu X, Zhang H, et al
    Lymphatic vessel density as a predictor of lymph node metastasis and its relationship with prognosis in urothelial carcinoma of the bladder.
    BJU Int. 2011;107:1930-5.
    Abstract     Related articles   

  762. SHAO P , Meng X, Li J, Lv Q, et al
    Laparoscopic extended pelvic lymph node dissection during radical cystectomy: technique and clinical outcomes.
    BJU Int. 2011;108:124-8.
    Abstract     Related articles   

  763. BARBIERI CE , Cha EK, Chromecki TF, Dunning A, et al
    Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
    BJU Int. 2011 Aug 18. doi: 10.1111/j.1464-410X.2011.010419.
    Abstract     Related articles   

  764. BOSTROM PJ , Alkhateeb S, Trottier G, Athanasopoulos PZ, et al
    Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.
    BJU Int. 2011 Aug 18. doi: 10.1111/j.1464-410X.2011.10371.
    Abstract     Related articles   

  765. ROELANTS M , Huygens A, Crnolatac I, Van Cleynenbreugel B, et al
    Evans blue as a selective dye marker for white-light diagnosis of non-muscle-invasive bladder cancer: an in vitro study.
    BJU Int. 2011 Aug 19. doi: 10.1111/j.1464-410X.2011.10465.
    Abstract     Related articles   

  766. KOGA F , Kihara K, Yoshida S, Yokoyama M, et al
    Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients.
    BJU Int. 2011 Aug 19. doi: 10.1111/j.1464-410X.2011.10425.
    Abstract     Related articles   

  767. SCOSYREV E , Messing EM
    Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
    BJU Int. 2011;108:700.
    Abstract     Related articles   

  768. BALAR AV , Milowsky MI
    Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer?
    BJU Int. 2011;108:699.
    Abstract     Related articles   

  769. ABDOLLAH F , Sun M, Schmitges J, Djahangirian O, et al
    Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
    BJU Int. 2011 Aug 24. doi: 10.1111/j.1464-410X.2011.10482.
    Abstract     Related articles   

  770. SEGAL R , Yafi FA, Brimo F, Tanguay S, et al
    Prognostic factors and outcome in patients with T1 high-grade bladder cancer: can we identify patients for early cystectomy?
    BJU Int. 2011 Aug 24. doi: 10.1111/j.1464-410X.2011.10462.
    Abstract     Related articles   

  771. SCOSYREV E , Golijanin D, Wu G, Messing E, et al
    The burden of bladder cancer in men and women: analysis of the years of life lost.
    BJU Int. 2011 Aug 23. doi: 10.1111/j.1464-410X.2011.10318.
    Abstract     Related articles   

  772. GILLITZER R , Farasaty-Ghazwiny M, Fritsch J, Schede J, et al
    Extraperitoneal ileal conduit.
    BJU Int. 2011;108:298-301.
    Abstract     Related articles   

  773. BRAUSI M
    Radical cystectomy for BCG failure: has the timing improved in recent years?
    BJU Int. 2011;108:186.
    Abstract     Related articles   

  774. SHELLEY MD , Cleves A, Wilt TJ, Mason MD, et al
    Gemcitabine chemotherapy for the treatment of metastatic bladder carcinoma.
    BJU Int. 2011;108:168-79.
    Abstract     Related articles   

  775. SOLOWAY MS , Hepps D, Katkoori D, Ayyathurai R, et al
    Radical cystectomy for BCG failure: has the timing improved in recent years?
    BJU Int. 2011;108:182-5.
    Abstract     Related articles   

  776. LAMM D
    Editorial comment: Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder.
    BJU Int. 2011;108:530.
    Abstract     Related articles   

  777. HERR HW
    Percivall Pott, the environment and cancer.
    BJU Int. 2011;108:479-81.
    Abstract     Related articles   

  778. KARAM JA
    Editorial comment: Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.
    BJU Int. 2011;108:537-8.
    Abstract     Related articles   

  779. NEUZILLET Y , Yonneau L, Lebret T, Herve JM, et al
    The Z-shaped ileal neobladder after radical cystectomy: an 18 years experience with 329 patients.
    BJU Int. 2011;108:596-602.
    Abstract     Related articles   

  780. GUPTA NP , Saini AK, Dogra PN, Seth A, et al
    Bipolar energy for transurethral resection of bladder tumours at low-power settings: initial experience.
    BJU Int. 2011;108:553-6.
    Abstract     Related articles   

  781. AZIZ A , Lessard A, Moore K, Hovington H, et al
    Improved cancer specific-survival in patients with carcinoma invading bladder muscle expressing cyclo-oxygenase-2.
    BJU Int. 2011;108:531-7.
    Abstract     Related articles   

  782. SFAKIANOS JP , Shariat SF, Favaretto RL, Rioja J, et al
    Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder.
    BJU Int. 2011;108:526-30.
    Abstract     Related articles   

  783. MAYER EK , Bottle A, Aylin P, Darzi AW, et al
    What is the role of risk-adjusted funnel plots in the analysis of radical cystectomy volume-outcome relationships?
    BJU Int. 2011;108:844-50.
    Abstract     Related articles   

  784. KURAMOTO T , Fujii R, Nagai H, Belladonna ML, et al
    IL-23 gene therapy for mouse bladder tumour cell lines.
    BJU Int. 2011;108:914-21.
    Abstract     Related articles   

  785. HAYN MH , Hellenthal NJ, Seixas-Mikelus SA, Mansour AM, et al
    Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases.
    BJU Int. 2011;108:882-7.
    Abstract     Related articles   

  786. MEIJER RP , van Onna IE, Kok ET, Bosch R, et al
    The risk profiles of three clinical types of carcinoma in situ of the bladder.
    BJU Int. 2011;108:839-43.
    Abstract     Related articles   

  787. CHOUDHURY A , Cowan R
    Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
    BJU Int. 2011;108:E313.
    Abstract     Related articles   

  788. LEE R , Chughtai B, Herman M, Shariat SF, et al
    Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC.
    BJU Int. 2011;108.
    Abstract     Related articles   

  789. SMITH AB , Raynor MC, Pruthi RS
    Peri- and postoperative outcomes of robot-assisted radical cystectomy (RARC).
    BJU Int. 2011;108.
    Abstract     Related articles   

  790. HOSSEINI A , Adding C, Nilsson A, Jonsson MN, et al
    Robotic cystectomy: surgical technique.
    BJU Int. 2011;108.
    Abstract     Related articles   

  791. BROWN AL , Cohen RJ
    Inverted papilloma of the urinary tract.
    BJU Int. 2011;107 Suppl 3:24-6.
    Abstract     Related articles   

  792. MARIAPPAN P , Finney SM, Head E, Somani BK, et al
    Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation acro
    BJU Int. 2011 Nov 1. doi: 10.1111/j.1464-410X.2011.10571.
    Abstract     Related articles   

  793. MUKHTAR S , Perry MJ
    Future prospects for bladder cancer biomarkers.
    BJU Int. 2011;108:1541-3.
    Abstract     Related articles   

  794. MESSER J , Shariat SF, Brien JC, Herman MP, et al
    Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
    BJU Int. 2011;108:701-5.
    Abstract     Related articles   

  795. NIELSEN JS , Rode F, Rahbek M, Andersson KE, et al
    Effect of the SK/IK channel modulator 4,5-dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591) on contractile force in rat, pig and human detrusor smooth muscle.
    BJU Int. 2011;108:771-7.
    Abstract     Related articles   

  796. LEVIDOU G , Gakiopoulou H, Kavantzas N, Saetta AA, et al
    Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma.
    BJU Int. 2011;108.
    Abstract     Related articles   

  797. VAN RHIJN BW
    Prospective trial to identify optimal bladder cancer surveillance protocol: reducing costs while maximizing sensitivity.
    BJU Int. 2011;108:1123-4.
    Abstract     Related articles   

  798. BAZARBASHI S , Soudy H, Abdelsalam M, Al-Jubran A, et al
    Co-administration of intravesical bacillus Calmette-Guerin and interferon alpha-2B as first line in treating superficial transitional cell carcinoma of the urinary bladder.
    BJU Int. 2011;108:1115-8.
    Abstract     Related articles   

  799. GILLION N , Xylinas E, Durand X, Ploussard G, et al
    Mid-term oncological control after laparoscopic radical cystectomy in men: a single-centre experience.
    BJU Int. 2011;108:1180-4.
    Abstract     Related articles   

  800. BARBIERE JM , Saeb-Parsy K, Greenberg DC, Wright KA, et al
    Trends in the use of radiotherapy and radical surgery for patients with bladder urothelial cell carcinoma in East Anglia, 1995-2006.
    BJU Int. 2011;108:1106-14.
    Abstract     Related articles   

  801. JENSEN JB , Pedersen KV, Olsen KO, Bisgaard UF, et al
    Mini-laparotomy approach to radical cystectomy.
    BJU Int. 2011;108:1125-30.
    Abstract     Related articles   

  802. ELSHAL AM , Barakat TS, Mosbah A, Abdel-Latif M, et al
    Complications of radical cysto-urethrectomy using modified Clavien grading system: prepubic versus perineal urethrectomy.
    BJU Int. 2011;108:1297-300.
    Abstract     Related articles   

  803. RIOJA J , Bandres E, Rosell Costa D, Rincon A, et al
    Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma.
    BJU Int. 2011;107:1833-8.
    Abstract     Related articles   

  804. BLICK CG , Nazir SA, Mallett S, Turney BW, et al
    Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
    BJU Int. 2011 Nov 28. doi: 10.1111/j.1464-410X.2011.10664.
    Abstract     Related articles   

  805. KHOCHIKAR M
    Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival.
    BJU Int. 2011;108.
    Abstract     Related articles   

  806. MAY M , Bastian PJ, Burger M, Bolenz C, et al
    Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder.
    BJU Int. 2011;108.
    Abstract     Related articles   

  807. AHARONY S , Baniel J, Yossepowitch O
    Clinically unconfirmed positive urinary cytology: diagnostic implications and oncological outcomes.
    BJU Int. 2011;108.
    Abstract     Related articles   

  808. HERMANN GG , Mogensen K, Carlsson S, Marcussen N, et al
    Fluorescence-guided transurethral resection of bladder tumours reduces bladder tumour recurrence due to less residual tumour tissue in Ta/T1 patients: a randomized two-centre study.
    BJU Int. 2011;108.
    Abstract     Related articles   

  809. JAGER W , Thomas C, Haag S, Hampel C, et al
    Early vs delayed radical cystectomy for 'high-risk' carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival.
    BJU Int. 2011;108.
    Abstract     Related articles   

  810. CANDA AE , Atmaca AF, Altinova S, Akbulut Z, et al
    Robot-assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracorporeal urinary diversion for bladder cancer: initial experience in 27 cases.
    BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10794.
    Abstract     Related articles   

  811. FEYISETAN O , Tracey C, Hellawell GO
    Probiotics, dendritic cells and bladder cancer.
    BJU Int. 2011 Dec 16. doi: 10.1111/j.1464-410X.2011.10749.
    Abstract     Related articles   

  812. PRIDGEON SW , Heer R, Taylor GA, Newell DR, et al
    Thiothymidine combined with UVA as a potential novel therapy for bladder cancer.
    Br J Cancer. 2011.
    Abstract     Related articles   

  813. ADHIM Z , Matsuoka T, Bito T, Shigemura K, et al
    In vitro and in vivo inhibitory effect of three Cox-2 inhibitors and epithelial-to-mesenchymal transition in human bladder cancer cell lines.
    Br J Cancer. 2011 Jul 12. doi: 10.1038/bjc.2011.
    Abstract     Related articles   

  814. MUNKSGAARD PP , Mansilla F, Brems Eskildsen AS, Fristrup N, et al
    Low ANXA10 expression is associated with disease aggressiveness in bladder cancer.
    Br J Cancer. 2011 Oct 6. doi: 10.1038/bjc.2011.
    Abstract     Related articles   

  815. TANAKA N , Miyajima A, Kosaka T, Miyazaki Y, et al
    Acquired platinum resistance enhances tumour angiogenesis through angiotensin II type 1 receptor in bladder cancer.
    Br J Cancer. 2011 Oct 4. doi: 10.1038/bjc.2011.
    Abstract     Related articles   

  816. VILLADSEN SB , Bramsen JB, Ostenfeld MS, Wiklund ED, et al
    The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer.
    Br J Cancer. 2011 Nov 22. doi: 10.1038/bjc.2011.
    Abstract     Related articles   

  817. POLESEL J , Gheit T, Talamini R, Shahzad N, et al
    Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.
    Br J Cancer. 2011 Nov 24. doi: 10.1038/bjc.2011.
    Abstract     Related articles   

  818. KEIDAR M , Walk R, Shashurin A, Srinivasan P, et al
    Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy.
    Br J Cancer. 2011;105:1295-301.
    Abstract     Related articles   

  819. MACKENZIE T , Zens MS, Ferrara A, Schned A, et al
    Diabetes and risk of bladder cancer: Evidence from a case-control study in New England.
    Cancer. 2011;117:1552-6.
    Abstract     Related articles   

  820. WU CT , Wu CF, Lu CH, Lin CC, et al
    Expression and function role of DNA methyltransferase 1 in human bladder cancer.
    Cancer. 2011 Apr 26. doi: 10.1002/cncr.26150.
    Abstract     Related articles   

  821. ALVA AS , Tallman CT, He C, Hussain MH, et al
    Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer: A multidisciplinary approach.
    Cancer. 2011 May 19. doi: 10.1002/cncr.26240.
    Abstract     Related articles   

  822. SHIGEHARA K , Sasagawa T, Kawaguchi S, Nakashima T, et al
    Etiologic role of human papillomavirus infection in bladder carcinoma.
    Cancer. 2011;117:2067-76.
    Abstract     Related articles   

  823. XING J , Dinney CP, Shete S, Huang M, et al
    Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
    Cancer. 2011 Jun 20. doi: 10.1002/cncr.26224.
    Abstract     Related articles   

  824. SHARIAT SF , Savage C, Chromecki TF, Sun M, et al
    Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: A decision-curve analysis.
    Cancer. 2011;117:2892-7.
    Abstract     Related articles   

  825. WOSNITZER MS , Hruby GW, Murphy AM, Barlow LJ, et al
    A comparison of the outcomes of neoadjuvant and adjuvant chemotherapy for clinical T2-T4aN0-N2M0 bladder cancer.
    Cancer. 2011 Jun 29. doi: 10.1002/cncr.26278.
    Abstract     Related articles   

  826. SONPAVDE G , Shariat SF
    Preoperative chemotherapy for bladder cancer: A standard waits to be optimally deployed.
    Cancer. 2011 Jul 5. doi: 10.1002/cncr.26239.
    Abstract     Related articles   

  827. INOUE K , Fukuhara H, Shimamoto T, Kamada M, et al
    Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer.
    Cancer. 2011 Jul 19. doi: 10.1002/cncr.26378.
    Abstract     Related articles   

  828. CHAMIE K , Saigal CS, Lai J, Hanley JM, et al
    Compliance with guidelines for patients with bladder cancer: Variation in the Delivery of Care.
    Cancer. 2011 Jul 11. doi: 10.1002/cncr.26198.
    Abstract     Related articles   

  829. CHAMIE K , Saigal CS, Lai J, Hanley JM, et al
    Quality of care in patients with bladder cancer: A case report?
    Cancer. 2011 Aug 5. doi: 10.1002/cncr.26402.
    Abstract     Related articles   

  830. ABOGUNRIN F , O'Kane HF, Ruddock MW, Stevenson M, et al
    The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
    Cancer. 2011 Sep 14. doi: 10.1002/cncr.26544.
    Abstract     Related articles   

  831. LOTAN Y
    The impact of biomarkers in multivariate algorithms for bladder cancer diagnosis in patients with hematuria.
    Cancer. 2011 Sep 14. doi: 10.1002/cncr.26535.
    Abstract     Related articles   

  832. OVERDEVEST JB , Thomas S, Kristiansen G, Hansel DE, et al
    CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.
    Cancer Res. 2011.
    Abstract     Related articles   

  833. PAONESSA JD , Ding Y, Randall KL, Munday R, et al
    Identification of an unintended consequence of Nrf2-directed cytoprotection against a key tobacco carcinogen plus a counteracting chemopreventive intervention.
    Cancer Res. 2011;71:3904-11.
    Abstract     Related articles   

  834. PUTLURI N , Shojaie A, Vasu VT, Vareed SK, et al
    Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression.
    Cancer Res. 2011.
    Abstract     Related articles   

  835. WANG M , Chu H, Yan F, Qin C, et al
    Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population.
    Carcinogenesis. 2011.
    Abstract     Related articles   

  836. NISHIYAMA N , Arai E, Nagashio R, Fujimoto H, et al
    Copy number alterations in urothelial carcinomas: their clinicopathological significance and correlation with DNA methylation alterations.
    Carcinogenesis. 2011;32:462-9.
    Abstract     Related articles   

  837. HIRATA H , Hinoda Y, Ueno K, Shahryari V, et al
    MicroRNA-1826 targets VEGFC, beta-catenin (CTNNB1) and MEK1 (MAP2K1) in human bladder cancer.
    Carcinogenesis. 2011.
    Abstract     Related articles   

  838. BHATTACHARYA A , Li Y, Geng F, Munday R, et al
    The principal urinary metabolite of allyl isothiocyanate, N-acetyl-S-(N-allylthiocarbamoyl)cysteine, inhibits the growth and muscle invasion of bladder cancer.
    Carcinogenesis. 2011.
    Abstract     Related articles   

  839. TEO MT , Landi D, Taylor C, Elliott F, et al
    The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes.
    Carcinogenesis. 2011.
    Abstract     Related articles   

  840. NISHIZAWA K , Nishiyama H, Matsui Y, Kobayashi T, et al
    Thioredoxin-interacting protein suppresses bladder carcinogenesis.
    Carcinogenesis. 2011;32:1459-66.
    Abstract     Related articles   

  841. SHIOTA M , Song Y, Yokomizo A, Kiyoshima K, et al
    Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.
    Clin Cancer Res. 2010;16:5654-63.
    Abstract     Related articles   

  842. YANG N , Feng S, Shedden K, Xie X, et al
    Urinary Glycoprotein Biomarker Discovery for Bladder Cancer Detection using LC-MS/MS and Label-free Quantification.
    Clin Cancer Res. 2011.
    Abstract     Related articles   

  843. REINERT T , Modin C, Mansilla Castano F, Lamy P, et al
    Comprehensive genome methylation analysis in bladder cancer;identification and validation of novel methylated genes and application of these as urinary tumor markers.
    Clin Cancer Res. 2011.
    Abstract     Related articles   

  844. FENDLER A , Stephan C, Yousef GM, Jung K, et al
    MicroRNAs as regulators of signal transduction in urological tumors.
    Clin Chem. 2011;57:954-68.
    Abstract     Related articles   

  845. AREND SM , van Soolingen D
    Editor's choice: Editorial commentary: Low level INH-resistant BCG: a sheep in wolf's clothing?
    Clin Infect Dis. 2011;52:89-93.
    Abstract     Related articles   

  846. ZEHNDER P , Desai M
    Extended lymph node dissection: bladder, kidney.
    Curr Opin Urol. 2011;21:110-4.
    Abstract     Related articles   

  847. GAKIS G , Todenhoefer T, Stenzl A
    The prognostic value of hematological and systemic inflammatory disorders in invasive bladder cancer.
    Curr Opin Urol. 2011.
    Abstract     Related articles   

  848. NIEGISCH G , Albers P
    Which patients benefit the most from neoadjuvant chemotherapy in advanced bladder cancer?
    Curr Opin Urol. 2011.
    Abstract     Related articles   

  849. HEMMINKI K , Bermejo JL, Ji J, Kumar R, et al
    Familial bladder cancer and the related genes.
    Curr Opin Urol. 2011.
    Abstract     Related articles   

  850. RU Y , Dancik GM, Theodorescu D
    Biomarkers for prognosis and treatment selection in advanced bladder cancer patients.
    Curr Opin Urol. 2011;21:420-7.
    Abstract     Related articles   

  851. FALKE J , Witjes JA
    Perioperative management of nonmuscle-invasive bladder cancer.
    Curr Opin Urol. 2011;21:403-8.
    Abstract     Related articles   

  852. MOSES KA , Zhang J, Hricak H, Bochner BH, et al
    Bladder cancer imaging: an update.
    Curr Opin Urol. 2011;21:393-7.
    Abstract     Related articles   

  853. KUBLER H , Gschwend JE
    Ileal neobladder in women with bladder cancer: cancer control and functional aspects.
    Curr Opin Urol. 2011.
    Abstract     Related articles   

  854. BELLMUNT J
    What are the expected developments in the medical treatment of bladder cancer.
    Eur J Cancer. 2011;47 Suppl 3:S294-7.
    Abstract     Related articles   

  855. MISHRA V , Mishra M, Ansari KM, Chaudhari BP, et al
    Edible oil adulterants, argemone oil and butter yellow, as aetiological factors for gall bladder cancer.
    Eur J Cancer. 2011.
    Abstract     Related articles   

  856. DUARTE-PEREIRA S , Paiva F, Costa VL, Ramalho-Carvalho J, et al
    Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
    Eur J Cancer. 2011;47:1106-14.
    Abstract     Related articles   

  857. ZLOTTA AR , Roumeguere T, Kuk C, Alkhateeb S, et al
    Select Screening in a Specific High-Risk Population of Patients Suggests a Stage Migration Toward Detection of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    Abstract     Related articles   

  858. STENZL A , Cowan NC, De Santis M, Kuczyk MA, et al
    Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines.
    Eur Urol. 2011.
    Abstract     Related articles   

  859. HERR HW , Dalbagni G, Donat SM
    Bacillus Calmette-Guerin Without Maintenance Therapy for High-Risk Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    Abstract     Related articles   

  860. CATTO JW
    Thirty-Five Years of Intravesical Bacillus Calmette-Guerin for Bladder Cancer: Where Now?
    Eur Urol. 2011.
    Abstract     Related articles   

  861. LAMMERS RJ , Witjes JA, Inman BA, Leibovitch I, et al
    The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review.
    Eur Urol. 2011.
    Abstract     Related articles   

  862. FERNANDEZ-GOMEZ J , Madero R, Solsona E, Unda M, et al
    The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guerin: External Validation of the EORTC Risk Tables.
    Eur Urol. 2011.
    Abstract     Related articles   

  863. CHALLACOMBE BJ , Bochner BH, Dasgupta P, Gill I, et al
    The Role of Laparoscopic and Robotic Cystectomy in the Management of Muscle-Invasive Bladder Cancer With Special Emphasis on Cancer Control and Complications.
    Eur Urol. 2011.
    Abstract     Related articles   

  864. VAN DER HORST G , van Asten JJ, Figdor A, van den Hoogen C, et al
    Real-Time Cancer Cell Tracking by Bioluminescence in a Preclinical Model of Human Bladder Cancer Growth and Metastasis.
    Eur Urol. 2011.
    Abstract     Related articles   

  865. FLEISCHMANN A , Rotzer D, Seiler R, Studer UE, et al
    Her2 Amplification is Significantly More Frequent in Lymph Node Metastases From Urothelial Bladder Cancer Than in the Primary Tumours.
    Eur Urol. 2011.
    Abstract     Related articles   

  866. VAN DEN BOSCH S , Alfred Witjes J
    Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review.
    Eur Urol. 2011.
    Abstract     Related articles   

  867. TILKI D , Burger M, Dalbagni G, Grossman HB, et al
    Urine Markers for Detection and Surveillance of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    Abstract     Related articles   

  868. ABOL-ENEIN H , Tilki D, Mosbah A, El-Baz M, et al
    Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study.
    Eur Urol. 2011.
    Abstract     Related articles   

  869. SYLVESTER RJ
    How Well Can You Actually Predict Which Non-Muscle-Invasive Bladder Cancer Patients Will Progress?
    Eur Urol. 2011.
    Abstract     Related articles   

  870. FERNANDEZ-GOMEZ J
    Reply from Authors re: Richard J. Sylvester. How Well Can You Actually Predict Which Non-Muscle-Invasive Bladder Cancer Patients Will Progress? Eur Urol. In press. doi:10.1016/j.eururo.2011.06.001.
    Eur Urol. 2011.
    Abstract     Related articles   

  871. NOVARA G , Ficarra V, Zattoni F
    Is robot-assisted radical cystectomy the right way to reduce complications in patients undergoing radical cystectomy?
    Eur Urol. 2011;59:219-21.
    Abstract     Related articles   

  872. HAYN MH , Hellenthal NJ, Hussain A, Stegemann AP, et al
    Defining morbidity of robot-assisted radical cystectomy using a standardized reporting methodology.
    Eur Urol. 2011;59:213-8.
    Abstract     Related articles   

  873. MAFFEZZINI M
    For wider acceptance of radical cystectomy and extended pelvic lymphadenectomy.
    Eur Urol. 2011;59:211-2.
    Abstract     Related articles   

  874. ROTH B , Birkhauser FD, Zehnder P, Burkhard FC, et al
    Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a prospective randomized trial.
    Eur Urol. 2011;59:204-10.
    Abstract     Related articles   

  875. LAMMERS RJ , Witjes WP, Hendricksen K, Caris CT, et al
    Smoking Status Is a Risk Factor for Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    Abstract     Related articles   

  876. OOSTERLINCK W , Sylvester R, Babjuk M, Kaasinen E, et al
    Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors?
    Eur Urol. 2011;59:374-6.
    Abstract     Related articles   

  877. OOSTERLINCK W , Kirkali Z, Sylvester R, da Silva FC, et al
    Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guerin and with bacillus Calmette-Guerin alone in patients with carcinoma in situ of the urinary bladder: results of an EORTC genito-urinary group randomized phase 2 tri
    Eur Urol. 2011;59:438-46.
    Abstract     Related articles   

  878. ZHANG H , Ye D
    Re: Hassan Abol-Enein, Derya Tilki, Ahmed Mosbah, et al. Does the Extent of Lymphadenectomy in Radical Cystectomy for Bladder Cancer Influence Disease-Free Survival? A Prospective Single-Center Study. Eur Urol 2011;60:572-7.
    Eur Urol. 2011.
    Abstract     Related articles   

  879. JENTZMIK F , Schrader AJ, Schrader M
    Re: Beat Roth, Frederic D. Birkhauser, Pascal Zehnder, et al. Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a p
    Eur Urol. 2011;59:e17-8.
    Abstract     Related articles   

  880. ZHU Y , Ye D
    Re: Beat Roth, Frederic D. Birkhauser, Pascal Zehnder, et al. Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a significant beneficial impact on early postoperative recovery and complications: results of a p
    Eur Urol. 2011;59:e15.
    Abstract     Related articles   

  881. SCHMITZ-DRAGER BJ
    Identifying Risk Factors in Patients With Non-Muscle-Invasive Bladder Cancer: Clinical Implications.
    Eur Urol. 2011.
    Abstract     Related articles   

  882. GOOSSENS-LAAN CA , Gooiker GA, van Gijn W, Post PN, et al
    A systematic review and meta-analysis of the relationship between hospital/surgeon volume and outcome for radical cystectomy: an update for the ongoing debate.
    Eur Urol. 2011;59:775-83.
    Abstract     Related articles   

  883. CATTO JW , Alcaraz A, Bjartell AS, De Vere White R, et al
    MicroRNA in prostate, bladder, and kidney cancer: a systematic review.
    Eur Urol. 2011;59:671-81.
    Abstract     Related articles   

  884. BABJUK M , Oosterlinck W, Sylvester R, Kaasinen E, et al
    EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.
    Eur Urol. 2011;59:997-1008.
    Abstract     Related articles   

  885. POUESSEL D , Culine S, Mongiat-Artus P
    Re: International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial.
    Eur Urol. 2011;60:870-1.
    Abstract     Related articles   

  886. STENZL A
    Reply to Alberto Bossi's Letter to the Editor re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18.
    Eur Urol. 2011.
    Abstract     Related articles   

  887. BOSSI A
    Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18.
    Eur Urol. 2011.
    Abstract     Related articles   

  888. CHA EK , Tirsar LA, Schwentner C, Christos PJ, et al
    Immunocytology Is a Strong Predictor of Bladder Cancer Presence in Patients With Painless Hematuria: A Multicentre Study.
    Eur Urol. 2011.
    Abstract     Related articles   

  889. SUNDAR S
    Re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009-18.
    Eur Urol. 2011.
    Abstract     Related articles   

  890. OLIVEIRA CA , Rodriguez O, Palou J, Palou-Redorta J, et al
    Re: Amit R. Patel, Edmund S. Sabanegh, J. Stephen Jones, et al. Bacillus Calmette-Guerin osteomyelitis mimicking spinal metastasis from urothelial cell carcinoma of the bladder. Eur Urol 2010;58:934-7.
    Eur Urol. 2011;60:e7.
    Abstract     Related articles   

  891. GUDJONSSON S
    Re: Willem Oosterlinck,Richard Sylvester, Marco Babjuk, et al. Should all patients receive an immediate chemotherapeutic drug instillation after resection of papillary bladder tumors? Eur Urol 2011;59:374-6.
    Eur Urol. 2011;60:e2-3.
    Abstract     Related articles   

  892. AGUNDEZ M , Grau L, Palou J, Algaba F, et al
    Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guerin response in patients with T1G3 high-risk bladder tumours.
    Eur Urol. 2011;60:131-40.
    Abstract     Related articles   

  893. OOI WL , Stockler M, Hayne D
    Re: Willem Oosterlinck, Ziya Kirkali,Richard Sylvester, et al. Sequential intravesical chemoimmunotherapy with mitomycin C and bacillus Calmette-Guerin and with bacillus Calmette-Guerin alone in patients with carcinoma in situ of the urinary bladder:
    Eur Urol. 2011;60:e1.
    Abstract     Related articles   

  894. ZUIVERLOON TC , Nieuweboer AJ, Vekony H, Kirkels WJ, et al
    Markers Predicting Response to Bacillus Calmette-Guerin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review.
    Eur Urol. 2011.
    Abstract     Related articles   

  895. GIANNARINI G , Petralia G, Thoeny HC
    Potential and Limitations of Diffusion-Weighted Magnetic Resonance Imaging in Kidney, Prostate, and Bladder Cancer Including Pelvic Lymph Node Staging: A Critical Analysis of the Literature.
    Eur Urol. 2011.
    Abstract     Related articles   

  896. VAN RHIJN BW , van der Kwast TH, Alkhateeb SS, Fleshner NE, et al
    A New and Highly Prognostic System to Discern T1 Bladder Cancer Substage.
    Eur Urol. 2011.
    Abstract     Related articles   

  897. SHARIAT SF , Ehdaie B, Rink M, Cha EK, et al
    Clinical Nodal Staging Scores for Bladder Cancer: A Proposal for Preoperative Risk Assessment.
    Eur Urol. 2011.
    Abstract     Related articles   

  898. PALOU J , Sylvester RJ, Rodriguez Faba O, Parada R, et al
    Female Gender and Carcinoma In Situ in the Prostatic Urethra Are Prognostic Factors for Recurrence, Progression, and Disease-Specific Mortality in T1G3 Bladder Cancer Patients Treated With Bacillus Calmette-Guerin.
    Eur Urol. 2011.
    Abstract     Related articles   

  899. EFSTATHIOU JA , Spiegel DY, Shipley WU, Heney NM, et al
    Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience.
    Eur Urol. 2011.
    Abstract     Related articles   

  900. WITJES JA
    Prognosis of T1G3 Bladder Cancer: How Well Can We Predict Progression?
    Eur Urol. 2011.
    Abstract     Related articles   

  901. MEIJER RP , van Rhijn BW
    A Plea for Long-Term Surveillance in Bacillus Calmette-Guerin-Treated Non-Muscle-Invasive Bladder Cancer.
    Eur Urol. 2011.
    Abstract     Related articles   

  902. CHROMECKI TF , Cha EK, Shariat SF
    Stage pT0 after radical cystectomy: are all patients equal?
    Eur Urol. 2011;60:603-4.
    Abstract     Related articles   

  903. FUNG B , Kessler TM, Haeni K, Burkhard FC, et al
    Bowel function remains subjectively unchanged after ileal resection for construction of continent ileal reservoirs.
    Eur Urol. 2011;60:585-90.
    Abstract     Related articles   

  904. ROSENBLATT R , Sherif A, Rintala E, Wahlqvist R, et al
    Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer.
    Eur Urol. 2011.
    Abstract     Related articles   

  905. CASH HL , Tao L, Yuan JM, Marsit CJ, et al
    LINE-1 hypomethylation is associated with bladder cancer risk among non-smoking Chinese.
    Int J Cancer. 2011 Mar 28. doi: 10.1002/ijc.26098.
    Abstract     Related articles   

  906. ERUSLANOV E , Neuberger M, Daurkin I, Perrin GQ, et al
    Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer.
    Int J Cancer. 2011 Apr 7. doi: 10.1002/ijc.26123.
    Abstract     Related articles   

  907. TAO L , Xiang YB, Chan KK, Wang R, et al
    Cytochrome P4501A2 phenotype and bladder cancer risk: The shanghai bladder cancer study.
    Int J Cancer. 2011 Apr 7. doi: 10.1002/ijc.26121.
    Abstract     Related articles   

  908. ROS MM , Bas Bueno-de-Mesquita HB, Buchner FL, Aben KK, et al
    Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Int J Cancer. 2011;128:2695-708.
    Abstract     Related articles   

  909. KOUTROS S , Silverman DT, Baris D, Zahm SH, et al
    Hair dye use and risk of bladder cancer in the new england bladder cancer study.
    Int J Cancer. 2011 Jun 15. doi: 10.1002/ijc.26245.
    Abstract     Related articles   

  910. VINALL RL , Zripoll A, Wang S, Pan CX, et al
    MiR-34a chemo-sensitizes bladder cancer cells to cisplatin treatment regardless of P53-Rb pathway status.
    Int J Cancer. 2011 Jun 23. doi: 10.1002/ijc.26256.
    Abstract     Related articles   

  911. KARAM JA , Huang S, Fan J, Stanfield J, et al
    Upregulation of TRAG3 gene in urothelial carcinoma of the bladder.
    Int J Cancer. 2011;128:2823-32.
    Abstract     Related articles   

  912. SZARVAS T , Laszlo V, Dorp FV, Reis H, et al
    Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancer.
    Int J Cancer. 2011 Aug 3. doi: 10.1002/ijc.26343.
    Abstract     Related articles   

  913. KECK B , Stoehr R, Wach S, Rogler A, et al
    The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.
    Int J Cancer. 2011;129:346-54.
    Abstract     Related articles   

  914. TATOKORO M , Koga F, Yoshida S, Kawakami S, et al
    Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells.
    Int J Cancer. 2011 Sep 30. doi: 10.1002/ijc.26475.
    Abstract     Related articles   

  915. HA YS , Kim JS, Yoon HY, Jeong P, et al
    Novel combination markers for predicting progression of non-muscle invasive bladder cancer.
    Int J Cancer. 2011 Oct 25. doi: 10.1002/ijc.27319.
    Abstract     Related articles   

  916. KIM CJ , Sakamoto K, Tambe Y, Inoue H, et al
    Opposite regulation of epithelial-to-mesenchymal transition and cell invasiveness by periostin between prostate and bladder cancer cells.
    Int J Oncol. 2011 Apr 5. doi: 10.3892/ijo.2011.
    Abstract     Related articles   

  917. YANO K , Horinaka M, Yoshida T, Yasuda T, et al
    Chetomin induces degradation of XIAP and enhances TRAIL sensitivity in urogenital cancer cells.
    Int J Oncol. 2011;38:365-74.
    Abstract     Related articles   

  918. TATARANO S , Chiyomaru T, Kawakami K, Enokida H, et al
    miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.
    Int J Oncol. 2011 Apr 20. doi: 10.3892/ijo.2011.1012.
    Abstract     Related articles   

  919. TADA Y , Yokomizo A, Shiota M, Tsunoda T, et al
    Aberrant DNA methylation of T-cell leukemia, homeobox 3 modulates cisplatin sensitivity in bladder cancer.
    Int J Oncol. 2011 May 23. doi: 10.3892/ijo.2011.1049.
    Abstract     Related articles   

  920. VASSOU D , Notas G, Hatzoglou A, Castanas E, et al
    Opioids increase bladder cancer cell migration via bradykinin B2 receptors.
    Int J Oncol. 2011 Jun 3. doi: 10.3892/ijo.2011.1063.
    Abstract     Related articles   

  921. MOIBI JA , Mak AL, Sun B, Moore RB, et al
    Urothelial cancer cell response to combination therapy of gemcitabine and TRAIL.
    Int J Oncol. 2011;39:61-71.
    Abstract     Related articles   

  922. MARCINKIEWICZ K , Scotland KB, Boorjian SA, Nilsson EM, et al
    The androgen receptor and stem cell pathways in prostate and bladder cancers (Review).
    Int J Oncol. 2011 Sep 28. doi: 10.3892/ijo.2011.1212.
    Abstract     Related articles   

  923. HSU SC , Yu CC, Yang JS, Lai KC, et al
    A novel synthetic 2-(3-methoxyphenyl)-6,7-methylenedioxoquinolin-4-one arrests the G2/M phase arrest via Cdc25c and induces apoptosis through caspase- and mitochondria-dependent pathways in TSGH8301 human bladder cancer cells.
    Int J Oncol. 2011 Oct 21. doi: 10.3892/ijo.2011.1241.
    Abstract     Related articles   

  924. WATSON CJ , O'Kane H, Maxwell P, Sharaf O, et al
    Identification of a methylation hotspot in the death receptor Fas/CD95 in bladder cancer.
    Int J Oncol. 2011 Nov 4. doi: 10.3892/ijo.2011.1250.
    Abstract     Related articles   

  925. TATARANO S , Chiyomaru T, Kawakami K, Enokida H, et al
    Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines.
    Int J Oncol. 2011 Dec 13. doi: 10.3892/ijo.2011.1294.
    Abstract     Related articles   

  926. SHIN YS , Kim SD, Cha JS, Kim MK, et al
    Clinical significance of immediate urine cytology after transurethral resection of bladder tumor in patients with non-muscle invasive bladder cancer.
    Int J Urol. 2011 Apr 11. doi: 10.1111/j.1442-2042.2011.02766.
    Abstract     Related articles   

  927. EDGERTON N , Sirintrapun SJ, Munoz M, Chen Z, et al
    Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 24 cases.
    Int J Urol. 2011;18:49-54.
    Abstract     Related articles   

  928. MATSUSHITA K , Cha EK, Matsumoto K, Baba S, et al
    Immunohistochemical biomarkers for bladder cancer prognosis.
    Int J Urol. 2011 Jul 20. doi: 10.1111/j.1442-2042.2011.02809.
    Abstract     Related articles   

  929. KOZYRAKIS D , Petraki C, Prombonas I, Grigorakis A, et al
    Lymphoepithelioma-like bladder cancer: Clincopathologic study of six cases.
    Int J Urol. 2011 Aug 4. doi: 10.1111/j.1442-2042.2011.02825.
    Abstract     Related articles   

  930. DING S , Xing N, Lu J, Zhang H, et al
    Overexpression of Eg5 predicts unfavorable prognosis in non-muscle invasive bladder urothelial carcinoma.
    Int J Urol. 2011;18:432-8.
    Abstract     Related articles   

  931. EL-GAMAL OM
    Editorial comment to paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.
    Int J Urol. 2011;18:357.
    Abstract     Related articles   

  932. JOUNG JY , Kwon WA, Cho IC, Kim EK, et al
    Paclitaxel and cisplatin chemotherapy for metastatic urothelial carcinoma after failure of two courses of platinum-based regimens.
    Int J Urol. 2011;18:350-7.
    Abstract     Related articles   

  933. TAKAYANAGI A , Masumori N, Takahashi A, Takagi Y, et al
    Upper urinary tract recurrence after radical cystectomy for bladder cancer: Incidence and risk factors.
    Int J Urol. 2011 Nov 28. doi: 10.1111/j.1442-2042.2011.02916.
    Abstract     Related articles   

  934. IP SW , Chu YL, Yu CS, Chen PY, et al
    Bee venom induces apoptosis through intracellular Ca(2+) -modulated intrinsic death pathway in human bladder cancer cells.
    Int J Urol. 2011 Dec 11. doi: 10.1111/j.1442-2042.2011.02876.
    Abstract     Related articles   

  935. RINK M , Dahlem R, Kluth L, Minner S, et al
    Older patients suffer from adverse histopathological features after radical cystectomy.
    Int J Urol. 2011;18:576-84.
    Abstract     Related articles   

  936. DE BERARDINIS E , Busetto GM, Antonini G, Giovannone R, et al
    T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy.
    Int Urol Nephrol. 2011.
    Abstract     Related articles   

  937. DALL'OGLIO MF , Antunes AA, Crippa A, Nesrallah AJ, et al
    Long-term outcomes of radical cystectomy with preservation of prostatic capsule.
    Int Urol Nephrol. 2010;42:951-7.
    Abstract     Related articles   

  938. PARK E , Ha HK, Chung MK
    Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer.
    Int Urol Nephrol. 2011.
    Abstract     Related articles   

  939. MITSUI Y , Yasumoto H, Arichi N, Honda S, et al
    Current chemotherapeutic strategies against bladder cancer.
    Int Urol Nephrol. 2011.
    Abstract     Related articles   

  940. COLLI J , Lee BR, Thomas R
    Population densities in relation to bladder cancer mortality rates in America from 1950 to 1994.
    Int Urol Nephrol. 2011.
    Abstract     Related articles   

  941. SHEN YJ , Zhu YP, Ye DW, Yao XD, et al
    Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a "second look" matters?
    Int Urol Nephrol. 2011.
    Abstract     Related articles   

  942. FENG CC , Ding Q, Zhang YF, Jiang HW, et al
    Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9.
    Int Urol Nephrol. 2011;43:383-90.
    Abstract     Related articles   


  943. International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial.
    J Clin Oncol. 2011.
    Abstract     Related articles   

  944. BAJORIN DF , Herr HW
    Kuhn's Paradigms: Are Those Closest to Treating Bladder Cancer the Last to Appreciate the Paradigm Shift?
    J Clin Oncol. 2011.
    Abstract     Related articles   

  945. WRONSKI S , Marszalek A
    Diagnostic Pitfalls of Rare Urinary Bladder Tumors: Differential Diagnosis of Lymphoma-Like Carcinoma of the Bladder--A Clinicopathologic Study and Literature Review.
    J Clin Oncol. 2010.
    Abstract     Related articles   

  946. NAIR BC , Williams NC, Cui C, Summers D, et al
    Conjunctival Melanoma: Bladder and Upper Urinary Tract Metastases.
    J Clin Oncol. 2010.
    Abstract     Related articles   

  947. ARORA NK , Reeve BB, Hays RD, Clauser SB, et al
    Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective.
    J Clin Oncol. 2011;29:1280-9.
    Abstract     Related articles   

  948. HAHN NM , Stadler WM, Zon RT, Waterhouse D, et al
    Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.
    J Clin Oncol. 2011;29:1525-30.
    Abstract     Related articles   

  949. NEVES TR , Soares MJ, Monteiro PG, Lima MS, et al
    Basaloid squamous cell carcinoma in the urinary bladder with small-cell carcinoma.
    J Clin Oncol. 2011;29:e440-2.
    Abstract     Related articles   

  950. KAUR-KNUDSEN D , Bojesen SE, Tybjaerg-Hansen A, Nordestgaard BG, et al
    Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study.
    J Clin Oncol. 2011;29:2875-82.
    Abstract     Related articles   

  951. STADLER WM , Lerner SP, Groshen S, Stein JP, et al
    Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
    J Clin Oncol. 2011;29:3443-9.
    Abstract     Related articles   

  952. DIZDAR O , Demirci U
    p53 Status in Locally Advanced Bladder Cancer.
    J Clin Oncol. 2011.
    Abstract     Related articles   

  953. KHADJAVI A , Barbero G, Destefanis P, Mandili G, et al
    Evidence of Abnormal Tyrosine Phosphorylated Proteins in the Urine of Patients With Bladder Cancer: The Road Toward a New Diagnostic Tool?
    J Urol. 2011.
    Abstract     Related articles   

  954. SIROY AE , MacLennan GT
    Primary melanoma of the bladder.
    J Urol. 2011;185:1096-7.
    Abstract     Related articles   

  955. YOUSSEF RF , Shariat SF, Kapur P, Kabbani W, et al
    Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder.
    J Urol. 2011;185:1112-7.
    Abstract     Related articles   

  956. MAEDA T , Kikuchi E, Matsumoto K, Miyajima A, et al
    Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor.
    J Urol. 2011;185:802-6.
    Abstract     Related articles   

  957. ABDOLLAH F , Sun M, Shariat SF, Schmitges J, et al
    The Importance of Pelvic Lymph Node Dissection in the Elderly Population: Implications for Interpreting the 2010 National Comprehensive Cancer Network Practice Guidelines for Bladder Cancer Treatment.
    J Urol. 2011.
    Abstract     Related articles   

  958. CHAN ES , Patel AR, Larchian WA, Heston WD, et al
    In Vivo Targeted Contrast Enhanced Micro-Ultrasound to Measure Intratumor Perfusion and Vascular Endothelial Growth Factor Receptor 2 Expression in a Mouse Orthotopic Bladder Cancer Model.
    J Urol. 2011.
    Abstract     Related articles   

  959. WILLIAMSON SR , Cheng L
    Perivascular epithelioid cell tumor of the bladder.
    J Urol. 2011;185:1473-4.
    Abstract     Related articles   

  960. HOTALING JM , Wright JL, Pocobelli G, Bhatti P, et al
    Long-term use of supplemental vitamins and minerals does not reduce the risk of urothelial cell carcinoma of the bladder in the VITamins And Lifestyle study.
    J Urol. 2011;185:1210-5.
    Abstract     Related articles   

  961. ZUIVERLOON TC , Tjin SS, Busstra M, Bangma CH, et al
    Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based FGFR3 Mutation Assay.
    J Urol. 2011.
    Abstract     Related articles   

  962. PILCHOWSKI R , Stohr R, von Eggeling F, Hartmann A, et al
    Specific Protein Patterns Characterize Metastatic Potential of Advanced Bladder Cancer.
    J Urol. 2011.
    Abstract     Related articles   

  963. MCKIERNAN JM , Barlow LJ, Laudano MA, Mann MJ, et al
    A Phase I Trial of Intravesical Nanoparticle Albumin-Bound Paclitaxel in the Treatment of Bacillus Calmette-Guerin Refractory Nonmuscle Invasive Bladder Cancer.
    J Urol. 2011.
    Abstract     Related articles   

  964. YAMAMOTO H , Sutoh M, Hatakeyama S, Hashimoto Y, et al
    Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells.
    J Urol. 2011;185:1930-8.
    Abstract     Related articles   

  965. AYARI C , Bergeron A, LaRue H, Menard C, et al
    Toll-like receptors in normal and malignant human bladders.
    J Urol. 2011;185:1915-21.
    Abstract     Related articles   

  966. MALLIN K , David KA, Carroll PR, Milowsky MI, et al
    Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007).
    J Urol. 2011;185:1631-6.
    Abstract     Related articles   

  967. CROCKETT DG , Wagner DG, Holmang S, Johansson SL, et al
    Upper urinary tract carcinoma in Lynch syndrome cases.
    J Urol. 2011;185:1627-30.
    Abstract     Related articles   

  968. STROPE SA
    Editorial comment.
    J Urol. 2011;185:1626.
    Abstract     Related articles   

  969. ITO Y , Kikuchi E, Tanaka N, Miyajima A, et al
    Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma.
    J Urol. 2011;185:1621-6.
    Abstract     Related articles   

  970. KIM WJ , Lee JW, Quan C, Youn HJ, et al
    Nicotinamide inhibits growth of carcinogen induced mouse bladder tumor and human bladder tumor xenograft through up-regulation of RUNX3 and p300.
    J Urol. 2011;185:2366-75.
    Abstract     Related articles   

  971. HAUTMANN RE , de Petriconi RC, Volkmer BG
    25 years of experience with 1,000 neobladders: long-term complications.
    J Urol. 2011;185:2207-12.
    Abstract     Related articles   

  972. DALBAGNI G , Bochner BH, Cronin A, Herr HW, et al
    A plea for a uniform surveillance schedule after radical cystectomy.
    J Urol. 2011;185:2091-6.
    Abstract     Related articles   

  973. JEONG IG , You D, Kim JW, Song C, et al
    Outcomes of single lymph node positive urothelial carcinoma after radical cystectomy.
    J Urol. 2011;185:2085-90.
    Abstract     Related articles   

  974. ABDOLLAH F , Schmitges J, Sun M, Thuret R, et al
    Hospital and Surgical Caseload are Predictors of Comprehensive Surgical Treatment for Bladder Cancer: A Population Based Study.
    J Urol. 2011.
    Abstract     Related articles   

  975. MORGAN TM , Keegan KA, Barocas DA, Ruhotina N, et al
    Predicting the Probability of 90-Day Survival of Elderly Patients With Bladder Cancer Treated With Radical Cystectomy.
    J Urol. 2011.
    Abstract     Related articles   

  976. ZEHNDER P , Studer UE, Skinner EC, Dorin RP, et al
    Super Extended Versus Extended Pelvic Lymph Node Dissection in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Comparative Study.
    J Urol. 2011.
    Abstract     Related articles   

  977. MIOCINOVIC R , Gong MC, Ghoneim IA, Fergany AF, et al
    Presacral and Retroperitoneal Lymph Node Involvement in Urothelial Bladder Cancer: Results of a Prospective Mapping Study.
    J Urol. 2011.
    Abstract     Related articles   

  978. BHALANI SM , Casalino DD, Manvar AM
    Paraganglioma of the bladder.
    J Urol. 2011;186:279-80.
    Abstract     Related articles   

  979. NEUTSCH L , Plattner VE, Polster-Wildhofen S, Zidar A, et al
    Lectin Mediated Biorecognition as a Novel Strategy for Targeted Delivery to Bladder Cancer.
    J Urol. 2011.
    Abstract     Related articles   

  980. SELMAN SH , Keck RW
    A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model.
    J Urol. 2011;186:702-6.
    Abstract     Related articles   

  981. GOLAN S , Sopov V, Baniel J, Groshar D, et al
    Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
    J Urol. 2011;186:436-41.
    Abstract     Related articles   

  982. RODRIGUEZ FABA O , Palou J, Rosales A, Breda A, et al
    Clinical predictive factors of poor outcome in patients with stage pT0 disease at radical cystectomy.
    J Urol. 2011;186:442-7.
    Abstract     Related articles   

  983. WOSNITZER MS , Domingo-Domenech J, Castillo-Martin M, Ritch C, et al
    Predictive Value of Microtubule Associated Proteins Tau and Stathmin in Patients With Nonmuscle Invasive Bladder Cancer Receiving Adjuvant Intravesical Taxane Therapy.
    J Urol. 2011.
    Abstract     Related articles   

  984. JEON HG , Yoon CY, Yu JH, Park MJ, et al
    Induction of Caspase Mediated Apoptosis and Down-Regulation of Nuclear Factor-kappaB and Akt Signaling are Involved in the Synergistic Antitumor Effect of Gemcitabine and the Histone Deacetylase Inhibitor Trichostatin A in Human Bladder Cancer Cells.
    J Urol. 2011.
    Abstract     Related articles   

  985. WOOD DP
    Re: long-term follow-up of t1 high-grade bladder cancer after intravesical bacille calmette-guerin treatment.
    J Urol. 2011;186:1809-10.
    Abstract     Related articles   

  986. WOOD DP
    Re: Long-Term Outcomes of a Randomized Controlled Trial Comparing Thermochemotherapy With Mitomycin-C Alone as Adjuvant Treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC).
    J Urol. 2011;186:1808-9.
    Abstract     Related articles   

  987. BRAUSI M , Witjes JA, Lamm D, Persad R, et al
    A Review of Current Guidelines and Best Practice Recommendations for the Management of Nonmuscle Invasive Bladder Cancer by the International Bladder Cancer Group.
    J Urol. 2011.
    Abstract     Related articles   

  988. KAMAT AM
    Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Con.
    J Urol. 2011;186:788-9.
    Abstract     Related articles   

  989. ROSEVEAR HM , Lightfoot AJ, Birusingh KK, Maymi JL, et al
    Factors affecting response to bacillus Calmette-Guerin plus interferon for urothelial carcinoma in situ.
    J Urol. 2011;186:817-23.
    Abstract     Related articles   

  990. HERR HW
    Is repeat transurethral resection needed for minimally invasive T1 urothelial cancer? Pro.
    J Urol. 2011;186:787-8.
    Abstract     Related articles   

  991. HUSMANN D
    Editorial comment.
    J Urol. 2011;186.
    Abstract     Related articles   

  992. FRANKE EI , Misseri R, Cain MP, Kaefer M, et al
    Nephrogenic adenoma in the augmented bladder.
    J Urol. 2011;186.
    Abstract     Related articles   

  993. KOKOROWSKI PJ , Routh JC, Borer JG, Estrada CR, et al
    Screening for malignancy after augmentation cystoplasty in children with spina bifida: a decision analysis.
    J Urol. 2011;186:1437-43.
    Abstract     Related articles   

  994. SERRETTA V
    Re: Urinary pH is highly associated with tumor recurrence during intravesical mitomycin C therapy for nonmuscle invasive bladder tumor. T. Maeda, E. Kikuchi, K. Matsumoto, A. Miyajima and M. Oya. J Urol 2011; 185: 802-806.
    J Urol. 2011;186:1557.
    Abstract     Related articles   

  995. WOOD DP
    Re: Two Instillations of Epirubicin as Prophylaxis for Recurrence After Transurethral Resection of Ta and T1 Transitional Cell Bladder Cancer: A Prospective, Randomized Controlled Study.
    J Urol. 2011;185:1644.
    Abstract     Related articles   

  996. WOOD DP
    Re: Practice Patterns and Recurrence After Partial Cystectomy for Bladder Cancer.
    J Urol. 2011;185:1643.
    Abstract     Related articles   

  997. WOOD DP
    Re: Mechanisms of Recurrence of Ta/T1 Bladder Cancer.
    J Urol. 2011;185:1642.
    Abstract     Related articles   

  998. WOOD DP
    Re: Pathological Stage Review is Indicated in Primary pT1 Bladder Cancer.
    J Urol. 2011;185:468.
    Abstract     Related articles   

  999. WOOD DP
    Re: Gene Signatures for the Prediction of Response to Bacillus Calmette-Guerin Immunotherapy in Primary pT1 Bladder Cancers.
    J Urol. 2011;185:468-469.
    Abstract     Related articles   

  1000. GRIEBLING TL
    Re: Impact of Patient Age on Outcome Following Bladder-Preserving Treatment for Non-Muscle-Invasive Bladder Cancer.
    J Urol. 2011;185:466-467.
    Abstract     Related articles   

  1001. TODENHOEFER T , Hennenlotter J, Witstruk M, Gakis G, et al
    Influence of Renal Excretory Function on the Performance of Urine Based Markers to Detect Bladder Cancer.
    J Urol. 2011.
    Abstract     Related articles   

  1002. MONTIE JE
    Re: effect of a minimum lymph node policy in radical cystectomy and pelvic lymphadenectomy on lymph node yields, lymph node positivity rates, lymph node density, and survivorship in patients with bladder cancer.
    J Urol. 2011;185:103.
    Abstract     Related articles   

  1003. MONTIE JE
    Re: gemcitabine versus bacille calmette-guerin after initial bacille calmette-guerin failure in non-muscle-invasive bladder cancer: a multicenter prospective randomized trial.
    J Urol. 2011;185:101-2.
    Abstract     Related articles   

  1004. VAN RHIJN BW , Kwast TH, Liu L, Fleshner NE, et al
    The FGFR3 Mutation is Related to Favorable pT1 Bladder Cancer.
    J Urol. 2011.
    Abstract     Related articles   

  1005. SALINAS-SANCHEZ AS , Donate-Moreno MJ, Lopez-Garrido MP, Gimenez-Bachs JM, et al
    Role of CYP1B1 Gene Polymorphisms in Bladder Cancer Susceptibility.
    J Urol. 2011.
    Abstract     Related articles   

  1006. ESWARA JR , Efstathiou JA, Heney NM, Paly J, et al
    Complications and Long-Term Results of Salvage Cystectomy After Failed Bladder Sparing Therapy for Muscle Invasive Bladder Cancer.
    J Urol. 2011.
    Abstract     Related articles   

  1007. HERR HW
    Intravesical Bacillus Calmette-Guerin Outcomes in Patients With Bladder Cancer and Asymptomatic Bacteriuria.
    J Urol. 2011.
    Abstract     Related articles   

  1008. REIS LO , Ferreira U, Billis A, Cagnon VH, et al
    Anti-Angiogenic Effects of the Superantigen Staphylococcal Enterotoxin B and Bacillus Calmette-Guerin Immunotherapy for Nonmuscle Invasive Bladder Cancer.
    J Urol. 2011.
    Abstract     Related articles   

  1009. MEIJER RP , Nunnink CJ, Wassenaar AE, Bex A, et al
    Standard Lymph Node Dissection for Bladder Cancer: Significant Variability in the Number of Reported Lymph Nodes.
    J Urol. 2011.
    Abstract     Related articles   

  1010. SHARIAT SF , Chromecki TF, Cha EK, Karakiewicz PI, et al
    Risk Stratification of Organ Confined Bladder Cancer After Radical Cystectomy Using Cell Cycle Related Biomarkers.
    J Urol. 2011.
    Abstract     Related articles   

  1011. KILTIE AE
    Using Gene Polymorphisms to Assess Bladder Cancer Risk: Progress and Challenges.
    J Urol. 2011.
    Abstract     Related articles   

  1012. SUGANO G , Bernard-Pierrot I, Lae M, Battail C, et al
    Milk fat globule--epidermal growth factor--factor VIII (MFGE8)/lactadherin promotes bladder tumor development.
    Oncogene. 2011;30:642-53.
    Abstract     Related articles   

  1013. SAYAN AE , Stanford R, Vickery R, Grigorenko E, et al
    Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL.
    Oncogene. 2011 Aug 8. doi: 10.1038/onc.2011.
    Abstract     Related articles   

  1014. LI F , Yang W, Guo D, Hu Z, et al
    LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.
    Oncol Rep. 2011 Mar 22. doi: 10.3892/or.2011.1227.
    Abstract     Related articles   

  1015. TAO J , Lu Q, Wu D, Li P, et al
    microRNA-21 modulates cell proliferation and sensitivity to doxorubicin in bladder cancer cells.
    Oncol Rep. 2011 Apr 4. doi: 10.3892/or.2011.1245.
    Abstract     Related articles   

  1016. AWSARE NS , Martin TA, Haynes MD, Matthews PN, et al
    Claudin-11 decreases the invasiveness of bladder cancer cells.
    Oncol Rep. 2011 Apr 4. doi: 10.3892/or.2011.1244.
    Abstract     Related articles   

  1017. YOSHITOMI T , Kawakami K, Enokida H, Chiyomaru T, et al
    Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
    Oncol Rep. 2011 Apr 8. doi: 10.3892/or.2011.1253.
    Abstract     Related articles   

  1018. MIYAKE M , Fujimoto K, Anai S, Ohnishi S, et al
    Heme oxygenase-1 promotes angiogenesis in urothelial carcinoma of the urinary bladder.
    Oncol Rep. 2011;25:653-60.
    Abstract     Related articles   

  1019. LI F , Ye ZQ, Guo DS, Yang WM, et al
    Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1.
    Oncol Rep. 2011 May 10. doi: 10.3892/or.2011.1304.
    Abstract     Related articles   

  1020. HONG SH , Choi YH
    Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells.
    Oncol Rep. 2011 Sep 7. doi: 10.3892/or.2011.1451.
    Abstract     Related articles   

  1021. FERRO M , Giuberti G, Zappavigna S, Perdona S, et al
    Chondroitin sulphate enhances the antitumor activity of gemcitabine and mitomycin-C in bladder cancer cells with different mechanisms.
    Oncol Rep. 2011 Oct 31. doi: 10.3892/or.2011.1526.
    Abstract     Related articles   

  1022. ZUO Q , Wu W, Li X, Zhao L, et al
    HDAC6 and SIRT2 promote bladder cancer cell migration and invasion by targeting cortactin.
    Oncol Rep. 2011 Nov 15. doi: 10.3892/or.2011.1553.
    Abstract     Related articles   

  1023. JIN Y , Murata H, Sakaguchi M, Kataoka K, et al
    Partial sensitization of human bladder cancer cells to a gene-therapeutic adenovirus carrying REIC/Dkk-3 by downregulation of BRPK/PINK1.
    Oncol Rep. 2011 Nov 10. doi: 10.3892/or.2011.1543.
    Abstract     Related articles   

  1024. COULANGE C
    [Cystoscopy].
    Prog Urol. 2010;20:822-6.
    Abstract     Related articles   

  1025. SAINT F , Quintens H, Roupret M, Amsellem-Ouazana D, et al
    [Diagnostic test for bladder cancer: The NMP22((R)).]
    Prog Urol. 2011;21:245-249.
    Abstract     Related articles   

  1026. PECOUX F , Fantoni JC, Berthon N, Lepage N, et al
    [Influence of occupational exposures in nonmuscle infiltration bladder cancer. Preliminary results of a prospective study from October2005 to February2009.]
    Prog Urol. 2011;21:405-411.
    Abstract     Related articles   

  1027. ISMAILI N , Amzerin M, Elmajjaoui S, Droz JP, et al
    [The role of chemotherapy in the management of bladder cancer.]
    Prog Urol. 2011;21:369-382.
    Abstract     Related articles   

  1028. DESCAZEAUD A
    [Highlights of the 2010 ERUS meeting, September 29 to October 1, 2010, Bordeaux, France].
    Prog Urol. 2011;21 Suppl 1:S1-6.
    Abstract     Related articles   

  1029. RAYNAL G
    [Oncological surgery and development: to refuse fate and search for prevention].
    Prog Urol. 2011;21:125.
    Abstract     Related articles   

  1030. NIANG L , Kane R, Labou I, Jalloh M, et al
    [Total cystectomies for cancers locally advanced of bladder about 12 cases in the service of urology of the general hospital of Grand-Yoff].
    Prog Urol. 2011;21:121-4.
    Abstract     Related articles   

  1031. PIGNOT G , Molinie V, Coloby P, Culine S, et al
    [New concepts in the management of MIBC in 2010].
    Prog Urol. 2011;21 Suppl 2:S38-42.
    Abstract     Related articles   

  1032. PIGNOT G , Irani J, Bastide C, Ravery V, et al
    [New concepts in management of NMIBC in 2010].
    Prog Urol. 2011;21 Suppl 2:S34-7.
    Abstract     Related articles   

  1033. BESSEDE T , Bigot P, Neuzillet Y, Pignot G, et al
    [The 2010 news: highlights of the ASCO-GU, UAE, ASCO, AUA congress...].
    Prog Urol. 2011;21 Suppl 2:S16-22.
    Abstract     Related articles   

  1034. COMPERAT E , Roupret M, Camparo P, Conort P, et al
    [Pathologic diagnosis and management of flat lesions of urothelium detected with aminolevulinic acid (Hexvix(R))].
    Prog Urol. 2011;21:157-65.
    Abstract     Related articles   

  1035. WALLERAND H , Roupret M, Larre S, Houede N, et al
    [Interest and terms of using fluorescence-guided cystoscopy in 2011 for bladder cancer management: Review of the French Urological Oncology Committee].
    Prog Urol. 2011;21:823-8.
    Abstract     Related articles   

  1036. ZECHA H , Schmid HP, Tschopp A, Sulser T, et al
    High incidence of independent second malignancies after non-muscle-invasive bladder cancer.
    Scand J Urol Nephrol. 2011.
    Abstract     Related articles   

  1037. GUDJONSSON S , Bendahl PO, Chebil G, Hoglund M, et al
    Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?
    Scand J Urol Nephrol. 2011.
    Abstract     Related articles   

  1038. RYK C , Wiklund NP, Nyberg T, De Verdier PJ, et al
    Ser608Leu polymorphisms in the nitric oxide synthase-2 gene may influence urinary bladder cancer pathogenesis.
    Scand J Urol Nephrol. 2011.
    Abstract     Related articles   

  1039. JENSEN JB , Hoyer S, Jensen KM
    Incidence of occult lymph-node metastasis missed by standard pathological examination in patients with bladder cancer undergoing radical cystectomy.
    Scand J Urol Nephrol. 2011.
    Abstract     Related articles   

  1040. JENSEN JB , Ulhoi BP, Jensen KM
    Prognostic value of lymph-node dissection in patients undergoing radical cystectomy following previous oncological treatment for bladder cancer.
    Scand J Urol Nephrol. 2011.
    Abstract     Related articles   

  1041. MALMSTROM PU , Grabe M, Haug ES, Hellstrom P, et al
    Role of hexaminolevulinate-guided fluorescence cystoscopy in bladder cancer: critical analysis of the latest data and European guidance.
    Scand J Urol Nephrol. 2011.
    Abstract     Related articles   

  1042. KONTOS S , Papatsoris A, Kominea A, Melachrinou M, et al
    Expression of ERbeta and Its Co-Regulators p300 and NCoR in Human Transitional Cell Bladder Cancer.
    Urol Int. 2011.
    Abstract     Related articles   

  1043. WU D , Tao J, Xu B, Qing W, et al
    Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells.
    Urol Int. 2011.
    Abstract     Related articles   

  1044. EKICI S , Eroglu A, Dogan Ekici AI, Turkeri L, et al
    Clusterin immunoreactivity as a predictive factor for progression of non-muscle-invasive bladder carcinoma.
    Urol Int. 2011;86:31-5.
    Abstract     Related articles   

  1045. DE PASQUALE V , Magistrelli A, Diomedi Camassei F, Caione P, et al
    Unusual bladder mass in a 14-year-old boy: bladder paraganglioma.
    Urol Int. 2011;86:117-20.
    Abstract     Related articles   

  1046. ODERDA M , Ruoppolo M, Marson F, Pisano F, et al
    Pathological features and adverse prognosis of a contemporary series of neuroendocrine bladder tumours.
    Urol Int. 2011;86:185-90.
    Abstract     Related articles   

  1047. SHAPUR N , Pode D, Katz R, Shapiro A, et al
    Predicting the Risk of High-Grade Bladder Cancer Using Noninvasive Data.
    Urol Int. 2011.
    Abstract     Related articles   

  1048. PHILIPPOU P , Kariotis I, Volanis D, Ploumides A, et al
    Plasmacytoid urothelial carcinoma of the bladder: a rare malignancy.
    Urol Int. 2011;86:370-2.
    Abstract     Related articles   

  1049. FECHNER G , Rogenhofer S, Hauser S, Muller SC, et al
    Evoluting the invaginated--one step closer to the perfect valve? Modified serosal lined tapered ileum (Kalble's procedure) as a continence mechanism for catheterizable pouches.
    Urol Int. 2011;86:269-72.
    Abstract     Related articles   

  1050. GUNIA S , May M, Koch S, Erbersdobler A, et al
    Is radical oncosurgery justified for the treatment of primary malignant fibrous histiocytoma of the urinary bladder? Report of two cases and analyses of disease-specific survival rates based on a review of the literature.
    Urol Int. 2011;86:261-8.
    Abstract     Related articles   

  1051. LIN Y , Sun G, Liu X, Chen Y, et al
    Clinical significance of T-cadherin tissue expression in patients with bladder transitional cell carcinoma.
    Urol Int. 2011;86:340-5.
    Abstract     Related articles   

  1052. WANG J , Wang FW
    Clinical characteristics and outcomes of patients with primary signet-ring cell carcinoma of the urinary bladder.
    Urol Int. 2011;86:453-60.
    Abstract     Related articles   

  1053. BRAUSI MA , Gontero P, Altieri V, Colombo R, et al
    Can Gemcitabine Instillation Ablate Solitary Low-Risk Non-Muscle-Invasive Bladder Cancer? Results of a Phase II Marker Lesion Study.
    Urol Int. 2011.
    Abstract     Related articles   

  1054. LI D , Liu H, Yan L, Tang Y, et al
    Lack of Association between hOGG1 Ser326Cys Polymorphism and the Risk of Bladder Cancer: A Meta-Analysis.
    Urol Int. 2011.
    Abstract     Related articles   

  1055. NUHN P , Bastian PJ, Novara G, Svatek RS, et al
    Concomitant carcinoma in situ in cystectomy specimens is not associated with clinical outcomes after surgery.
    Urol Int. 2011;87:42-8.
    Abstract     Related articles   

  1056. ZHU Y , Yu M, Li Z, Kong C, et al
    ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival.
    Urology. 2011;77:510.
    Abstract     Related articles   

  1057. LI Y , Yang X, Su LJ, Flaig TW, et al
    Pazopanib Synergizes with Docetaxel in the Treatment of Bladder Cancer Cells.
    Urology. 2011.
    Abstract     Related articles   

  1058. MONTGOMERY JS , Weizer AZ, Montie JE
    Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
    Urology. 2011;77:667-8.
    Abstract     Related articles   

  1059. DONAT SM
    Editorial comment. Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
    Urology. 2011;77:666-7.
    Abstract     Related articles   

  1060. LIBERMAN D , Lughezzani G, Sun M, Alasker A, et al
    Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
    Urology. 2011;77:660-6.
    Abstract     Related articles   

  1061. LAVELLE RS , Williams SB, O'Leary MP
    An 84-year-old female with gross hematuria.
    Urology. 2011;77:533-4.
    Abstract     Related articles   

  1062. TALAAT S , Somji S, Toni C, Garrett SH, et al
    Kindlin-2 Expression in Arsenite- and Cadmium-transformed Bladder Cancer Cell Lines and in Archival Specimens of Human Bladder Cancer.
    Urology. 2011;77:1507.
    Abstract     Related articles   

  1063. WEI B , Xu Z
    Re: Li et al.: XRCC3 T241M Polymorphism and Bladder Cancer Risk: A Meta-analysis (Urology 2011;77:e511-e515).
    Urology. 2011;78:237-8.
    Abstract     Related articles   

  1064. CHENG H , Luo C, Wu X, Zhang Y, et al
    shRNA Targeting PLCepsilon Inhibits Bladder Cancer Cell Growth In Vitro and In Vivo.
    Urology. 2011.
    Abstract     Related articles   

  1065. DONAT SM
    Re: Khan et al.: analysis of early complications of robotic-assisted radical cystectomy using a standardized reporting system (Urology 2011;77:357-362).
    Urology. 2011;77:1016-7.
    Abstract     Related articles   

  1066. SHAH AN , Uppal GS, Tappin MJ
    Bacille Calmette-Guerin and ocular inflammations.
    Urology. 2011;77:1014-5.
    Abstract     Related articles   

  1067. BASSI P
    Editorial comment.
    Urology. 2011;77:883.
    Abstract     Related articles   

  1068. SVATEK RS , Parekh DJ
    Editorial comment.
    Urology. 2011;77:876-7.
    Abstract     Related articles   

  1069. SAGALOWSKY AI
    Editorial comment.
    Urology. 2011;77:859.
    Abstract     Related articles   

  1070. GHONEIM IA , Miocinovic R, Stephenson AJ, Garcia JA, et al
    Neoadjuvant systemic therapy or early cystectomy? Single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder.
    Urology. 2011;77:867-70.
    Abstract     Related articles   

  1071. DING T , Wang YK, Cao YH, Yang LY, et al
    Clinical utility of fluorescence in situ hybridization for prediction of residual tumor after transurethral resection of bladder urothelial carcinoma.
    Urology. 2011;77:855-9.
    Abstract     Related articles   

  1072. SCHUMACHER MC , Jonsson MN, Hosseini A, Nyberg T, et al
    Surgery-related complications of robot-assisted radical cystectomy with intracorporeal urinary diversion.
    Urology. 2011;77:871-6.
    Abstract     Related articles   

  1073. YANG G , Whitson JM, Breyer BN, Konety BR, et al
    Oncological and functional outcomes of radical cystectomy and orthotopic bladder replacement in women.
    Urology. 2011;77:878-83.
    Abstract     Related articles   

  1074. YOUSSEF RF , Shariat SF, Lotan Y, Wood CG, et al
    Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma.
    Urology. 2011;77:861-6.
    Abstract     Related articles   

  1075. ZHANG X , Shi X, Li J, Hu Z, et al
    Novel Immunotherapy for Metastatic Bladder Cancer Using Vaccine of Human Interleukin-2 Surface-modified MB 49 Cells.
    Urology. 2011.
    Abstract     Related articles   

  1076. ALI-EL-DEIN B
    Editorial comment.
    Urology. 2011;77:1114-5.
    Abstract     Related articles   

  1077. YEE DS , Ishill NM, Lowrance WT, Herr HW, et al
    Ethnic Differences in Bladder Cancer Survival.
    Urology. 2011.
    Abstract     Related articles   

  1078. MARGEL D , Alkhateeb SS, Finelli A, Fleshner N, et al
    Diminished Efficacy of Bacille Calmette-Guerin Among Elderly Patients with Nonmuscle Invasive Bladder Cancer.
    Urology. 2011.
    Abstract     Related articles   

  1079. SKOLARUS TA , Ye Z, Montgomery JS, Weizer AZ, et al
    Use of Restaging Bladder Tumor Resection for Bladder Cancer Among Medicare Beneficiaries.
    Urology. 2011.
    Abstract     Related articles   

  1080. LEE CT , Mei M, Ashley J, Breslow G, et al
    Patient Resources Available to Bladder Cancer Patients: A Pilot Study of Healthcare Providers.
    Urology. 2011.
    Abstract     Related articles   

  1081. GUZZO TJ , Hockenberry MS, Mucksavage P, Bivalacqua TJ, et al
    Smoking Knowledge Assessment and Cessation Trends in Patients With Bladder Cancer Presenting to a Tertiary Referral Center.
    Urology. 2011.
    Abstract     Related articles   

  1082. PAPADOPOULOS G , Doumas K
    Re: Liberman et al.: Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder (Urology 2011;77:660-663).
    Urology. 2011;78:486-7.
    Abstract     Related articles   

  1083. HEMAL AK , Stansel I, Babbar P, Patel M, et al
    Robotic-assisted nephroureterectomy and bladder cuff excision without intraoperative repositioning.
    Urology. 2011;78:357-64.
    Abstract     Related articles   

  1084. MARIN-AGUILERA M , Mengual L, Ribal MJ, Ars E, et al
    Utility of Urothelial mRNA Markers in Blood for Staging and Monitoring Bladder Cancer.
    Urology. 2011.
    Abstract     Related articles   

  1085. WILLIAMS SB , Viani KL, Loughlin KR
    A 72-year-old male with left testicular pain. Diagnosis: BCG granuloma of the epididymis.
    Urology. 2011;78:505-7.
    Abstract     Related articles   

  1086. GREEN WJ , James PA, Ratan HL
    Potential use of RNA interference as therapeutic strategy in urologic cancer.
    Urology. 2011;78:500-4.
    Abstract     Related articles   

  1087. SALEM HK , Mahfouz S
    Changing Patterns (Age, Incidence, and Pathologic Types) of Schistosoma-associated Bladder Cancer in Egypt in the Past Decade.
    Urology. 2011.
    Abstract     Related articles   

  1088. TAKAHASHI H , Nakatsuji H, Takahashi M, Avirmed S, et al
    Up-regulation of Plakophilin-2 and Down-regulation of Plakophilin-3 are Correlated with Invasiveness in Bladder Cancer.
    Urology. 2011.
    Abstract     Related articles   

  1089. XU Z , Wei B, Ruan J, Zhu M, et al
    Re: Cheng et al.: shRNA Targeting PLC Inhibits Bladder Cancer Cell Growth In Vitro and In Vivo (Urology 2011;78:474e.7-474e.11).
    Urology. 2011;78:1446-7.
    Abstract     Related articles   

  1090. LI F , An SL, Zhou Y, Liang ZK, et al
    Milk and Dairy Consumption and Risk of Bladder Cancer: A Meta-analysis.
    Urology. 2011;78:1298-305.
    Abstract     Related articles   

  1091. LAMM DL
    Editorial comment.
    Urology. 2011;78:854-5.
    Abstract     Related articles   

  1092. FLAIG TW , Wilson S, van Bokhoven A, Varella-Garcia M, et al
    Detection of circulating tumor cells in metastatic and clinically localized urothelial carcinoma.
    Urology. 2011;78:863-7.
    Abstract     Related articles   

  1093. ROUISSI K , Ben Bahria I, Bougatef K, Marrakchi R, et al
    The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.
    BMC Cancer. 2011;11:101.
    Abstract     Related articles   

  1094. LAUSS M , Frigyesi A, Ryden T, Hoglund M, et al
    Robust assignment of cancer subtypes from expression data using a uni-variate gene expression average as classifier.
    BMC Cancer. 2010;10:532.
    Abstract     Related articles   

  1095. PEUHU E , Kaunisto A, Laihia JK, Leino L, et al
    Molecular targets for the protodynamic action of cis-urocanic acid in human bladder carcinoma cells.
    BMC Cancer. 2010;10:521.
    Abstract     Related articles   

  1096. NORDENTOFT I , Dyrskjot L, Bodker JS, Wild PJ, et al
    Increased expression of Transcription Factor TFAP2 alpha correlates with chemosensitivity in advanced bladder cancer.
    BMC Cancer. 2011;11:135.
    Abstract     Related articles   

  1097. YEH CY , Shih SM, Yeh HH, Wu TJ, et al
    Transcriptional activation of the Axl and PDGFR-alpha by c-Met through a ras- and Src-independent mechanism in human bladder cancer.
    BMC Cancer. 2011;11:139.
    Abstract     Related articles   

  1098. MURALI A , Kasman LM, Voelkel-Johnson C
    Adenoviral infectivity of Exfoliated Viable Cells in Urine: Implications for the Detection of Bladder Cancer.
    BMC Cancer. 2011;11:168.
    Abstract     Related articles   

  1099. ABDEL RAHEEM AM , Hameed DA, ElGanainy EO, Mosad E, et al
    Can Bcl-XL expression predict the radio sensitivity of bilharzial-related squamous bladder carcinoma? A prospective comparative study.
    BMC Cancer. 2011;11:16.
    Abstract     Related articles   

  1100. DATTA A , Adelson ME, Mogilevkin Y, Mordechai E, et al
    Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer.
    BMC Cancer. 2011;11:234.
    Abstract     Related articles   


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Pierre Fabre.

Design:


;